Date,Agency,Category,Information,Link
7. July 2025,Council for International Organizations of Medical Sciences,Guidance,"Version 2.3 of the CIOMS cumulative glossary with a focus on pharmacovigilance",
7. July 2025,European Commission,Guidance,"EUDAMED Production Release 2.15.0",https://www.linkedin.com/feed/update/urn:li:activity:7345365726276251648?  
7. July 2025,"European Directorate for the Quality of Medicines & HealthCare EDQM",Guidance,"Pharmeuropa 37.3 just released",https://www.linkedin.com/feed/update/urn:li:activity:7346082914004086784?
7. July 2025,European Medicines Agency,Report,"Real-world evidence framework to support EU regulatory decision-making",https://www.linkedin.com/feed/update/urn:li:activity:7345718149930991616?
7. July 2025,European Medicines Agency,Information Sheet,"Review of real-world data studies",https://www.linkedin.com/feed/update/urn:li:activity:7345719177002803202? 
7. July 2025,European Medicines Agency,Guidance,ICH E20 Adaptive Designs for Clinical Trials,https://www.linkedin.com/feed/update/urn:li:activity:7345719652443971584?
7. July 2025,European Medicines Agency,"Regulation,Regulation (EC) No 1234/2008 as amended (The Variations Regulation)",https://www.linkedin.com/feed/update/urn:li:activity:7345720242301509632?
7. July 2025,European Medicines Agency,Form,"Declaration Enterprise as a Micro Small or Medium-sized Enterprise (SME)"
7. July 2025,Health Canada,Guidance,"Summary of ICH Guidelines – Health Canada (June 2025) Implemented"
7. July 2025,"Health Products Regulatory Authority (HPRA), Ireland",Guidance,"Reporting Serious Adverse Reactions and Serious Adverse Events Associated with Human Tissues and Cells",https://www.linkedin.com/feed/update/urn:li:activity:7346547851847499776?
7. July 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Types of application for marketing authorisations (legal basis of applications)
7. July 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Standardised format for the periodic safety update report,https://www.linkedin.com/feed/update/urn:li:activity:7346495265656233985?
7. July 2025,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,Medical Device Industry Standard Information Sheet,https://www.linkedin.com/feed/update/urn:li:activity:7345720965512790018?
7. July 2025,Swissmedic,Form,Swissmedic Forms for July 2025
7. July 2025,Swissmedic,Guidance,Injectable products for wrinkle treatment
7. July 2025,Swissmedic,Guidance,Products without an intended medical purpose
7. July 2025,Swissmedic,Guidance,Safety Reporting in clinical trials
7. July 2025,Swissmedic,Guidance,Requirements for the return of medicinal products
7. July 2025,Swissmedic,Guidance,DHPC HMP
7. July 2025,Swissmedic,Guidance,RMP ICH E2E information submission HMP
7. July 2025,Swissmedic,Guidance,"Homeopathics, anthroposophics & complementary medicinal products"
7. July 2025,Swissmedic,Guidance,Transfer of marketing authorisation
7. July 2025,South African Health Products Regulatory Authority,Guidance,Variations Communication,https://www.linkedin.com/feed/update/urn:li:activity:7346434232405180420?
7. July 2025,"Team Notified Body, Europe",Guidance,Software classification under the IVDR V2,https://www.linkedin.com/feed/update/urn:li:activity:7345329303665930240? 
7. July 2025,"Team Notified Body, Europe",Guidance,Code of Conduct for Notified Bodies under Regulations (EU) 2017/745 and (EU) 2017/746,https://www.linkedin.com/feed/update/urn:li:activity:7345371736739078146?
7. July 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Preparing for Good Clinical Practice (GCP) inspections,https://www.linkedin.com/feed/update/urn:li:activity:7346084081207533570?
7. July 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Changing the sponsor of a therapeutic good,https://www.linkedin.com/feed/update/urn:li:activity:7346083577765261313?
7. July 2025,USA Food & Drug Administration FDA,Guidance,"Myelodysplastic Syndromes: Developing Drug and Biological Products for Treatment",https://www.linkedin.com/feed/update/urn:li:activity:7346421367736573952?
7. July 2025,USA Food & Drug Administration FDA,Guidance,"Small Volume Parenteral Drug Products and Pharmacy Bulk Packages for Parenteral Nutrition: Aluminum Content and Labeling",https://www.linkedin.com/feed/update/urn:li:activity:7346415743980232704?
 7. July 2025,ISO (International Organization for Standardization),Standards,"ISO Update June 1. 2025 to July 1. 2025",https://www.linkedin.com/feed/update/urn:li:activity:7347867058375712768?
 7. July 2025,Medicines and Healthcare products Regulatory Agency,Guidance,"Medical devices: UK approved bodies",https://www.linkedin.com/feed/update/urn:li:activity:7347914477750697984?
 7. July 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,"Updated 'medical devices exempt from PFAS ban' to include other therapeutic goods",https://www.linkedin.com/feed/update/urn:li:activity:7347916496490119168?
 7. July 2025,"Health Sciences Authority (HSA), Singapore",Guidance,"GN-21 Guidance on Change Notification for Registered Medical Devices Rev 6.",https://www.linkedin.com/feed/update/urn:li:activity:7347915438732787714? 
 7. July 2025,MedTech Leading Voice,Newsletter,Medical Literature Review Guide,https://www.linkedin.com/feed/update/urn:li:activity:7347851869278420992?
5. July 2025,MedTech Leading Voice,Video,"The QA/RA Week That Was – 5. July 2025",https://www.linkedin.com/feed/update/urn:li:activity:7347227981137764353?
4. July 2025,MedTech Leading Voice,Video,"Preview Regulatory Roundup Monday 7. July 2025",https://www.linkedin.com/feed/update/urn:li:activity:7346779897538723840? 
3. July 2025,"Health Products Regulatory Authority (HPRA), Ireland",Guidance,"Reporting Serious Adverse Reactions and Serious Adverse Events Associated with Human Tissues and Cells",https://www.linkedin.com/feed/update/urn:li:activity:7346547851847499776?
3. July 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Standardised format for the periodic safety update report,https://www.linkedin.com/feed/update/urn:li:activity:7346495265656233985?
3. July 2025,South African Health Products Regulatory Authority,Guidance,Variations Communication,https://www.linkedin.com/feed/update/urn:li:activity:7346434232405180420?
3. July 2025,MedTech Leading Voice,Prompt-Sheet,How to Rebuild your Linkedin Profile,https://www.linkedin.com/feed/update/urn:li:activity:7346419002497282048? 
3. July 2025,USA Food & Drug Administration FDA,Guidance,"Myelodysplastic Syndromes: Developing Drug and Biological Products for Treatment",https://www.linkedin.com/feed/update/urn:li:activity:7346421367736573952?
3. July 2025,USA Food & Drug Administration FDA,Guidance,"Small Volume Parenteral Drug Products and Pharmacy Bulk Packages for Parenteral Nutrition: Aluminum Content and Labeling",https://www.linkedin.com/feed/update/urn:li:activity:7346415743980232704?
2. July 2025,MedTech Leading Voice,Video,"The QA/RA Month That Was: June 2025",https://www.linkedin.com/feed/update/urn:li:activity:7346178552775532544?
2. July 2025,MedTech Leading Voice,Flipbook,A brief guide to user needs,https://www.linkedin.com/feed/update/urn:li:activity:7346086377177931777?
2. July 2025,MedTech Leading Voice,Video,A brief guide to user needs,https://www.linkedin.com/feed/update/urn:li:activity:7346055157597528064?
2. July 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Preparing for Good Clinical Practice (GCP) inspections,https://www.linkedin.com/feed/update/urn:li:activity:7346084081207533570?
2. July 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Changing the sponsor of a therapeutic good,https://www.linkedin.com/feed/update/urn:li:activity:7346083577765261313?
2. July 2025,European Directorate for the Quality of Medicines & HealthCare EDQM,Guidance,Pharmeuropa 37.3 just released,https://www.linkedin.com/feed/update/urn:li:activity:7346082914004086784?
2. July 2025,European Medicines Agency,Guidance,Medicinal Product master data for better regulation and better health,https://www.linkedin.com/feed/update/urn:li:activity:7346081972554723329?
2. July 2025,MedTech Leading Voice,Video,"The QA/RA Month That Was: June 2025",https://www.linkedin.com/feed/update/urn:li:activity:7346178552775532544?
1. July 2025,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,Medical Device Industry Standard Information Sheet,https://www.linkedin.com/feed/update/urn:li:activity:7345720965512790018?
1. July 2025,European Medicines Agency,"Regulation,Regulation (EC) No 1234/2008 as amended ('The Variations Regulation')",https://www.linkedin.com/feed/update/urn:li:activity:7345720242301509632?
1. July 2025,European Medicines Agency,Guidance,ICH E20 Adaptive Designs for Clinical Trials,https://www.linkedin.com/feed/update/urn:li:activity:7345719652443971584?
1. July 2025,European Medicines Agency,Information Sheet,Review of real-world data studies,https://www.linkedin.com/feed/update/urn:li:activity:7345719177002803202? 
1. July 2025,European Medicines Agency,Report,"Real-world evidence framework to support EU regulatory decision-making",https://www.linkedin.com/feed/update/urn:li:activity:7345718149930991616?
 30. June 2025,MedTech Leading Voice,Roundup,Regulatory Roundup 30. June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7345405781271359488?
 30. June 2025,Team-NB,Position Paper,Code of Conduct for Notified Bodies under Regulations (EU) 2017/745 and (EU) 2017/746,https://www.linkedin.com/feed/update/urn:li:activity:7345371736739078146?
 30. June 2025,Team-NB,Position Paper,Software classification under the IVDR V2,https://www.linkedin.com/feed/update/urn:li:activity:7345329303665930240? 
 30. June 2025,MedTech Leading Voice,Newsletter,EU AI Act,https://www.linkedin.com/feed/update/urn:li:activity:7345306735047262208?
 30. June 2025,European Commission,Guidance,EUDAMED Production Release 2.15.0,https://www.linkedin.com/feed/update/urn:li:activity:7345365726276251648? 
30. June 2025,ANVISA Brazil,Report,Clinical Research of Drugs and Biological Products,https://www.linkedin.com/feed/update/urn:li:activity:7343524329642467329?
30. June 2025,Egyptian Drug Authority,Guidance,Issuing a notification for import approval or a letter of lack of competence,
30. June 2025,European Commission,Status Overview,Overview of CABs/NBs at each stage of the designation process,https://www.linkedin.com/feed/update/urn:li:activity:7341848915182338053?
30. June 2025,European Commission,Regulation,(EU) 2021/2226 medical devices IFU may be provided in electronic form,https://www.linkedin.com/feed/update/urn:li:activity:7343986300032626688?
30. June 2025,European Medicines Agency,Guidance,Expert decision and opinion Clinical Evaluation Consultation Procedure (CECP),https://www.linkedin.com/feed/update/urn:li:activity:7343908377736998913?
30. June 2025,Health Canada,Guidance,New requirements for second language product monographs and package insert,
30. June 2025,Health Canada,Guidance,"Submission information for biologic drugs (Division 4, Schedule D)",https://www.linkedin.com/feed/update/urn:li:activity:7343548592986488833?
30. June 2025,"Health Products Regulatory Authority (HPRA), Ireland",Guidance,Parallel Imports of Human Medicines,
30. June 2025,"Health Sciences Authority (HSA), Singapore",Guidance,"Introducing ""SHARE"" - Your digital portal for Medical Devices",https://www.linkedin.com/feed/update/urn:li:activity:7343505906417983488? 
30. June 2025,International Council for Harmonisation,Guidance,ICH E20 Adaptive Designs for Clinical Trials,https://www.linkedin.com/feed/update/urn:li:activity:7343912240258932738?
30. June 2025,International Council for Harmonisation,Guidance,ICH M4Q(R2) Step 2 Presentation Now Available on the ICH Website,
30. June 2025,Medicines and Healthcare products Regulatory Agency,Collection,Airlock: the regulatory sandbox for AIaMD,https://www.linkedin.com/feed/update/urn:li:activity:7342854372608909313?
30. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Introducing new medicines in the NHS in the UK pathway,https://www.linkedin.com/feed/update/urn:li:activity:7342864280775536640?
30. June 2025,Medicines and Healthcare products Regulatory Agency,Report,Business Plan 2025-2026,
30. June 2025,Medicines and Healthcare products Regulatory Agency,Report,MHRA Corporate Plan 2023-26,
30. June 2025,Medicines and Healthcare products Regulatory Agency,Collection,Medicines: clinical trials hub,
30. June 2025,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,In Vitro Diagnostic Reagents Exempted from Clinical Trials (2025) (No. 23 [2025]),https://www.linkedin.com/feed/update/urn:li:activity:7343197289072517121?
30. June 2025,Swissmedic,Forms,Swissmedic Forms for June 2025,
30. June 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,"Application to import, supply, or export, non-compliant medical devices",https://www.linkedin.com/feed/update/urn:li:activity:7343179383840366592?
30. June 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,"Determining if your product is a cosmetic, a biological or a blood component",https://www.linkedin.com/feed/update/urn:li:activity:7344244654877425665?
30. June 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Medical devices exempt from PFAS ban,https://www.linkedin.com/feed/update/urn:li:activity:7344243141807357958?
30. June 2025,USA Food & Drug Administration FDA,Guidance,Q1 Stability Testing of Drug Substances and Drug Products,https://www.linkedin.com/feed/update/urn:li:activity:7343174428660232193?
30. June 2025,USA Food & Drug Administration FDA,Guidance,Early Lyme Disease as Manifested by Erythema Migrans,https://www.linkedin.com/feed/update/urn:li:activity:7343910438222409729?
30. June 2025,USA Food & Drug Administration FDA,Guidance,Conducting Remote Regulatory Assessments Questions and Answers,https://www.linkedin.com/feed/update/urn:li:activity:7344257468845240322?
30. June 2025,USA Food & Drug Administration FDA,Guidance,Unique Device Identifier Requirements for Combination Products,https://www.linkedin.com/feed/update/urn:li:activity:7344257085473275906?
30. June 2025,USA Food & Drug Administration FDA,Guidance,Cybersecurity in Medical Devices: Quality System Considerations,https://www.linkedin.com/feed/update/urn:li:activity:7344256677514297344?
30. June 2025,USA Food & Drug Administration FDA,Guidance,Antibacterial Therapies for Patients With an Unmet Medical Need Q&A,https://www.linkedin.com/feed/update/urn:li:activity:7344256310558777345?
30. June 2025,USA Food & Drug Administration FDA,Whitepaper,Securing Technology and Equipment Used for Medical Product Manufacturing,https://www.linkedin.com/feed/update/urn:li:activity:7344283687003324416?
28. June 2025,MedTech Leading Voice,Video,"The QA/RA Week That Was – 28. June 2025",https://www.linkedin.com/feed/update/urn:li:activity:7344682532711399424?
27. June 2025,MedTech Leading Voice,Roundup,Video Preview Regulatory Roundup 30. June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7344410176369664001?
27. June 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,"Determining if your product is a cosmetic, a biological or a blood component",https://www.linkedin.com/feed/update/urn:li:activity:7344244654877425665?
27. June 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Medical devices exempt from PFAS ban,https://www.linkedin.com/feed/update/urn:li:activity:7344243141807357958?
27. June 2025,USA Food & Drug Administration FDA,Guidance,Conducting Remote Regulatory Assessments Questions and Answers,https://www.linkedin.com/feed/update/urn:li:activity:7344257468845240322?
27. June 2025,USA Food & Drug Administration FDA,Guidance,Unique Device Identifier Requirements for Combination Products,https://www.linkedin.com/feed/update/urn:li:activity:7344257085473275906?
27. June 2025,USA Food & Drug Administration FDA,Guidance,Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions,https://www.linkedin.com/feed/update/urn:li:activity:7344256677514297344?
27. June 2025,USA Food & Drug Administration FDA,Guidance,Antibacterial Therapies for Patients With an Unmet Medical Need for the Treatment of Serious Bacterial Diseases – Questions and Answers,https://www.linkedin.com/feed/update/urn:li:activity:7344256310558777345?
27. June 2025,USA Food & Drug Administration FDA,Whitepaper,Securing Technology and Equipment (Operational Technology) Used for Medical Product Manufacturing,https://www.linkedin.com/feed/update/urn:li:activity:7344283687003324416?
26. June 2025,European Commission,Regulation,(EU) 2025/1234 of 25 June 2025 amending Implementing Regulation (EU) 2021/2226 as regards the medical devices for which the instructions for use may be provided in electronic form,https://www.linkedin.com/feed/update/urn:li:activity:7343986300032626688?
26. June 2025,International Council for Harmonisation,Guidance,ICH E20 Adaptive Designs for Clinical Trials,https://www.linkedin.com/feed/update/urn:li:activity:7343912240258932738?
26. June 2025,USA Food & Drug Administration FDA,Guidance,Early Lyme Disease as Manifested by Erythema Migrans: Developing Drugs for Treatment,https://www.linkedin.com/feed/update/urn:li:activity:7343910438222409729?
26. June 2025,European Commission,Guidance,"Expert decision and opinion in the context of the Clinical Evaluation Consultation Procedure (CECP) Expert panels on medical devices and in vitro diagnostic devices (Expamed)
Mechanical Ventilator, Class IIb:",https://www.linkedin.com/feed/update/urn:li:activity:7343908377736998913?
25. June 2025,MedTech Leading Voice,Guidance,Video: How to Use GPT AI to assist with creating an Intended Use Statement,https://www.linkedin.com/feed/update/urn:li:activity:7343533459954425856?
25. June 2025,MedTech Leading Voice,Guidance,Flipbook: How to Use GPT AI to assist with creating an Intended Use Statement,https://www.linkedin.com/feed/update/urn:li:activity:7343533436239769600?
30. June 2025,Health Canada,Guidance,"Guidance document on submission information for biologic drugs (Division 4, Schedule D): Overview",https://www.linkedin.com/feed/update/urn:li:activity:7343548592986488833?
30. June 2025,ANVISA Brazil,Report,8th Annual Report on Clinical Research of Drugs and Biological Products,https://www.linkedin.com/feed/update/urn:li:activity:7343524329642467329?
30. June 2025,"Health Sciences Authority (HSA), Singapore",Guidance,Introducing 'SHARE' - Your digital portal for Medical Devices,https://www.linkedin.com/feed/update/urn:li:activity:7343505906417983488? 
30. June 2025,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,In Vitro Diagnostic Reagents Exempted from Clinical Trials (2025) (No. 23 [2025]),https://www.linkedin.com/feed/update/urn:li:activity:7343197289072517121?
30. June 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,"Viewing and responding to a notification from the dashboard about an application for consent to import, supply or export medical devices that do not meet the Essential Principles",https://www.linkedin.com/feed/update/urn:li:activity:7343179383840366592?
30. June 2025,USA Food & Drug Administration FDA,Guidance,Q1 Stability Testing of Drug Substances and Drug Products,https://www.linkedin.com/feed/update/urn:li:activity:7343174428660232193?
30. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Introducing new medicines in the NHS in the UK - pathway,https://www.linkedin.com/feed/update/urn:li:activity:7342864280775536640?
30. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,AI Airlock: the regulatory sandbox for AIaMD,https://www.linkedin.com/feed/update/urn:li:activity:7342854372608909313?
22. June 2025,MedTech Leading Voice,Newsletter,MDSAP Enters a New Era,https://www.linkedin.com/feed/update/urn:li:activity:7342781461676126209?
21. June 2025,European Commission,Overview,Overview of CABs/NBs at each stage of the designation process,https://www.linkedin.com/feed/update/urn:li:activity:7341848915182338053?
20. June 2025,MedTech Leading Voice,Roundup,Video Preview Regulatory Roundup 23. June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7341813319210610688?
19. June 2025,MedTech Leading Voice,Guidance,How to Use GPT AI to assist with an FMEA,https://www.linkedin.com/feed/update/urn:li:activity:7341539017978478595?
23. June 2025,Egyptian Drug Authority,Consultation,Requirements for manufacturing companies (IVD reagents/medical supplies),
23. June 2025,European Commission,Guidance,MDCG 2019-11 Rev.1 Guidance on Qualification and Classification of Software in Regulation (EU) 2017/745 – MDR and Regulation (EU) 2017/746 – IVDR,https://www.linkedin.com/feed/update/urn:li:activity:7340963175967739905?
23. June 2025,European Commission,Guidance,MDCG 2025-4 - Guidance on the safe making available of medical device software (MDSW) apps on online platforms (June 2025),https://www.linkedin.com/feed/update/urn:li:activity:7340602844833579008? 
23. June 2025,European Commission,Guidance,MDCG 2025-5 Questions & Answers regarding performance studies of in vitro diagnostic medical devices under regulation (EU) 2017/746,https://www.linkedin.com/feed/update/urn:li:activity:7341050283570982914?
23. June 2025,European Commission,Guidance,MDCG 2025-6 Interplay between the EU MDR EU IVDR and EU AI Act,https://www.linkedin.com/feed/update/urn:li:activity:7341688929370226691?
23. June 2025,European Medicines Agency,Guidance,Abbreviations used in EMA scientific committees & CMD documents,https://www.linkedin.com/feed/update/urn:li:activity:7340967046463057920?
23. June 2025,European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use (CHMP) 16-19 June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7341820248607649794?
23. June 2025,European Medicines Agency,Meeting,EMA Management Board: highlights of June 2025 meeting,https://www.linkedin.com/feed/update/urn:li:activity:7340659243701731329?
23. June 2025,European Medicines Agency,Guidance,Questions and Answers about the SEND proof-of-concept for industry,https://www.linkedin.com/feed/update/urn:li:activity:7340649173337149441? 
23. June 2025,European Medicines Agency,Guidance,Questions and answers for biological medicinal products,
23. June 2025,European Medicines Agency,Guidance,Quick guide for UPD notifications via the User interface and via email,
23. June 2025,European Medicines Agency,Guidance,Use of real-world data in non interventional studies for regulatory purposes,https://www.linkedin.com/feed/update/urn:li:activity:7340970629661110272?
23. June 2025,Health Canada,Bulletin,Cancellation of MDELs for non-compliance with annual licence review requirements:2025,https://www.linkedin.com/feed/update/urn:li:activity:7340260578713608192?
23. June 2025,Health Canada,Guidance,Data Protection under C.08.004.1 of the Food and Drug Regulations,https://www.linkedin.com/feed/update/urn:li:activity:7341707162584293376?
23. June 2025,ISO (International Organization for Standardization),Standards,ISO Update May 1. 2025 to June 1. 2025,https://www.linkedin.com/feed/update/urn:li:activity:7340655229979242496?
23. June 2025,Martin King,Guidance,How can GPT AI assist in building an FMEA?,https://www.linkedin.com/feed/update/urn:li:activity:7341534482098749441?
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Custom-made medical devices in Great Britain,
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Device specific vigilance guidance,
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Electronic Common Technical Document (eCTD) submissions update,https://www.linkedin.com/feed/update/urn:li:activity:7340980885329973248?
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Field safety notices: guidance for manufacturers,
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: examples of reportable incidents,
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: periodic safety update report,https://www.linkedin.com/feed/update/urn:li:activity:7341718273568174080?
23. June 2025,Medicines and Healthcare products Regulatory Agency,Collection,Medical devices: post-market surveillance,
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: post-market surveillance requirements,
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: get scientific advice from MHRA,https://www.linkedin.com/feed/update/urn:li:activity:7340978853525229568?
23. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,The Innovative Devices Access Pathway (IDAP),
23. June 2025,"MEDSAFE, New Zealand",Consultation,Guideline on the Bioequivalence of medicines,https://www.linkedin.com/feed/update/urn:li:activity:7340270643822690304?  
23. June 2025,Ministry of Food and Drug Safety of Republic of Korea,Report,"MFDS,the 2024 Medical Device Approval Report",https://www.linkedin.com/feed/update/urn:li:activity:7341773241566289920?
23. June 2025,South African Health Products Regulatory Authority,Guidance,Regulatory Information Management System Technical Files Website Upload,https://www.linkedin.com/feed/update/urn:li:activity:7340253705310535682?
23. June 2025,Swissmedic,Forms,Swissmedic Forms for June 2025,
23. June 2025,"Therapeutic Goods Administration (TGA), Australia",Report,Action Plan for Medical Devices - Final Progress Report Card: December 2024,https://www.linkedin.com/feed/update/urn:li:activity:7340241744812228608?
23. June 2025,USA Food & Drug Administration FDA,Guidance,ANDAs:Pre-Submission Facility Correspondence Related to Prioritized Generic Drug Submissions,https://www.linkedin.com/feed/update/urn:li:activity:7340247741014441984?
23. June 2025,USA Food & Drug Administration FDA,Guidance,Post-Warning Letter Meetings Under GDUFA,https://www.linkedin.com/feed/update/urn:li:activity:7341703063348371456?
16. June 2025,ANVISA Brazil,Regulation,"Ordinance GM/MS No. 6,931, of June 4, 2025",https://www.linkedin.com/feed/update/urn:li:activity:7339185196732178433?
16. June 2025,European Commission,Guidance,Health Technology Assessment Regulation Capacity Building,https://www.linkedin.com/feed/update/urn:li:activity:7338228815891951616?
16. June 2025,European Commission,Regulation,Master UDI-DI for contact lenses,https://www.linkedin.com/feed/update/urn:li:activity:7339168492744585216?
16. June 2025,European Commission,News,COMBINE programme launched a pilot for clinical trials and performance studies,
16. June 2025,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment Committee (PRAC) 2 – 5 June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7336725535617671168?
16. June 2025,European Medicines Agency,Report,Annual Report 2024,https://www.linkedin.com/feed/update/urn:li:activity:7338789074402492416?
16. June 2025,European Medicines Agency,Guidance,The summary-of-product-characteristics guideline and paediatric aspects,https://www.linkedin.com/feed/update/urn:li:activity:7339177993153531904? 
16. June 2025,European Medicines Agency,Newsflash,CTIS newsflash – 10 June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7339177536649617408?
16. June 2025,International Council for Harmonisation,Guidance,ICH E21 Step 2 Presentation Now Available,https://www.linkedin.com/feed/update/urn:li:activity:7339331566638145538? 
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,New Medical Devices Post-Market Surveillance requirements,https://www.linkedin.com/feed/update/urn:li:activity:7337863886689169408?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,User Reference Guide – MORE Incident Submissions,https://www.linkedin.com/feed/update/urn:li:activity:7337895160732676098?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Documentation data requirements under the new PMS regulations,https://www.linkedin.com/feed/update/urn:li:activity:7337156496515850241?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Borderlines with medical devices and other products in Great Britain,https://www.linkedin.com/feed/update/urn:li:activity:7338084045488095232?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Risk minimisation measures for medicines,https://www.linkedin.com/feed/update/urn:li:activity:7338088704818774017?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,"Clinical trials for medicines: manage your authorisation, report safety issues",https://www.linkedin.com/feed/update/urn:li:activity:7338093138969829377?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Collection,Decentralised manufacture hub,https://www.linkedin.com/feed/update/urn:li:activity:7338213329611485184?
16. June 2025,Medical Device Single Audit Program MDSAP,Procedure,Auditing Organization (AO) Application For Recognition Procedure,
16. June 2025,Medical Device Authority Malaysia,Guidance,Harmonised Borderline Products In ASEAN,https://www.linkedin.com/feed/update/urn:li:activity:7339239664253390848?
16. June 2025,Medical Device Authority Malaysia,Guidance,Harmonised Classification of Medical Devices in ASEAN,https://www.linkedin.com/feed/update/urn:li:activity:7339237972375945218?
16. June 2025,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,Classification and Definition of IVD Reagents Related to NGS (No. 22 [2025]),https://www.linkedin.com/feed/update/urn:li:activity:7339194323520876544?
16. June 2025,Swissmedic,Forms,Swissmedic Forms for June 2025,
16. June 2025,Swissmedic,Guidance,Export Certificates,
16. June 2025,Swissmedic,Guidance,Criteria Annexes 4–10 KPTPO,
16. June 2025,Team AB,Information,PMS Plan to comply with the GB PMS Requirements 16. June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7337156496515850241?
16. June 2025,USA Food & Drug Administration FDA,Report,Office of Clinical Pharmacology (OCP) 2024 Annual Report,https://www.linkedin.com/feed/update/urn:li:activity:7339385697314787328?
16. June 2025,USA Food & Drug Administration FDA,Guidance,ST&F Manual of Policies and Procedures (MAPP),https://martincking.github.io/Standards-Selector/?dropdownwindow=FDA&designation=&title=Good%20Review%20Practices:%20Standard%20Safety%20Tables%20and%20Figures&abstract=
16. June 2025,USA Food & Drug Administration FDA,Guidance,ST&F Integrated Guide,https://martincking.github.io/Standards-Selector/index.html?dropdownwindow=FDA&designation=&title=Standard%20Safety%20Tables%20and%20Figures%20ST&F%20Integrated%20Guide&abstract=
16. June 2025,USA Food & Drug Administration FDA,Guidance,OCMQ Manual of Policies and Procedures (MAPP),https://martincking.github.io/Standards-Selector/?dropdownwindow=FDA&designation=&title=OCMQ%20Manual%20of%20Policies%20and%20Procedures%20(MAPP)&abstract=
16. June 2025,USA Food & Drug Administration FDA,Report,Office of Clinical Pharmacology (OCP) 2024 Annual Report,https://www.linkedin.com/feed/update/urn:li:activity:7339385697314787328?
16. June 2025,USA Food & Drug Administration FDA,Newsletter,"FDA Regulatory Science Newsletter, Issue 1 of 2025, published by the U.S. Food and Drug Administration (FDA)",https://www.linkedin.com/feed/update/urn:li:activity:7339597414397341698?
16. June 2025,International Council for Harmonisation,Guidance,ICH E21 Step 2 Presentation Inclusion of Pregnant and Breastfeeding Individuals in Clinical Trials,https://www.linkedin.com/feed/update/urn:li:activity:7339331566638145538? 
16. June 2025,Medical Device Authority Malaysia,Guidance,Harmonised Borderline Products in ASEAN,https://www.linkedin.com/feed/update/urn:li:activity:7339239664253390848?
16. June 2025,Medical Device Authority Malaysia,Guidance,Harmonised Classification of Medical Devices in ASEAN,https://www.linkedin.com/feed/update/urn:li:activity:7339237972375945218?
16. June 2025,NMPA-National Medical Products Administration,Guidance,Classification and Definition of In Vitro Diagnostic Reagents Related to Next-Generation Gene Sequencing (No. 22 [2025]),https://www.linkedin.com/feed/update/urn:li:activity:7339194323520876544?
16. June 2025,ANVISA,Regulation,"Ordinance GM/MS No. 6,931, of June 4, 2025",https://www.linkedin.com/feed/update/urn:li:activity:7339185196732178433?
16. June 2025,European Medicines Agency,Guidance,The summary-of-product-characteristics guideline and paediatric aspects,https://www.linkedin.com/feed/update/urn:li:activity:7339177993153531904? 
16. June 2025,European Medicines Agency,Newsflash,CTIS newsflash – 10 June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7339177536649617408?
16. June 2025,European Commission,Regulation,Assignment of Unique Device Identifiers for contact lenses,https://www.linkedin.com/feed/update/urn:li:activity:7339168492744585216?
16. June 2025,European Medicines Agency,Report,ANNUAL REPORT 2024,https://www.linkedin.com/feed/update/urn:li:activity:7338789074402492416?
16. June 2025,European Commission,Guidance,HTAR Capacity Building Programme,https://www.linkedin.com/feed/update/urn:li:activity:7338228815891951616?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Collection,Decentralised manufacture hub,https://www.linkedin.com/feed/update/urn:li:activity:7338213329611485184?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,"Clinical trials for medicines: manage your authorisation, report safety issues",https://www.linkedin.com/feed/update/urn:li:activity:7338093138969829377?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Risk minimisation measures for medicines,https://www.linkedin.com/feed/update/urn:li:activity:7338088704818774017?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Borderline products: medical devices and other products,https://www.linkedin.com/feed/update/urn:li:activity:7338084045488095232?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Documentation for implementation of data requirements under the new Post-Marketing Surveillance regulations,https://www.linkedin.com/feed/update/urn:li:activity:7337900224922705920?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,MORE Registrations - user reference guide,https://www.linkedin.com/feed/update/urn:li:activity:7337895160732676098?
16. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,MHRA guidance on new Medical Devices Post-Market Surveillance requirements,https://www.linkedin.com/feed/update/urn:li:activity:7337863886689169408?
16. June 2025,European Medicines Agency,Meeting,Meeting highlights from the Pharmacovigilance Risk Assessment Committee () 2-5 June 2025,https://www.linkedin.com/feed/update/urn:li:activity:7336725535617671168?
16. June 2025,Team AB,Information,Have you generated your PMS Plan to comply with the GB PMS Requirements?,https://www.linkedin.com/feed/update/urn:li:activity:7337156496515850241?
9. June 2025,ANVISA Brazil,Guidance,Medicines Market Regulation Chamber (CMED) approves internal regulations,
9. June 2025,Council for International Organizations of Medical Sciences,Guidance,Glossary of ICH terms and definitions,
9. June 2025,European Commission,Template,Manufacturer Incident Report (MIR) template version 7.3.1 SB10449 Update,
9. June 2025,European Data Protection Board,Guidance,Fundamentals of Secure AI Systems with Personal Data,
9. June 2025,European Medicines Agency,Guidance,IDMP Process for the electronic submission of medicinal product Information,
9. June 2025,European Medicines Agency,Consultation,herbal medicinal products used in children and adolescents,
9. June 2025,European Medicines Agency,Consultation,ICH E21 inclusion of pregnant and breastfeeding individuals in clinical trials,
9. June 2025,European Medicines Agency,Guidance,"On-boarding - Substance, Product, Organisation and Referentials (SPOR)",
9. June 2025,European Directorate for the Quality of Medicines & HealthCare,Report,Certification monthly report of activities: End of May 2025,
9. June 2025,"Health Sciences Authority (HSA), Singapore",Guidance,SHARE for Medical Devices Industry Briefing Session,
9. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Regulatory considerations for therapeutic use of bacteriophages in the UK,
9. June 2025,MedTech Europe,Report,Decarbonising Healthcare: How a Competitive MedTech Industry Can Contribute,
9. June 2025,McKinsey & Company,Article,Scaling gen AI in the medtech industry,
9. June 2025,Swissmedic,Forms,Swissmedic Forms for June 2025,
9. June 2025,Swissmedic,Guidance,Product Information for Human Medicinal Products,
9. June 2025,Swissmedic,Guidance,Formal Requirements for Submissions,
9. June 2025,Swissmedic,Guidance,Time Limits for Authorisation Applications,
9. June 2025,Swissmedic,Guidance,Temporary Authorisation for Human Medicinal Products,
9. June 2025,Swissmedic,Guidance,Immunological Veterinary Medicinal Products in Epizootic Outbreaks,
9. June 2025,Swissmedic,Guidance,Product Information for Veterinary Medicinal Products,
9. June 2025,Swissmedic,Guidance,Instructions for Filling the eDok_KLV Folder Structure,
9. June 2025,Swissmedic,Guidance,Submission of Clinical Trials,
9. June 2025,Swissmedic,Guidance,Clinical Trial Application Dossier,
9. June 2025,Swissmedic,Guidance,Amendments in Clinical Trials,
9. June 2025,Swissmedic,Guidance,eIAM Portal Administrator,
9. June 2025,USA Food & Drug Administration FDA,Guidance,M13B Bioequivalence for Immediate-Release Solid Oral Dosage Forms,
9. June 2025,USA Food & Drug Administration FDA,News,FDA Launches Agency-Wide AI Tool,
9. June 2025,USA Food & Drug Administration FDA,Guidance,Transfer of a Premarket Notification (510(k)) Clearance â€“ Questions and Answers,
9. June 2025,USA Food & Drug Administration FDA,Guidance,Raw Data for Safety and Effectiveness Studies,
9. June 2025,USA Food & Drug Administration FDA,Guidance,Over-the-Counter Monograph Procedure for Minor Changes C001,
9. June 2025,USA Food & Drug Administration FDA,Guidance,M11 Technical Specification: Clinical Electronic Structured Harmonised Protocol,
9. June 2025,USA Food & Drug Administration FDA,Guidance,Hernia Mesh â€“ Package Labeling Recommendations,
2. June 2025,ANVISA Brazil,Guidance,Manual de uso do SIUD Sistema de IdentificaÃ§Ã£o Ãšnica de Dispositivos MÃ©dicos,
2. June 2025,Council for International Organizations of Medical Sciences,Consultation,Benefit-risk balance for medicinal products,
2. June 2025,Egyptian Drug Authority,Consultation,ICH Q1 Draft Guideline & Step 2,
2. June 2025,Egyptian Drug Authority,Consultation,Bioequivalence studies for generic Veterinary medicinal products,
2. June 2025,European Commission,Presentation,"EUDAMED Workshop â€“ 21 May 2025 - Stuttgart, Germany",
2. June 2025,European Commission,Consultation,Clinical assessments of medical devices & IVDs at the Union level,
2. June 2025,European Commission,Proposal,EMDN Helpdesk â€“ Officially live,
2. June 2025,European Medicines Agency,Meeting,Committee for Medicinal Products for Human UseÂ (CHMP) 19-22 May2025,
2. June 2025,European Medicines Agency,Guidance,Quality of medicines questions and answers: Part 2,
2. June 2025,European Directorate for the Quality of Medicines & HealthCare,Guidance,How to read a CEP,
2. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
2. June 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Innovative Licensing and Access Pathway (ILAP),
2. June 2025,MedTech Europe,Guidance,Practical guide to the use of the European Medical Device Nomenclature (EMDN),
2. June 2025,Swissmedic,Forms,Swissmedic Forms for May 2025,
2. June 2025,Swissmedic,Guidance,Incident economic operators,
2. June 2025,Swissmedic,Guidance,Marketing Authorisation for Global Health Products MAGHP Procedure,
2. June 2025,Swissmedic,Guidance,Amendment to GMP compliance by foreign manufacturers,
2. June 2025,"Therapeutic Goods Administration (TGA), Australia",News,GMP Clearance: Backlog reduction strategy commencing 1 July 2025,
2. June 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Adoption of International Scientific Guidelines in Australia,
2. June 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Advertising to health professionals so that consumer rules do not apply,
2. June 2025,USA Food & Drug Administration FDA,Guidance,Electronic Submission Template for Medical Device Q-Submissions,
2. June 2025,USA Food & Drug Administration FDA,Guidance,Requests for Feedback and Meetings: The Q-Submission Program,
2. June 2025,USA Food & Drug Administration FDA,Guidance,Replacing Color Additives in Approved or Marketed Drug Products,
26. May 2025,ANVISA Brazil,Guidance,National Guideline for Antimicrobial Management in Neonatology Services,
26. May 2025,European Commission,Presentation,Health technology assessment for patients and clinical experts,
26. May 2025,European Commission,Consultation,Establishment of an expert panel on orphan and paediatric devices,
26. May 2025,European Commission,Proposal,Simplify several EU regulations (GDPR etc.) to assist small medium enterprises,
26. May 2025,European Medicines Agency,Newsflash,CTIS newsflash â€“ 16 May 2025,
26. May 2025,European Medicines Agency,Guidance,"SOP - Validation, Publication, & Maintenance of real-world data sources & studies",
26. May 2025,European Medicines Agency,Guidance,Questions and answers for marketing authorisation on nitrosamine impurities,
26. May 2025,European Medicines Agency,Guidance,Data Protection Notice For the Organisation Management System (OMS),
26. May 2025,European Directorate for the Quality of Medicines & HealthCare,Guidance,"Guide to the preparation, use and quality assurance of blood components",
26. May 2025,"Health Products Regulatory Authority (HPRA), Ireland",Guidance,Registration of Processes under Article 61(5) of the Clinical Trial Regulation,
26. May 2025,"Health Products Regulatory Authority (HPRA), Ireland",Form,Application for the Register for Exemption,
26. May 2025,"Health Sciences Authority (HSA), Singapore",Consultation,Exemption from Registration Requirements for Artificial Intelligence â€“ SAMD,
26. May 2025,International Council for Harmonisation,Meeting,"ICH Assembly Meeting, Madrid, Spain, May 2025",
26. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Using control arms based on real-world data to support regulatory decisions,
26. May 2025,Medicines and Healthcare products Regulatory Agency,Regulation,The Medical Devices (Amendment) (Great Britain) Regulations 2025,
26. May 2025,Medical Device Single Audit Program MDSAP,Documents,MDSAP Documents for May 2025,
26. May 2025,Pharmacy and Poisons Board (PPB) of Kenya,Guidance,Look-alike Packaging of Health Products and Technologies,
26. May 2025,Sedgwick,Report,Recall Index Report United States edition Q1 2025,
26. May 2025,Sedgwick,Report,Recall Index Report European Edition Q1 2025,
26. May 2025,South African Health Products Regulatory Authority,Guidance,Questions and Answers: Licensing of Medical Device Establishments,
26. May 2025,Swissmedic,Forms,Swissmedic Forms for May 2025,
26. May 2025,Swissmedic,Guidance,Urgent amendment to the Swiss Pharmacopoeia,
26. May 2025,Swissmedic,Guidance,"Notifications according to Article 41, MPLO",
26. May 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,GMP clearance application and submission user guide,
26. May 2025,World Health Organisation WHO,Guidance,Transforming the paediatric medicines ecosystem: strategic roadmap 2025â€“2030,
19. May 2025,ANVISA Brazil,Guidance,Second edition of Q&A on RDC 894/2024 Cosmetovigilance,
19. May 2025,ANVISA Brazil,Newsletter,Post-Market Monitoring Newsletter - 1st Edition/2025,
19. May 2025,Egyptian Drug Authority,Guidance,"""WhatsApp"" service to facilitate communication with companies and factories",
19. May 2025,European Commission,Guidance,AI Literacy - Questions & Answers,
19. May 2025,European Commission,Survey,Results of the 12th NB survey,
19. May 2025,European Commission,Consultation,EU Biotech Act,
19. May 2025,European Medicines Agency,Guidance,IDMP Process for the electronic submission of medicinal product Information,
19. May 2025,European Medicines Agency,Guidance,Plasma Master File (PMF) requirements. Q&A for PMF Holders,
19. May 2025,European Medicines Agency,Guidance,Changes policy on the publication of clinical data - medicinal products,
19. May 2025,European Medicines Agency,Guidance,Policy on the publication of clinical data - medicinal products,
19. May 2025,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report April 2025,
19. May 2025,European Directorate for the Quality of Medicines & HealthCare,Guidance,Quality and Safety of Organs for Transplantation,
19. May 2025,European Directorate for the Quality of Medicines & HealthCare,News,Adoption of mycoplasmas general chapter & monographs with latest analytics,
19. May 2025,International Pharmaceutical Excipients Council Federation(IPEC),Guidance,Risk Assessment Guide for Pharmaceutical Excipients,
19. May 2025,International Medical Device Regulators Forum,Guidance,IMDRF Standard Operating Procedures Edition 13 Version 2,
19. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: apply for a parallel import licence,
19. May 2025,Medicines and Healthcare products Regulatory Agency,Consultation,Harmonisation ICH E6 (R3) Guideline,
19. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,International Recognition Procedure,
19. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Register a homeopathic medicine,
19. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,: Medical Devices Post Market Surveillance,
19. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Manufacturerâ€™s Online Reporting Environment (MORE) & MORE implementation,
19. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: reclassify your product,
19. May 2025,Department of Health Hong Kong Special Administration,Guidance,Personalised Medical Devices (TR-009),
19. May 2025,Department of Health Hong Kong Special Administration,Guidance,Overview of the Medical Device Administrative Control System (GN-01),
19. May 2025,Department of Health Hong Kong Special Administration,Guidance,Definitions & Abbreviations MDACS (GN-00),
19. May 2025,Department of Health Hong Kong Special Administration,Guidance,Software Medical Devices and Cybersecurity  (TR-007) Update,
19. May 2025,Swissmedic,Forms,Swissmedic Forms for May 2025,
19. May 2025,Swissmedic,Guidance,CH Guide Manufacturer Incident Report (MIR),
19. May 2025,Swissmedic,Guidance,Cannabis fÃ¼r medizinische Zwecke,
19. May 2025,Swissmedic,Guidance,Authorisation of co-marketing medicinal product,
19. May 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Regulatory requirements for in vitro diagnostic (IVD) companion diagnostics (CDx),
12. May 2025,Egyptian Drug Authority,Guidance,Quality Module for Human Pharmaceuticals submitted for Re-registration,
12. May 2025,Egyptian Drug Authority,Guidance,Provision of a new service through the Department of Medical Supplies Variables,
12. May 2025,European Commission,Template,Manufacturer Incident Report (MIR) template version 7.3.1,
12. May 2025,European Commission,Meeting,Pharmaceutical Committee 102nd Meeting,
12. May 2025,European Data Protection Board,Letter,Simplification of record-keeping: EDPB and EDPS adopt letter to EU Commission,
12. May 2025,European Medicines Agency,Guidance,Policy on access to EudraVigilance data for medicinal products for human use,
12. May 2025,European Medicines Agency,Guidance,Product Management Service (PMS) - (ISO) standards for (IDMP) in Europe,
12. May 2025,European Medicines Agency,Guidance,"SOPs for assignment and renewal of micro-, SME enterprise status",
12. May 2025,European Medicines Agency,Guidance,NDSG workplan 2025-2028 Data and AI in medicines regulation,
12. May 2025,European Medicines Agency,Consultation,Part IV Guidelines on Good Manufacturing Practice specific to ATMPs,
12. May 2025,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment CommitteeÂ (PRAC) 5 - 8 May 2025,
12. May 2025,European Directorate for the Quality of Medicines & HealthCare,Guidance,Validation of eCTD submissions for CEP applications,
12. May 2025,ISO (International Organization for Standardization),Standards,"ISO Update April 1, 2025 to May 1, 2025",
12. May 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
12. May 2025,Medicines and Healthcare products Regulatory Agency,Consultation,M13B Bioequivalence for Immediate Release Solid Oral Dosage Forms,
12. May 2025,MedTech Europe,Response,Towards a Revised EU Regulatory Framework for Medical Devices,
12. May 2025,South African Health Products Regulatory Authority,Guidance,"SAHPRA Engagement Portal â€“ Variation, Renewal and Response Applications",
12. May 2025,Swissmedic,Forms,Swissmedic Forms for May 2025,
12. May 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Using the 'TGA assessed' claim on medicine labels,
12. May 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Understanding regulation of custom-made medical devices,
12. May 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Understanding specified articles in personalised medical devices regulation,
12. May 2025,USA Food & Drug Administration FDA,Guidance,Reduce the Risk of Disease Agents Associated with Sepsis by Human Cells,
12. May 2025,USA Food & Drug Administration FDA,Guidance,Reduce the Risk of Mycobacterium tuberculosis (Mtb) by Human Cells,
12. May 2025,USA Food & Drug Administration FDA,News,Expanded Use of Unannounced Inspections at Foreign Manufacturing Facilities,
12. May 2025,USA Food & Drug Administration FDA,News,First AI-Assisted Scientific Review Pilot and Aggressive Agency-Wide AI Rollout,
5. May 2025,ANVISA Brazil,Report,2024 Management Report,
5. May 2025,Council for International Organizations of Medical Sciences,Guidance,Severe cutaneous adverse reactions (SCAR),
5. May 2025,Council for International Organizations of Medical Sciences,Report,Artificial intelligence in pharmacovigilance,
5. May 2025,European Commission,Info session,Commissionâ€™s proposal for a Critical Medicines Act,
5. May 2025,European Commission,Update,Notified Body Update (50) Active MDR (17) IVDR 1 Withdrawn,
5. May 2025,European Medicines Agency,Newsflash,CTIS newsflash â€“ 29. April 2025,
5. May 2025,European Medicines Agency,Update,CTIS Simplification Task Force: topics for analysis,
5. May 2025,European Medicines Agency,Paper,For a Reflection Paper on a tailored clinical approach in Biosimilar development,
5. May 2025,"Health Products Regulatory Authority (HPRA), Ireland",Guidance,NDS Web Extranet,
5. May 2025,Medical Device Authority Malaysia,Guidance,Advice Use of Spare Parts for Medical Device Maintenance Purposes,
5. May 2025,Medical Device Authority Malaysia,Guidance,Medical Device for the Purpose of Export Only,
5. May 2025,Medical Device Authority Malaysia,Guidance,Unregistered Medical Devices Under Special Access Exemption Application,
5. May 2025,"NMPA-National Medical Products Administration, Peoples Republic of China",Standards,"The ""Quality Management Standards for Online Sales of Medical Devices""",
5. May 2025, Regulatory Affairs Professionals Society (RAPS),Publication,SaMD Applicable requirements for market entry in the EU and US,
5. May 2025,Swiss Federal Council,News,The Federal Council defines guidelines for expanding the supply of medical devices,
5. May 2025,Swissmedic,Forms,Swissmedic Forms for April 2025,
5. May 2025,Swissmedic,Guidance,In-house medicinal product,
5. May 2025,Swissmedic,Guidance,Products containing cannabidiol,
5. May 2025,Swissmedic,Guidance,Formal Requirements,
5. May 2025,Swissmedic,Guidance,GMP compliance by foreign manfacturers,
5. May 2025,Swissmedic,Guidance,Authorisation of Asian medicinal products,
5. May 2025,Swissmedic,Guidance,Authorisation for homeopathic and anthroposophic medicinal products,
5. May 2025,Swissmedic,Guidance,Parallel Import of a human medicinal product according,
5. May 2025,USA Food & Drug Administration FDA,Report,FY 2024 GDUFA Science and Research Report,
5. May 2025,USA Food & Drug Administration FDA,Guidance,Registration & Listing of Cosmetic Product Facilities and Products,
28. April 2025,ANVISA Brazil,Guidance,Implementation of a Quality Management System (QMS) SNVS,
28. April 2025,"Cofepris, Mexico",Regulation,NOM-241-SSA1-2025 Good Manufacturing Practices for Medical Devices,
28. April 2025,"Cofepris, Mexico",Guidance,Questions & Answers  NOM-241-SSA1-2025,
28. April 2025,Drug Regulatory Authority of Pakistan,Guidance,DRAP-PSW Gateway: Online Application  for Pharmaceutical Export Certificates,
28. April 2025,Egyptian Drug Authority,Guidance,Stability Studies Review and Evaluation Time Frame Year 2025,
28. April 2025,Egyptian Drug Authority,Guidance,Link for the completion of the permissible stability studies,
28. April 2025,Egyptian Drug Authority,Consultation,Guideline for Good Clinical Practice E6(r3),
28. April 2025,European Commission,Update,Notified Body Update (50) Active MDR (15) IVD 1 Withdrawn,
28. April 2025,European Commission,Guidance,EUDAMED Release notes Playground v 3.11.0 2025,
28. April 2025,European Data Protection Board,Report,Annual Report 2024 Protecting Personal Data in a Changing Landscape,
28. April 2025,European Medicines Agency,Guidance,Business Process Descriptions,
28. April 2025,European Medicines Agency,Report,"Industry stakeholders and EU network experts surveys, fostering innovation",
28. April 2025,European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use (CHMP) 22-25 April 2025,
28. April 2025,European Directorate for the Quality of Medicines & HealthCare,News,EPC adopts cutting-edge HTS chapter,
28. April 2025,Health Canada,Guidance,Updated: Filing submissions electronically,
28. April 2025,MedTech Europe,Response,EC Call for evidence on the Life Sciences Strategy,
28. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Option to Apply UK Only Stickers to Medicines Expires 30. June 2025,
28. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
28. April 2025,National Institute of Standards and Technology (NIST),Consultation,"NIST Updates Privacy Framework, Tying It to Recent Cybersecurity Guidelines",
28. April 2025,Swissmedic,Forms,Swissmedic Forms for April 2025,
28. April 2025,Swissmedic,Consultation,ICH Guideline M13B Bioequivalence Immediate-Release Solid  Dosage Forms,
28. April 2025,World Health Organisation WHO,Guidance,Implementing Patient Blood Management to Improve Global Blood Health Status,
21. April 2025,ANVISA Brazil,Guidance,Procedural instruction for registration and post-registration of biological products,
21. April 2025,ANVISA Brazil,Guidance,Guidelines on health framework for ultrasensitive PCR parameter,
21. April 2025,ANVISA Brazil,Guidance,Guide on studies of forced degradation in drugs published,
21. April 2025,Egyptian Drug Authority,Guidance,Regulatory Guide on Cosmetic Claims,
21. April 2025,European Commission,News,"""Master UDI-DI Implementation: Updates and Deadlines for Medical Devices",
21. April 2025,European Data Protection Board,Guidance,processing of personal data through blockchain technologies,
21. April 2025,European Medicines Agency,Guidance,Anonymisation of personal in risk management plans,
21. April 2025,European Medicines Agency,Guidance,Q&A how should third party audit(s) be reflected in part C of the QP declaration?,
21. April 2025,European Medicines Agency,Guidance,Q&A Practical arrangements companion diagnostics consultation procedure,
21. April 2025,European Medicines Agency,Guidance,Comments ICH M15 Guideline for Model Informed Drug Development (MIDD),
21. April 2025,European Medicines Agency,Guidance,Procedural advice on paediatric applications,
21. April 2025,European Medicines Agency,Report,surveys on early engagement fostering innovation,
21. April 2025,International Council for Harmonisation,Guidance,Stability Testing of Drug Substances and Drug Products Q1,
21. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Risk minimisation measures for medicines,
21. April 2025,South African Health Products Regulatory Authority,Guidance,Medical Devices and in Vitro Diagnostics Communications to Industry,
21. April 2025,Swissmedic,Forms,: Swissmedic Forms for April 2025,
21. April 2025,"Team Notified Body, Europe",Press Release,Classification of IVDâ€™s intended for screening or detection of SARS-CoV-2,
21. April 2025,"Team Notified Body, Europe",Guidance,TEAM NB Position Paper on IVDR Certification Process,
21. April 2025,"Team Notified Body, Europe",Guidance,Submission of Technical Documentation under Annex II and III of MDR 2017/745,
21. April 2025,"Team Notified Body, Europe",Position Paper,European Artificial Intelligence Regulation V2,
21. April 2025,World Health Organisation WHO,Report,Expert Committee on Specifications for Pharmaceutical Preparations,
21. April 2025,World Health Organisation WHO,Report,"WHO Drug Information - Volume 39, No. 1",
14. April 2025,ANVISA Brazil,Report,monitoring and intervention in potential risk in health services,
14. April 2025,Central Drugs Standard Control Organization,Regulation,Market Standing Certificate (MSC) & Non-Conviction Certificate (NCC),
14. April 2025,Egyptian Drug Authority,Guidance,Non-sterile local supplies previously traded,
14. April 2025,European Commission,Initiative,AI Continent Action Plan,
14. April 2025,European Commission,Regulation,Harmonized Standards MDR,
14. April 2025,European Commission,Regulation,Harmonized Standards IVDR,
14. April 2025,European Data Protection Board,Guidance,Study on the secondary use of personal data in the context of scientific research,
14. April 2025,European Data Protection Board,Guidance,AI Privacy Risks & Mitigations Large Language Models (LLMs),
14. April 2025,European Medicines Agency,Guidance,Good Manufacturing PracticeÂ andÂ Good Distribution Practice: Q&A,
14. April 2025,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment CommitteeÂ (PRAC) 7- 10- April 2025,
14. April 2025,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report March 2025,
14. April 2025,European Directorate for the Quality of Medicines & HealthCare,Consultation,Pharmeuropa 37.2 just released (54 drafts published),
14. April 2025,"Health Products Regulatory Authority (HPRA), Ireland",Guidance,Good Distribution Practice of Medicinal Products for Human Use,
14. April 2025,International Medical Device Regulators Forum,Guidance,Terms of Reference,
14. April 2025,International Medical Device Regulators Forum,Guidance,IMDRF Standard Operating Procedures,
14. April 2025,ISO (International Organization for Standardization),Standards,"ISO Update March 1, 2025 to April 1, 2025",
14. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Early Access to Medicines Scheme â€“ Overview,
14. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Clinical investigations,
14. April 2025,Medicines and Healthcare products Regulatory Agency,Regulation,Clinical Trials regulations signed into law,
14. April 2025,"NMPA-National Medical Products Administration, Peoples Republic of China",Standards,Abolition of Two Medical Device Industry Standards (No. 36 [2025]),
14. April 2025,Swissmedic,Guidance,Expansion of the Swissmedic position paper on real world evidence,
14. April 2025,Swissmedic,Forms,: Swissmedic Forms for April 2025,
14. April 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Understanding labelling and presentation requirements for listed medicines,
14. April 2025,USA Food & Drug Administration FDA,Guidance,Plan to Phase Out Animal TestingÂ for MABs,
14. April 2025,USA Executive Office of the President,Memorandum,"M-25-21, M-25-22 playbook for responsible AI adoption",
7. April 2025,ANVISA Brazil,Guidance,Safety assessment of impurities & degradation products of synthetic drugs,
7. April 2025,Central Drugs Standard Control Organization,Guidance,Draft risk-based classification of Medical Devices: Cardiovascular & Neurological,
7. April 2025,Central Drugs Standard Control Organization,Guidance,Medical Devices FAQ Doc No.:CDSCO/FAQ/MD/01/2024 Addendum No.: 01,
7. April 2025,European Medicines Agency,Guidance,Guideline on the quality aspects of mRNA vaccines,
7. April 2025,European Medicines Agency,Guidance,Linking to electronic product information (ePI) from EU medicine packages,
7. April 2025,European Medicines Agency,Guidance,Scientific Data Requirements for a Plasma Master File 5 Revision 1 & Annexes,
7. April 2025,European Medicines Agency,Template,Request for advice on the clinical development strategy or clinical data,
7. April 2025,European Medicines Agency,Template,Request for advice on the orphan device status from the Expert Panels,
7. April 2025,European Medicines Agency,Guidance,IRIS guide to registration and Research Product Identifier s RPIs,
7. April 2025,European Medicines Agency,Reflection Paper,A tailored clinical approach in biosimilar development,
7. April 2025,European Medicines Agency,Reflection Paper,Real-world data in non interventional studies used to generate evidence.,
7. April 2025,European Medicines Agency,Document,Journey towards a roadmap for regulatory guidance on real-world evidence,
7. April 2025,"Health Products Regulatory Authority (HPRA), Ireland",Guidance,Verification of economic operator registration for medical device inspections,
7. April 2025,International Medical Device Regulators Forum,Consultation,Playbook for Medical Device Regulatory Reliance Programs,
7. April 2025,International Medical Device Regulators Forum,Outcome Statement,"27th Session of the IMDRF 10-14 March 2025 Shibuya, Tokyo, JAPAN",
7. April 2025,International Medical Device Regulators Forum,Guidance,Medical Devices: PMS: National Competent Authority Report Exchange Criteria,
7. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Innovative Licensing and Access Pathway (ILAP),
7. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Exceptional Use Authorisation,
7. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Current Fees,
7. April 2025,Medicines and Healthcare products Regulatory Agency,Guidance,National assessment procedure for medicines,
7. April 2025,Medical Device Authority Malaysia,Guidance,Online Product Classification Application Process,
7. April 2025,Medical Device Authority Malaysia,Guidance,Implementation of Validity Period for Product Classification Letter,
7. April 2025,Swissmedic,Guidance,Medical Device Exemption Procedure,
7. April 2025,Swissmedic,Guidance,Packaging for human medicinal products,
7. April 2025,Swissmedic,Guidance,Procedure with prior notification,
7. April 2025,Swissmedic,Guidance,Fast-track authorisation procedure,
7. April 2025,Swissmedic,Guidance,Temporary authorisation for human medicinal products,
7. April 2025,Swissmedic,Forms,Swissmedic Forms for April 2025,
7. April 2025,Saudi Food & Drug Authority,Guidance,ISO 13485 Requirements and Corresponding SFDA-MDS Requirements,
7. April 2025,USA Food & Drug Administration FDA,Guidance,Evaluation of Sex-Specific Data in Medical Device Clinical Studies,
31. March 2025,ANVISA Brazil,Consultation,Database for Unique Identification of Medical Devices,
31. March 2025,ANVISA Brazil,Regulation,Adjustments to the new regulation of medical devices for IVDs,
31. March 2025,European Commission,Presentation,The EU HTA Regulation: Health Technology Developers of Medicinal Products,
31. March 2025,European Medicines Agency,Report,Advice from the Expert Panels to Manufacturers of High Risk Medical Devices,
31. March 2025,European Medicines Agency,Report,Good Manufacturing and Distribution Practice Inspectors Working Group 2024,
31. March 2025,European Medicines Agency,Newsflash,CTIS newsflash â€“ 25 March 2025,
31. March 2025,European Medicines Agency,Guidance,Unforeseen variations according to Article 5 of (EC) No 1234/2008,
31. March 2025,European Medicines Agency,Guidance,Post-authorisation procedural advice for users of the centralised procedure,
31. March 2025,European Medicines Agency,Guidance,Pre-authorisation procedural advice for users of the centralised procedure,
31. March 2025,European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use (CHMP) 24-27 March 2025,
31. March 2025,"Health Products Regulatory Authority (HPRA), Ireland",Guidance,Traditional Herbal Medicinal Products Registration Scheme,
31. March 2025,"Health Products Regulatory Authority (HPRA), Ireland",Guidance,Batch-Specific Requests for Human Medicines,
31. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,"Safety communications medicines, medical devices & other healthcare products",
31. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,"Medicines: register to manufacture, import or distribute active substances",
31. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Blue Guide: advertising and promoting medicines,
31. March 2025,Medical Device Authority Malaysia,Guidance,Implementation of Medical Device Import Permit,
31. March 2025,Medical Device Authority Malaysia,Guidance,Medical Devices that have been Approved by other Recognized Countries,
31. March 2025,National Institute of Standards and Technology (NIST),Guidance,Guidelines on Mitigating Cyberattacks Against AI,
31. March 2025,Swissmedic,Guidance,Product quality reviews,
31. March 2025,Swissmedic,Template,Example of a product list,
31. March 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Preparing for Good Clinical Practice (GCP) inspections,
31. March 2025,"Therapeutic Goods Administration (TGA), Australia",Strategic Plan,Access strategic plan: Updated for 2025-2028,
31. March 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Complying with the Unique Device Identification requirements for medical devices,
31. March 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Complying with the Unique Device Identification timeframes for medical devices,
31. March 2025,USA Food & Drug Administration FDA,Guidance,FDA Data Standards Catalog,
31. March 2025,USA Food & Drug Administration FDA,Guidance,Study Data Technical Conformance Guide,
31. March 2025,World Health Organisation WHO,Guidance,Ethics and governance of artificial intelligence forÂ health,
24. March 2025,"Access ConsortiumÂ - Australia, Canada, Singapore, Switzerland, UK",Strategic Plan,Strategic Plan 2025-2028,
24. March 2025,European Commission,Guidance,MDCG 2020-16 rev.4 Guidance on IVD Classification Rules - IVDR 2017/746,
24. March 2025,European Medicines Agency,Guidance,Assessment templates and guidance,
24. March 2025,European Medicines Agency,Report,The European medicines agencies network strategy 2028,
24. March 2025,European Medicines Agency,Report,Analysis and summaries of public consultation results,
24. March 2025,European Medicines Agency,Report,2024 Annual Report on EudraVigilance for the European Parliament,
24. March 2025,European Medicines Agency,Guidance,ICH M11 Technical Specification Updated Step 2b,
24. March 2025,European Medicines Agency,Qualification,AI tool to diagnose inflammatory liver disease (MASH) in biopsy samples,
24. March 2025,Health Canada,Guidance,Regulating authorities under the Food and Drugs Act: Overview,
24. March 2025,Health Canada,Guidance,Regulatory enrolment process (REP),
24. March 2025,Health Canada,Guidance,Environmental risk management authorities under the Food and Drugs Act,
24. March 2025,Health Canada,Consultation,Guidance on co-packaged drug products,
24. March 2025,International Council for Harmonisation,Guidance,ICH M11 Step 2b Technical Specification Document & Template Now Available,
24. March 2025,International Council for Harmonisation,Guidance,M13B Bioequivalence for Immediate Release Solid Oral Dosage Forms,
24. March 2025,International Council for Harmonisation,Guidance,ICH electronic Common Technical Document - eCTD v4.0 Step 4,
24. March 2025,Medicines and Healthcare products Regulatory Agency,Collection,Decentralised manufacture hub,
24. March 2025,MedTech Europe,Paper,Submission of Vigilance Reports to Notified Bodies EU MDR & IVDR,
24. March 2025,MedTech Europe,Paper,Future governance of medical technologies in Europe,
24. March 2025,MedTech Europe,Paper,Digitalisation of Technical Documentation,
24. March 2025,"NMPA-National Medical Products Administration, Peoples Republic of China",Regulation,Adjusting and Optimizing the Production of Imported Medical Device Products,
24. March 2025,"NMPA-National Medical Products Administration, Peoples Republic of China",Standards,Abolishing Two Medical Device Industry Standards (No. 31 [2025]),
24. March 2025,"NMPA-National Medical Products Administration, Peoples Republic of China",Notice,2025 Medical Device Industry Standard Formulation and Revision Plan,
24. March 2025,Swissmedic,Standards,Export Certificates,
24. March 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Proposed changes to IVD medical device classifications and definitions,
24. March 2025,"Therapeutic Goods Administration (TGA), Australia",Report,Performance Report - 2023-24,
24. March 2025,"Therapeutic Goods Administration (TGA), Australia",Report,Performance Reports,
24. March 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,"Consent supply, export medical devices that do not meet the Essential Principles",
24. March 2025,USA Food & Drug Administration FDA,Fees,Over-The-Counter Monograph Drug User Fee Program (OMUFA),
17. March 2025,Egyptian Drug Authority,Guidance,Compliance with the application form for trade names for human pharmaceuticals,
17. March 2025,Egyptian Drug Authority,Guidance,Solubility Rate Studies for Imported / Local Human Pharmaceutical Products,
17. March 2025,European Commission,Guidance,Questions and Answers on the Critical Medicines Act,
17. March 2025,European Commission,Fact Sheet,Critical Medicines Act: Improving & securing supply of critical medicines,
17. March 2025,European Commission,Factsheet,EU actions to address medicine shortages and improve security of supply,
17. March 2025,European Medicines Agency,Guidance,Key documents related to the European Shortages Monitoring Platform,
17. March 2025,European Medicines Agency,Guidance,"FAQs How to create, submit and withdraw CTA - CTIS Training - Module 10",
17. March 2025,European Medicines Agency,Guidance,Product Management Service (PMS) roadmap,
17. March 2025,European Medicines Agency,Guidance,Clinical Evaluation Consultation Procedure (CECP) for a drug-eluting stent,
17. March 2025,European Medicines Agency,Guidance,List of Clinical Evaluation Procedures CECP Opinions,
17. March 2025,European Medicines Agency,Guidance,IRIS guide for applicants,
17. March 2025,European Medicines Agency,Newsflash,CTIS newsflash â€“ 11. March 2025,
17. March 2025,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report February 2025,
17. March 2025,"Health Sciences Authority (HSA), Singapore",Consultatiion,Best Practices Guide for Medical Device Cybersecurity,
17. March 2025,ISO (International Organization for Standardization),Standards,"ISO Update February 1, 2025 to March 1, 2025",
17. March 2025,"MEDSAFE, New Zealand",Policy,Policy Statement on Clinical trials - Protocol clarification letters,
17. March 2025,Department of Health & Social Care,Policy Paper,Government response to the Regulatory Horizons Council,
17. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Footnotes removed referencing Article 8 of EU Regulation 2023/1182,
17. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Register medical devices to place on the market,
17. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Certificates of Free Sale Reference Guide,
17. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Good clinical practice for clinical trials,
17. March 2025,Medicines and Healthcare products Regulatory Agency,Newsletter,Regulating and evaluating digital mental health technologies,
17. March 2025,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,Key Points and Judgment Principles for Medical Device Clinical Trials,
17. March 2025,Swissmedic,Guidance,swissdamed Privacy Notice and Terms of Use,
17. March 2025,Swissmedic,Guidance,Collaborative Assessment Procedures Project ORBIS,
17. March 2025,"Team Notified Body, Europe",Statement,Certificates with Conditions â€“ Team NB Statement,
17. March 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Advertising requirements for disease education activities,
17. March 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Applying to use a restricted representation,
17. March 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Advertising compliance self assessment checklist,
17. March 2025,USA Food & Drug Administration FDA,Notification,Data Integrity â€“ Medical Devices,
10. March 2025,Egyptian Drug Authority,Guidance,Registration of Synthetic Peptides Human Pharmaceutical Products rDNA Origin,
10. March 2025,European Commission,Regulation,Regulation on the European Health Data Space (EHDS),
10. March 2025,European Commission,Guidance,Frequently Asked Questions on the European Health Data Space,
10. March 2025,European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use (CHMP) 24-27 February 2025,
10. March 2025,European Medicines Agency,Guidance,A new clinical trial map of the Clinical Trials Information System,
10. March 2025,European Medicines Agency,Guidance,Regulatory Procedure Management for PLM in IRIS â€“ FAQs,
10. March 2025,European Medicines Agency,Guidance,FAQs How to submit an annual safety report and respond to related RFIs,
10. March 2025,European Medicines Agency,Guidance,"FAQs How to create, submit and withdraw a CTA",
10. March 2025,European Union Agency for Cybersecurity (ENISA),Report,ENISA NIS360 2024,
10. March 2025,Health Canada,Guidance,Drug Product Database (DPD) Data Extract,
10. March 2025,International Medical Device Regulators Forum,Guidance,Terminologies-Categorized Adverse Event Reporting: terminology and codes,
10. March 2025,Journal of Medical Device Regulation,Paper,"High-Quality PMCF Surveys Under EU MDR â€“ Planning, Execution & Data Analysis",
10. March 2025,"MEDSAFE, New Zealand",Journal,Prescriber Update Vol. 46. No. 1 - March 2025,
10. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Good laboratory practice (GLP) for safety tests on chemicals,
10. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Advanced therapy medicinal products: regulation and licensing in UK,
10. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,UK-wide licensing for human medicines,
10. March 2025,Medical Dictionary for Regulatory Activities,Guidance,MedDRA Latest Version 28.0 and Support Documentation,
10. March 2025,Swissmedic,Guidance,Information of PSUR PBRER submission HMP,
10. March 2025,Swissmedic,Guidance,Authorisation of herbal medicinal products,
10. March 2025,Swissmedic,Guidance,Renewal & discontinuation or change of status (main authorisation/export licence),
10. March 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,"Procedure for recalls, product alerts and product corrections (PRAC)",
10. March 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Medical devices that do not meet the Essential Principles,
10. March 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Essential Principles: consent for non-compliance,
10. March 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Consent for medical devices that do not meet the Essential Principles,
10. March 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Application for consent medical devices that do not meet the Essential Principles,
10. March 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,"Devices containing medicinal, microbial, recombinant or animal substances",
3. March 2025,ANVISA Brazil,Guidance,New rules for post-market monitoring of cosmetics,
3. March 2025,Egyptian Drug Authority,Guidance,procedures for import of laboratory and diagnostic reagents,
3. March 2025,European Commission,Consultation,"Medical devices, instructions for use may be provided in electronic form",
3. March 2025,European Commission,Guidance,"Fact Sheets, Success Stories, Rare diseases and European Reference Networks",
3. March 2025,European Medicines Agency,Guidance,Centralised procedure for similar biological medicinal products applications,
3. March 2025,European Medicines Agency,Guidance,Marketing Authorisation Application (MAA) Pre-submission interactions form,
3. March 2025,European Medicines Agency,Guidance,Pre-authorisation procedural advice for users of the centralised procedure,
3. March 2025,European Medicines Agency,Report,New Approach Methodologies EU-IN Horizon Scanning Report,
3. March 2025,European Medicines Agency,Guidance,Questions and answers for biological medicinal products,
3. March 2025,European Medicines Agency,Guidance,Considerations regarding the implementation of ICH M13A,
3. March 2025,European Medicines Agency,Newsflash,CTIS newsflash - 25 February 2025,
3. March 2025,European Medicines Agency,Guidance,Infographic - Orphan Medicines in the EU,
3. March 2025,Health Canada,Guidance,Submitting risk management plans,
3. March 2025,"Health Products Regulatory Authority (HPRA), Ireland",Guidance,National Scientific and Regulatory Advice,
3. March 2025,International Pharmaceutical Excipients Council Federation (IPEC),Guidance,Third party Audit and Certification Programmes,
3. March 2025,International Pharmaceutical Excipients Council Federation (IPEC),Guidance,Product Development using Quality-by-Design (QbD),
3. March 2025,ISO (International Organization for Standardization),Standards,"ISO Update January 1, 2025 to February 1, 2025",
3. March 2025,Medicines and Healthcare products Regulatory Agency,Standard,Implementation of medical devices future regime,
3. March 2025,Medicines and Healthcare products Regulatory Agency,Consultation,"Response, Consultation on Medical Devices Regulations: Routes to market",
3. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Guidance on the licensing of biosimilar products,
3. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Advanced therapy medicinal products: regulation and licensing in UK,
3. March 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Licensing plasma master files and vaccine antigen master files,
3. March 2025,MedTech Europe,Paper,Clinical strategy - pre-submission dialogue between manufacturer and Notified Body,
3. March 2025,"NMPA-National Medical Products Administration, Peoples Republic of China",Standards,10 Medical Device Industry Standards (No. 21 [2025]),
3. March 2025,Swissmedic,Forms,Swissmedic Forms for February 2025,
3. March 2025,Swissmedic,Guidance,FSCA economic operators,
3. March 2025,"Therapeutic Goods Administration (TGA), Australia",Report,Pharmacovigilance Inspection Program metrics report: January to December 2022,
3. March 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Demonstrating the quality of listed probiotic medicines,
3. March 2025,"Therapeutic Goods Administration (TGA), Australia",Form,Updating organisation administrator,
3. March 2025,USA Food & Drug Administration FDA,Report,Accelerating Rare disease Cures (ARC) Program Annual Report,
3. March 2025,USA Food & Drug Administration FDA,Report,Drug Safety Priorities 2024,
24. February 2025,Central Drugs Standard Control Organization,Form,Draft (IVD-MD) adverse event reporting form for Comments,
24. February 2025,European Commission,Guidance,Expert decision and opinion in the context of the Clinical Evaluation Consultation,
24. February 2025,European Commission,Update,Notified Body Update (13) Active 1 Withdrawn 1 Suspended IVDR,
24. February 2025,European Commission,Newsletter,Medical Devices News,
24. February 2025,European Data Protection Board,Report,Coordinated Supervision Committee Report of Activities 2022-2024,
24. February 2025,European Medicines Agency,Guidance,Product Management Service (PMS) â€“ Frequently Asked Questions,
24. February 2025,European Medicines Agency,Guidance,Post-authorisation Procedural Advice for Users of theÂ Centralised Procedure,
24. February 2025,European Medicines Agency,Guidance,Checklist for the submission of Type IA and Type,
24. February 2025,European Medicines Agency,Guidance,Biosimilar medicines:Â marketing authorisation,
24. February 2025,European Medicines Agency,Guidance,Sponsor Handbook Clinical Trials Information System CTIS,
24. February 2025,European Medicines Agency,Guidance,Introductory guide CTIS for SMEs and Academia,
24. February 2025,European Medicines Agency,Guidance,"How to search, view and download a Clinical, Clinical Trial Application",
24. February 2025,European Medicines Agency,Guidance,FAQs Introduction to the Clinical Trials Regulation (EU) No 536/2014,
24. February 2025,European Medicines Agency,Guidance,Data protection notice Clinical Trials Information System (CTIS),
24. February 2025,Health Canada,Guidance,Managing Applications for Medical Device Licences: Overview,
24. February 2025,"Health Products Regulatory Authority (HPRA)Â , Ireland",Guidance,Certificate of free sale process updates,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Registration of in vitro diagnostic devices with expiring CE certificates,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Regulating medical devices in the UK,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Reusable or upclassified Class I devices and/or expiring CE certificates,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Good Pharmacovigilance Practices that apply to UK MAHs and the MHRA,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Wholesalers & manufacturers guidance - Windsor Framework,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: reclassify your product,
24. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Clinical Investigations,
24. February 2025,Swissmedic,Forms,Swissmedic Forms for February 2025,
24. February 2025,Swissmedic,Report,Swissmedic assessment of post-market surveillance,
24. February 2025,Swissmedic,Guidance,Vigilance-Kontaktperson fÃ¼r Medizinprodukte,
24. February 2025,Swissmedic,Guidance,Incident Report User,
24. February 2025,Swissmedic,Guidance,Incident Economic Operators,
24. February 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,International Guidelines Adopted in Australia February 2025,
24. February 2025,USA Food & Drug Administration FDA,Guidance,Drug development tool to facilitate clinical trial research on alcohol use disorder,
17. February 2025,Egyptian Drug Authority,Guidance,Adding new distributor(s) to notify the registration of a medical requirement,
17. February 2025,European Commission,Call for Applications,Pilot coordinated assessment for CI/PS,
17. February 2025,European Commission,Guidance,MDCG 2019-6 rev.5 â€“ Q&A: Requirements relating to notified bodies,
17. February 2025,European Commission,Infographic,Health Policy Platform (EUHPP) Overview,
17. February 2025,European Medicines Agency,Guidance,Request advice from Expert Panels on clinical investigations and/or development,
17. February 2025,European Medicines Agency,Guidance,The linguistic review process of product information in the centralised procedure,
17. February 2025,European Medicines Agency,Guidance,Implementation strategy ofÂ ICHÂ GuidelineÂ M12 on drug interaction studies,
17. February 2025,European Medicines Agency,Consultation,Assessment & reporting of mechanistic models informed drug development,
17. February 2025,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment CommitteeÂ (PRAC) 10-13 February 2025,
17. February 2025,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report January 2025,
17. February 2025,"Federal Office for Information Security, Germany",Report,Security assessment of wearable devices with medical functionalities (SiWamed),
17. February 2025,Federal Council Swiss Government,Press Release,AI regulation: Federal Council to ratify Council of Europe Convention,
17. February 2025,InternationalÂ ElectrotechnicalÂ Commission,Standards,Design Specification for the second edition of IEC 62304,
17. February 2025,InternationalÂ ElectrotechnicalÂ Commission,Standards,IEC 62304 2nd Edition Change Rationales,
17. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Good Pharmacovigilance Practices that apply to UK MAHs and the MHRA,
17. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Importing investigational medicinal products into UK from approved countries,
17. February 2025,Medicines and Healthcare products Regulatory Agency,Report,MHRA Real-World Evidence Scientific Dialogue Programme,
17. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Digital mental health technology: qualification and classification,
17. February 2025,Medical Device Authority Malaysia,Press release,Achievements Throughout 2023 â€“ 2024,
17. February 2025,"NMPA-National Medical Products Administration, Peoples Republic of China",Consultation,Supervision and Administration of Export Drug Production,
17. February 2025,"NMPA-National Medical Products Administration, Peoples Republic of China",Report,China Medical Device Standards Management Annual Report (2024),
17. February 2025,South African Health Products Regulatory Authority,Guidance,Renewal of Human and Veterinary Medicines Requirements and Process,
17. February 2025,Swissmedic,Forms,Swissmedic Forms for February 2025,
17. February 2025,Swissmedic,Position Paper,Decentralised clinical trials (DCTs) with medicinal products in Switzerland,
10. February 2025,"Cofepris, Mexico",Consultation,"Registration of a Medical Device, its Modifications and Extensions.",
10. February 2025,Drug Regulatory Authority of Pakistan,Guidance,"Notification regarding Therapeutic Goods (Advertisement) Rules, 2025",
10. February 2025,Egyptian Drug Authority,Guidance,"customs processing medical, laboratory supplies, devices, diagnostic reagents",
10. February 2025,European Commission,News,First request submission period for (JSCs) under the HTA Regulation.,
10. February 2025,European Commission,Guidance,"Prohibited artificial intelligence (AI) practices, as defined by the AI Act.",
10. February 2025,European Commission,Guidance,AI system definition to facilitate the first AI Actâ€™s rules application,
10. February 2025,European Commission,Guidance,MDCG 2025-2 EMDN Update Submissions from 2024,
10. February 2025,European Commission,Guidance,MDCG 2025-3 EMDN Version History,
10. February 2025,European Medicines Agency,Report,Nanotechnology-based medicinal products for human use,
10. February 2025,European Medicines Agency,Guidance,Q&A on (Regulations MDR (EU) 2017/745 and IVDR (EU) 2017/746),
10. February 2025,European Medicines Agency,Guidance,non-clinical and clinical requirements advanced therapy products in clinical trials,
10. February 2025,Health Canada,Guidance,Pre-market guidance for machine learning-enabled medical devices,
10. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Digital mental health technology: qualification and classification,
10. February 2025,Medicines and Healthcare products Regulatory Agency,Consultation,Draft guidance on individualised mRNA cancer immunotherapies,
10. February 2025,Medicines and Healthcare products Regulatory Agency,Regulation,(Amendment) (Modular Manufacture and Point of Care) Regulations 2025,
10. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Regulations and current approaches to product marking for the GB market,
10. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Decision tree for nanotechnology-based products for medical applications,
10. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,"Clinical trials for medicines: manage your authorisation, report safety issues",
10. February 2025,Medical Device Authority Malaysia,Guidance,Placement of HIV Self-Test (HIVST) Kit In Malaysia Market,
10. February 2025,Medical Device Authority Malaysia,Guidance,Advertisement of Medical Device,
10. February 2025,South African Health Products Regulatory Authority,Guidance,Approval of a dosimetry service in South Africa,
10. February 2025,Swissmedic,Forms,Swissmedic Forms for February 2025,
10. February 2025,Swissmedic,Guidance,Formal Requirements,
10. February 2025,Swissmedic,Guidance,Directory Overview of documents to be submitted,
10. February 2025,Swissmedic,Guidance,Instandhaltung von Medizinprodukten,
10. February 2025,Swissmedic,Guidance,Instructions for filling the eDok_KLV folder structure,
10. February 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Guidance for the use of medicinal cannabis in Australia: Overview,
10. February 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Request to cancel an ARTG entry,
10. February 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,TGA publishes literature review of sunscreen ingredients,
10. February 2025,USA Food & Drug Administration FDA,Guidance,Risk of Transmission of Mycobacterium tuberculosis (Mtb),
10. February 2025,USA Food & Drug Administration FDA,Guidance,Risk of Transmission of Disease Agents Associated with Sepsis,
10. February 2025,USA Food & Drug Administration FDA,Guidance,FAQs: Guidance for Institutional Review Boards and Clinical Investigators,
10. February 2025,USA Food & Drug Administration FDA,Guidance,Institutional Review Board (IRB) Written Procedures,
3. February 2025,Egyptian Drug Authority,Announcement,Importing dental appliances and supplies,
3. February 2025,Egyptian Drug Authority,Guidance,FAQs examination and analysis and accreditation of standard materials.,
3. February 2025,European Commission,Guidance,MDCG 2024-2 Rev.1 Procedures to European Medical Device Nomenclature,
3. February 2025,European Commission,Form,MDCG 2025-1 EMDN Ad hoc procedure form,
3. February 2025,European Commission,Guidance,MDCG 2021-12 Rev.1 FAQ European Medical Device Nomenclature (EMDN),
3. February 2025,European Commission,Guidance,Advice on SARS-CoV-2 on request from the Medical Device Coordination Group,
3. February 2025,European Commission,News,Joint Action on Expertise on Cancer launched,
3. February 2025,European Commission,News,Joint Action on Respiratory Diseases launched,
3. February 2025,European Commission,News,Biotech and Biomanufacturing Hub to support innovative companies,
3. February 2025,European Medicines Agency,Guidance,ICHÂ E6Â good clinical practiceÂ - ScientificÂ guideline,
3. February 2025,European Medicines Agency,Guidance,CTIS public portal: Full trial information,
3. February 2025,European Medicines Agency,Guidance,On the qualification of non-mutagenic impurities,
3. February 2025,European Medicines Agency,Guidance,Procedural advice for post-orphan medicinal product designation activities,
3. February 2025,European Medicines Agency,Meeting,Committee for Medicinal Products for Human UseÂ (CHMP) 27-30 January 2025,
3. February 2025,International Medical Device Regulators Forum,Guidance,Considerations for Medical Device Software and Software Specific Risk,
3. February 2025,International Medical Device Regulators Forum,Guidance,Good machine learning practice for medical device development,
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Supply unlicensed medicinal products (specials),
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Import a human medicine,
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Notification of intent to import an unlicensed medicinal product,
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Innovative Licensing and Access Pathway (ILAP),
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,UK-wide licensing for human medicines: supplementary guidance,
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: get scientific advice from MHRA,
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Access New Active Substance and Biosimilar Work Sharing Initiatives,
3. February 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Regulating medical devices in the UK,
3. February 2025,Department of Health & Social Care,Policy Paper,Design for Life roadmap,
3. February 2025,National Institute for Healthcare & Excellence,News,Medical Devices Access Iniative MMD,
3. February 2025,"MEDSAFE, New Zealand",Guidance,Updates to the Data sheet template and explanatory guide,
3. February 2025,Swissmedic,Forms,Swissmedic Forms for January 2025,
3. February 2025,Swissmedic,Guidance,Preparation for blinded dispensing,
3. February 2025,Swissmedic,Guidance,General procedure for foreign governmental inspections in Switzerland,
3. February 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Australian regulatory guidelines for sunscreens (ARGS),
3. February 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Medical device conformity assessment application,
3. February 2025,World Health Organisation WHO,Glossary,"Glossary of health data, statistics and public health indicators",
3. February 2025,World Health Organisation WHO,Report,Clinical research landscape of monoclonal antibodies,
27. January 2025,ANVISA Brazil,Guidance,New rules for post-market monitoring of cosmetics,
27. January 2025,Association for the Advancement of Medical Instrumentation,Standard,ANSI/AAMI EQ56:2024; Standard for a medical equipment management program,
27. January 2025,Association for the Advancement of Medical Instrumentation,Standard,ANSI/AAMI EQ110:2024;Health technology management educational programs,
27. January 2025,Association for the Advancement of Medical Instrumentation,Standard,ANSI/AAMI EQ103:2024; (AEM) program in healthcare delivery organizations,
27. January 2025,Egyptian Drug Authority,Registry,Egyptian drug registry for blood disease drugs,
27. January 2025,Central Drugs Standard Control Organization,Guidance,Validation of Rapid Diagnostics for Pathogen Identification & AST,
27. January 2025,European Commission,Guidance,Scientific consultations on medical devices & in vitro diagnostic medical devices,
27. January 2025,European Data Protection Board,Guidance,Guidelines 01/2025 on Pseudonymisation,
27. January 2025,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment CommitteeÂ (PRAC) 13-16 January 2025,
27. January 2025,European Medicines Agency,Guidance,Specific adverse reaction follow-up questionnaires (Specific AR FUQ),
27. January 2025,European Medicines Agency,Guidance,Product Management Service (PMS) roadmap,
27. January 2025,International Society for Pharmaceutical Engineering (ISPE),Guidance,Evaluation of Pharma Airborne Particle Emissions from Containment Systems,
27. January 2025,International Council for Harmonisation,Guidance,The ICH E6(R3) Introductory Training Presentation is now available,
27. January 2025,Medical Device Authority Malaysia,Consultation,Importation of Medical Device for Personal Use,
27. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: get scientific advice from MHRA,
27. January 2025,Ministry of Food and Drug Safety of Republic of Korea,Guidance,Guideline on Evaluation of New Extended Release(ER) Preparations,
27. January 2025,"Department for Science, Innovation & Technology",Report,AI Opportunities Action Plan,
27. January 2025,"NMPA-National Medical Products Administration, Peoples Republic of China",Consultation,Using Brain-Computer Interface Technology for AI Algorithms,
27. January 2025,Swissmedic,Forms,Swissmedic Forms for January 2025,
27. January 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,International Guidelines Adopted in Australia January 2025,
27. January 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Use of market authorisation evidence from comparable overseas regulators,
27. January 2025,USA Food & Drug Administration FDA,Guidance,Bioanalytical Method Validation for Biomarkers,
27. January 2025,USA Food & Drug Administration FDA,Report,CDRH Annual Report,
20. January 2025,ANVISA Brazil,Regulation,DCB: new regulatory framework published,
20. January 2025,Central Drugs Standard Control Organization,Guidance,Update of risk based classification for stakeholder comments,
20. January 2025,European Commission,Guidance,Q&As and Flow-Charts on Gradual Roll-Out of EUDAMED,
20. January 2025,European Commission,Communication,Action Plan on the Cybersecurity of Hospitals and Healthcare Providers,
20. January 2025,European Commission,Guidance,Questions and answers on cybersecurity of hospitals and healthcare providers,
20. January 2025,European Commission,Factsheet,Cybersecurity of hospitals and healthcare providers,
20. January 2025,European Directorate for the Quality of Medicines & HealthCare,Guidance,European Pharmacopoeia Supplement 11.8 â€“ Notification for CEP holders,
20. January 2025,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report December 2024,
20. January 2025,European Medicines Agency,Guidance,Chapter 3.II: XEVPRM User Guidance,
20. January 2025,European Medicines Agency,Guidance,Electronic submission of Article 57(2) data Questions & Answers (Q&As),
20. January 2025,European Medicines Agency,Guidance,Chapter 5: eXtended EudraVigilance Product Report Acknowledgement Message,
20. January 2025,European Medicines Agency,Newsflash,CTIS newsflash â€“ 14 January 2025,
20. January 2025,European Medicines Agency,Report,Human Medicines in 2024,
20. January 2025,International Council for Harmonisation,Guidance,ICH E6(R3) Guideline reaches Step 4 of the ICH Process,
20. January 2025,MedTech Europe,Survey,MedTech Europe IVDR & MDR Survey Results 2024,
20. January 2025,MedTech Europe,Paper,EU HTA Regulation & EU Harmonised Assessment for Digital Medical Devices & AI,
20. January 2025,Medicines and Healthcare products Regulatory Agency,Consultation,ICH M15 Guideline for Model Informed Drug Development (MIDD),
20. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,The Medical Devices (Post-market Surveillance Requirements) (Amendment),
20. January 2025,Medicines and Healthcare products Regulatory Agency,Consultation,Vector Copy Number and addition of PCR validation annexes,
20. January 2025,Saudi Food & Drug Authority,Guidance,Regulation and Requirements for Conducting Clinical Trials on Drug,
20. January 2025,Swissmedic,Forms,Swissmedic Forms for January 2025,
20. January 2025,Swissmedic,Guidance,Orphan Drug,
20. January 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,International Guidelines Adopted in Australia January 2025,
20. January 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Demonstrating the quality of listed probiotic medicines,
20. January 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Understanding application audit rules for medical devices including (IVDs),
20. January 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,Transitioning to new manufacturer evidence for (IVDs),
20. January 2025,USA Food & Drug Administration FDA,Guidance,Premarket Approval Application & Device Exemption Modular Review,
20. January 2025,USA Food & Drug Administration FDA,Guidance,Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria,
20. January 2025,USA Food & Drug Administration FDA,Guidance,Prevention and Treatment of Chemotherapy-Induced Peripheral Neuropathy,
20. January 2025,USA Food & Drug Administration FDA,Publication,"Narrow Therapeutic Index Drugs: FDA Experience, Views, and Operations",
20. January 2025,USA Food & Drug Administration FDA,Agenda,Rare Disease Innovation Hub,
20. January 2025,USA Food & Drug Administration FDA,Report,Accreditation Scheme for Conformity Assessment (ASCA) Annual Report 2024,
13. January 2025,European Commission,Guidance,"MDCG 2023-3 rev.2 â€“ Q&A on vigilance terms MDR, IVDR",
13. January 2025,European Commission,Guidance,MDCG 2024-7 rev.1 & Annex  Preliminary assessment review (PAR) form,
13. January 2025,European Directorate for the Quality of Medicines & HealthCare,Guidance,Pharmeuropa 37.1 just released,
13. January 2025,European Medicines Agency,Guidance,IRIS guide for applicants,
13. January 2025,European Medicines Agency,Guidance,New Organisation First User EU QPPV/RP or Change of EU QPPV/RP,
13. January 2025,European Medicines Agency,Guidance,Information package for certificates of EMA issued medicinal products,
13. January 2025,ISO (International Organization for Standardization),Standards,"ISO Update December 1, 2024 to January 1, 2025",
13. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Regulation of devices in Northern Ireland,
13. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
13. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Qualified person responsible-pharmacovigilance (QPPV) & (PSMF),
13. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Guidance on pharmacovigilance procedures,
13. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Guidance on MAH and QPPV location,
13. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Windsor Framework Hub,
13. January 2025,Swissmedic,Forms,Swissmedic Forms for January 2025,
13. January 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,International Guidelines Adopted in Australia January 2025,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Communications From Firms to Health Care Providers Q&A,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Pulse Oximeters for Medical Purposes,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Draft Guidance on Artificial Intelligence-Enabled Device Software Functions,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Considerations for AI to Support Regulatory Decision-Making,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Study of Sex Differences in the Clinical Evaluation of Medical Products,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Sex-Specific & Gender-Specific Data in Medical Device Clinical Studies,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Validation of Certain IVD Device for Emerging Pathogens during 564 Emergency,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Accelerated Approval &  Determining a Confirmatory Trial,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Considerations for Including Tissue Biopsies in Clinical Trials,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Section 506j discontinuance or Interruption in Manufacturing of a Device,
13. January 2025,USA Food & Drug Administration FDA,Guidance,"Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)",
13. January 2025,USA Food & Drug Administration FDA,Guidance,Developing Drugs for Optical Imaging,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Developing Drugs and Biological Products for Weight Reduction,
13. January 2025,USA Food & Drug Administration FDA,Guidance,Compounding Using Bulk Drug Substances Under Section 503A & 503B,
13. January 2025,USA Food & Drug Administration FDA,Report,CDER: New Drug Therapy Approvals 2024,
6. January 2025,ANVISA Brazil,Guidance,Anvisa concludes the 2nd cycle of review and consolidation of normative acts,
6. January 2025,Egyptian Drug Authority,Guidance,Online Complaints and Interview Requests of the General Directorate of Stability,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Windsor Framework (WF) Guide to Product Categorisation for New Applications,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,UK medicines export and labelling for international regulators,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Sourcing medicines for the UK market,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Windsor Framework Hub,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Exceptions and modifications to the EU guidance on GVP practices,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,150-day assessment for national applications for medicines,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Procedures for UK paediatric investigation plan (PIPs),
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,herbal medicinal products and homeopathic medicinal products,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Renewing marketing authorisations for medicines,
6. January 2025,Medicines and Healthcare products Regulatory Agency,Guidance,Exporting active substances manufactured in GB for use in EEA and NI,
6. January 2025,Swissmedic,Amendment,In Vitro Diagnostic Medical Devices (IVDs) and the Medical Devices Ordinance,
6. January 2025,Swissmedic,Guidance,Optimisation of labelling phase for human medicinal products,
6. January 2025,Swissmedic,Guidance,Procurement of medical devices in healthcare institutions,
6. January 2025,Swissmedic,Guidance,Obligations Economic Operators CH,
6. January 2025,Swissmedic,Guidance,Description of document protection,
6. January 2025,"Therapeutic Goods Administration (TGA), Australia",Guidance,International Guidelines Adopted in Australia,
6. January 2025,USA Food & Drug Administration FDA,Briefing,Combined FDA and Sponsor Oncologic Drugs Advisory Committee,
6. January 2025,USA Food & Drug Administration FDA,Guidance,"Deviations for Clinical Investigations of Drugs, Biological Products, & Devices",
6. January 2025,USA Food & Drug Administration FDA,Guidance,M15 General Principles for Model-Informed Drug Development,
6. January 2025,USA Food & Drug Administration FDA,Guidance,E11A Pediatric Extrapolation,
6. January 2025,USA Food & Drug Administration FDA,Guidance,Advanced Manufacturing Technologies Designation Program,
6. January 2025,USA Food & Drug Administration FDA,Guidance,SOPP 8422: Processing and Review of Trans-BLA Submissions,
6. January 2025,USA Food & Drug Administration FDA,Guidance,Guidance Agenda: CBER Calendar Year 2025,
6. January 2025,USA Food & Drug Administration FDA,Guidance,Considerations for Complying With 21 CFR 211.110,
30. December 2024,ANVISA Brazil,Guidance,Dashboard for clinical investigations with medical devices,
30. December 2024,ANVISA Brazil,Regulation,"Consulta PÃºblica nÂ° 1.301, de 16 de dezembro de 2024",
30. December 2024,Association for the Advancement of Medical Instrumentation,Standard,AAMI TIR17:2024; Compatibility of materials subject to sterilization,
30. December 2024,Egyptian Drug Authority,Guidance,FAQs For Good Practice of Reliance of Post Approval Changes,
30. December 2024,Egyptian Drug Authority,Consultation,Application for Reliance Pathway for Laboratory Testing for Veterinary Use,
30. December 2024,Egyptian Drug Authority,Guidance,Fourth edition of the regulatory guide No. (450) of 2023,
30. December 2024,Egyptian Drug Authority,Guidance,Mechanism for Receiving the Updated Analysis Points for Stability studies,
30. December 2024,European Commission,Consultation,Performance pharmacovigilance activities for human medicines (EU) 520/2012,
30. December 2024,European Data Protection Board,Opinion,28/2024 aspects related to the processing of personal data - context of AI models,
30. December 2024,European Directorate for the Quality of Medicines & HealthCare,Guidance,MHRA Windsor Framework hub,
30. December 2024,European Directorate for the Quality of Medicines & HealthCare,Guidance,Procedure for marketing authorisations approved in Northern Ireland,
30. December 2024,European Directorate for the Quality of Medicines & HealthCare,Guidance,ICH Technical Requirements for Pharmaceuticals for Human Use Guidelines,
30. December 2024,European Directorate for the Quality of Medicines & HealthCare,Guidance,Licensing of biosimilar products,
30. December 2024,European Directorate for the Quality of Medicines & HealthCare,Guidance,Variations to marketing authorisations (MAs),
30. December 2024,European Directorate for the Quality of Medicines & HealthCare,Guidance,Comparator products in bioequivalence/therapeutic equivalence studies,
30. December 2024,Global Harmonization Working Party,Meeting,"28th GHWP Annual Meeting, Kuala Lumpur",
30. December 2024, Swissmedic,Forms,Swissmedic Forms for December 2024,
30. December 2024, Swissmedic,Guidance,FAQ Notifications,
30. December 2024, Swissmedic,Guidance,FAQ on in vitro diagnostic medical device notifications,
30. December 2024,Team AB,Regulations,(Post-market Surveillance Requirements) (Great Britain) Regulations 2024,
30. December 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Review of draft guidance documents - Audit framework for medical devices,
30. December 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Medical device application audits,
30. December 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Selection criteria for non-mandatory application audits,
30. December 2024,USA Food & Drug Administration FDA,Guidance,Clinical Decision Support Software (FAQs),
30. December 2024,USA Food & Drug Administration FDA,Guidance,How TAP Facilitates Engagement with Non-FDA Parties,
30. December 2024,USA Food & Drug Administration FDA,Report,Progress Reflection Paper on the Generic Drug Cluster,
30. December 2024,USA Food & Drug Administration FDA,Regulation,Final Rule to Broaden Types of Nonprescription Drugs Available to Consumers,
23. December 2024,ANVISA Brazil,Guidance,Anvisa approves Annual Management Plan for 2025,
23. December 2024,European Commission,Guidance,COMBINE programme for clinical trials and medical devices,
23. December 2024,European Commission,Guidance,MDCG 2019-13 sampling of MDR Class IIa / Class IIb and IVDR Class B / C,
23. December 2024,European Commission,Guidance,MDCG 2022-3 rev.1 - Verification of manufactured class D IVDs,
23. December 2024,European Commission,Factsheet,Factsheet for healthcare professionals and health institutions,
23. December 2024,European Directorate for the Quality of Medicines & HealthCare,Guidance,FAQ system suitability test in assay chromatographic procedures,
23. December 2024,European Medicines Agency,Guidance,Scientific Explorer - Frequently Asked Questions (FAQs),
23. December 2024,European Medicines Agency,Guidance,Instructions on how to submit a request for certificates of medicinal products,
23. December 2024,European Medicines Agency,Guidance,Questions and answers for biological medicinal products,
23. December 2024,European Medicines Agency,Guidance,"Questions & Answers How to create, submit and withdraw a CTA",
23. December 2024,European Medicines Agency,Guidance,Applicants seeking scientific advice and protocol assistance,
23. December 2024,European Medicines Agency,Report,Industry stakeholder platform on the operation of the centralised procedure,
23. December 2024,European Medicines Agency,Report,electronic product information ePI pilot report,
23. December 2024,European Medicines Agency,Meeting,Committee for Medicinal Products for Human UseÂ (CHMP) 9-12 December 2024,
23. December 2024,European Medicines Agency,Guidance,Post-authorisation procedural advice for users of the centralised procedure,
23. December 2024,European Medicines Agency,Guidance,Pre-authorisation procedural advice for users of the centralised procedure,
23. December 2024,European Medicines Agency,Guidance,Procedural advice for medicinal products for markets outside the European Union,
23. December 2024,European Medicines Agency,Guidance,Consultation by NB on ancillary medicinal substance in a medical device,
23. December 2024,European Medicines Agency,Guidance,Product Management Service PMS  (IDMP) in Europe - Chapter 2,
23. December 2024,European Medicines Agency,Guidance,Product Management Service (PMS) FAQs,
23. December 2024,European Medicines Agency,Guidance,Consultation to the EMA on companion diagnostics,
23. December 2024,European Medicines Agency,Guidance,Questions & Answers Consultation to the EMA on companion diagnostics,
23. December 2024,Medicines and Healthcare products Regulatory Agency,Guidance,In-house manufacture of medical devices in Great Britain,
23. December 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: register as a broker,
23. December 2024,Medicines and Healthcare products Regulatory Agency,Guidance,"Medicines: register to manufacture, import or distribute active substances",
23. December 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: reclassify your product,
23. December 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Clinical investigations guidance,
23. December 2024, Pharmaceutical Inspection Co-operation Scheme PIC/S,Guidance,Remote Assessments,
23. December 2024, Swissmedic,Forms,Swissmedic Forms for December 2024,
23. December 2024, Swissmedic,Guidance,Export Certificates,
23. December 2024,"Team Notified Body, Europe",Guidance,"MDR Certification Process (Pre-application, Application and Post Application)",
23. December 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,International Guidelines Adopted in Australia,
23. December 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Serious Scarcity Substitution Instruments (SSSIs),
23. December 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,"Procedure for recalls, product alerts and product corrections (PRAC)",
23. December 2024,USA Food & Drug Administration FDA,Guidance,Global Unique Device Identification Database (GUDID),
16. December 2024,ANVISA Brazil,Guidance,applications for classification of borderline products,
16. December 2024,ANVISA Brazil,Guidance,Writing manual of the Brazilian Pharmacopoeia,
16. December 2024,Egyptian Drug Authority,News,Fast Track Application to Trade Names & Cards Evaluation Unit for Human Products,
16. December 2024,Egyptian Drug Authority,Guidance,Registration of Synthetic Peptides Pharmaceutical Products of rDNA Origin,
16. December 2024,Egyptian Drug Authority,Guidance,"Label data for medical and laboratory supplies, devices, diagnostic reagentsâ€¦",
16. December 2024,European Commission,Form,Manufacturer Information Form on Interruption or Discontinuation,
16. December 2024,European Commission,Report,On the operation of Article 17 of Regulation (EU) 2017/745,
16. December 2024,European Commission,Consultation,EU rules on medical devices and in vitro diagnostics â€“ targeted evaluation,
16. December 2024,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report November 2024,
16. December 2024,European Medicines Agency,Guidance,Quality of medicines questions and answers: Part 1,
16. December 2024,European Medicines Agency,Report,Mid-year report 2024,
16. December 2024,European Medicines Agency,Guidance,(IDMP) in Europe - Chapter 1: Registration requirements,
16. December 2024,European Medicines Agency,Information,CTIS public portal: Full trial information,
16. December 2024,European Medicines Agency,Guidance,Q&A Regulatory Procedure Management for the Product Lifecycle Management,
16. December 2024,European Medicines Agency,Guidance,IRIS guide for applicants,
16. December 2024,International Council for Harmonisation,Guidance,ICH Q9(R1) IWG Updated Q9(R1) Annex 1- Q8/Q9/Q10 Questions & Answers,
16. December 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Implementation of medical devices future regime Roadmap,
16. December 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply for a licence to market a medicine in the UK,
16. December 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Replication competent virus assays,
16. December 2024,Swissmedic,Guidance,Medical devices â€“ content requirements for CAPA plan,
16. December 2024,Swissmedic,Forms,Dec-24,
16. December 2024,"Team Notified Body, Europe",News,Class D oversight by EURLs: endorsement of Multi Services Agreement template,
16. December 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Ensuring compliance after removing the Product Information insert,
16. December 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Australian Regulatory Guidelines for Medical Devices (ARGMD),
16. December 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Application to amend the Poisons Standard,
16. December 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Updates to requirements and guidance for labels of injectable medicines,
16. December 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,ICH Guidelines Adopted in Australia,
16. December 2024,USA Food & Drug Administration FDA,Guidance,"NDA e-Submission of NDA, BLA for Planning of Bioresearch Monitoring (BIMO)",
16. December 2024,USA Food & Drug Administration FDA,Guidance,FDAâ€™s Role in the Revision of the Declaration of Helsinki,
16. December 2024,USA Food & Drug Administration FDA,Guidance,Registration and Listing of Cosmetic Product Facilities and Products,
16. December 2024,World Health Organisation WHO,Guidance,Implementation of a Quality System in Blood Establishments,
16. December 2024,World Health Organisation WHO,Guidance,Identify Barriers in Blood Services using Blood System Self-assessment (â€ŽBSS),
9. December 2024,ANVISA Brazil,News,"Anvisa launches its new legislation Portal, AnvisaLegis",
9. December 2024,European Commission,Guidance,MDCG 2024-15 clinical investigation reports in the absence of EUDAMED,
9. December 2024,European Commission,Information,24 European Reference Networks for Rare Diseases,
9. December 2024,European Directorate for the Quality of Medicines & HealthCare,News,180th session of the European Pharmacopoeia Commission,
9. December 2024,European Directorate for the Quality of Medicines & HealthCare,Publication,ELISA determination of physical particle titre of AAV2-based vector preparations,
9. December 2024,European Medicines Agency,Guidance,Data Quality Framework for EU medicines regulation,
9. December 2024,European Medicines Agency,Guidance,Good Clinical Practice â€“ ICH E6(R3) Annex 2,
9. December 2024,European Medicines Agency,Guidance,Abbreviations used in EMA scientific committees & CMD documents,
9. December 2024,European Medicines Agency,Guidance,Veterinary medicines Format for the electronic submission,
9. December 2024,European Medicines Agency,Concept Paper,Need for Revision of the Addendum on Weight Control in Children,
9. December 2024,European Medicines Agency,Guidance,Clinical requirements for non-replacement therapy in haemophilia A and B,
9. December 2024,European Medicines Agency,Guidance,Submission Investigational medicinal products EudraVigilance (XEVMPD),
9. December 2024,"Health Sciences Authority (HSA), Singapore",Guidance,"GN-37-R1 Change Management Program (CMP) for SaMD, ML SaMD)",
9. December 2024,"Health Sciences Authority (HSA), Singapore",Pilot,"Change Management Program (CMP) for SaMD, including ML-enabled SaMD)",
9. December 2024,ISO (International Organization for Standardization),Standard,ISO Update November 1. to 1. December 2024,
9. December 2024,International Council for Harmonisation,Guidance,ICH M15 General Principles for Model-informed Drug Development MIDD,
9. December 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Good laboratory practice (GLP) for safety tests on chemicals,
9. December 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Clinical investigations guidance,
9. December 2024,Swissmedic,Guidance,"Swissmedic eGov Portal	Forms: December 2024",
9. December 2024,Swissmedic,Guidance,Temporary authorisation for human medicinal products,
9. December 2024,Swissmedic,Guidance,Authorisation veterinary medicinal product under Art. 13 TPA,
9. December 2024,Swissmedic,Consultation,ICH Guidelines E6(R3) and M15 Open in Switzerland Until 28 February 2025,
9. December 2024,"Team Notified Body, Europe",Position Paper,regulatory framework for the medical devices sector,
9. December 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Changes to the Permissible Ingredients Determination,
9. December 2024,USA Food & Drug Administration FDA,Guidance,Predetermined Change Control Plan for AI-Enabled Device Software Functions,
9. December 2024,USA Food & Drug Administration FDA,Guidance,Accelerated Approval â€“ Expedited Program for Serious Conditions,
9. December 2024,USA Food & Drug Administration FDA,Report,Draft Best Practices for FDA Communication with Interested Parties,
9. December 2024,USA Food & Drug Administration FDA,Report,Report on Risks and Benefts to Health of Non-Device Software Functions,
9. December 2024,World Health Organisation WHO,Guidance,WHO Drug Information Volume 38 Number 2 2024,
9. December 2024,World Health Organisation WHO,Guidance,WHO Drug Information Volume 38 Number 3 2024,
2. December 2024,ANVISA Brazil,News,Anvisa approves update of the 2024-2025 Regulatory Agenda,
2. December 2024,ANVISA Brazil,Guidance,Notification and Registration of Medical Devices,
2. December 2024,Egyptian Drug Authority,Guidance,Reliance Pathway for Laboratory Testing of Medical Products,
2. December 2024,Egyptian Drug Authority,Form,Application Form and CMC Differences Form for Reliance Pathway 2024,
2. December 2024,European Commission,Guidance,MDCG 2024-14 - Guidance on the implementation UDI-DI for contact lenses,
2. December 2024,European Commission,Report,CEN-CENELEC Sector Forum for Healthcare Standards (SFHS/ABHS),
2. December 2024,European Commission,Report,Context of the Performance Evaluation Consultation Procedure (PECP),
2. December 2024,European Commission,Dashboard update,Study the monitoring of availability of medical devices on the EU market,
2. December 2024,European Directorate for the Quality of Medicines & HealthCare,News,General Chapter Elemental Impurities (G-07) Harmonised Pharmacopoeial Group,
2. December 2024,European Directorate for the Quality of Medicines & HealthCare,Guidance,Content of the dossier for sterile substances,
2. December 2024,European Medicines Agency,Presentation,SME Info Day - EMA activities on medical devices,
2. December 2024,European Medicines Agency,Guidance,QRD statements for metered dose inhalers containing fluorinated gases,
2. December 2024,European Medicines Agency,Consultation,Guideline on demonstration of therapeutic equivalence for nasal products,
2. December 2024,European Medicines Agency,Fees,New Fee Regulation (from 1 January 2025),
2. December 2024,European Medicines Agency,Guidance,Scientific guidelines with SmPC recommendations,
2. December 2024,European Medicines Agency,Guidance,SMS Guidance for External Users,
2. December 2024,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment CommitteeÂ (PRAC) 25-28 November 2024,
2. December 2024,International Council for Harmonisation,Guidance,Good Clinical Practice â€“ ICH E6(R3) Annex 2,
2. December 2024,International Council for Harmonisation,Guidance,ICH Q13 IWG Video Training Material Modules 1-12,
2. December 2024,International Council for Harmonisation,Consultation,"Post-Approval Chemistry, Manufacturing,& Controls Collaborative Assessment",
2. December 2024,National Agency for Food & Drug Administration & Control Nigeria,Guidance,Good Manufacturing Practice for Pharmaceutical Products,
2. December 2024,National Agency for Food & Drug Administration & Control Nigeria,Guidance,Clinical Trial Application In Nigeria,
2. December 2024,Medicines and Healthcare products Regulatory Agency,Guidance,MHRA Windsor Framework Video Explainers,
2. December 2024,South African Health Products Regulatory Authority,Guidance,Sealing and Unsealing of Hazardous Substances,
2. December 2024,"Team Notified Body, Europe",Position Paper,"Questionnaire, Artificial Intelligence in Medical Devices",
2. December 2024,"Team Notified Body, Europe",Press Release,MDR Technical Documentation Training for Manufacturers,
2. December 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,IVD sponsors: a roadmap to market,
2. December 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Use of Medicinal Cannabis,
2. December 2024,USA Food & Drug Administration FDA,Guidance,Transitional Enforcement Policy for EtO Facility Changes for Class III Devices,
2. December 2024,USA Food & Drug Administration FDA,Guidance,Follow-Up Testing for an Ames-Positive Drug (Active Ingredient) or Metabolite,
2. December 2024,USA Food & Drug Administration FDA,Guidance,Ovarian Toxicity in Premenopausal Adults Development for Oncologics,
2. December 2024,USA Food & Drug Administration FDA,Guidance,Use of Circulating Tumor Deoxyribonucleic Acid for Drug Development,
25. November 2024,ANVISA Brazil,Regulation,"RDC NÂº 938, DE 14 DE NOVEMBRO DE 2024",
25. November 2024,ANVISA Brazil,Regulation,"RDC NÂº 937, DE 14 DE NOVEMBRO DE 2024",
25. November 2024,Egyptian Drug Authority,Consultation,Labelling Requirements for Investigational Medicinal Products,
25. November 2024,Egyptian Drug Authority,Monograph,Release of the third edition of the Egyptian Herbal Monograph 2024,
25. November 2024,European Commission,Guidance,Gradual roll out of EUDAMED Q&A,
25. November 2024,European Union,Directive,(EU) 2024/2853 on liability for defective products,
25. November 2024,European Union,Regulation,(EU) 2024/2847 Cyber Resilience Act,
25. November 2024,European Medicines Agency,Call to Action,Antimicrobial Resistance,
25. November 2024,European Medicines Agency,Report,Social Media Data for Real World Evidence in Regulatory Decision Making,
25. November 2024,European Medicines Agency,Template,Request advice clinical development strategy MDCG 2024-10,
25. November 2024,European Medicines Agency,Template,Request advice on the orphan device status MDCG 2024-10,
25. November 2024,European Medicines Agency,Newsflash,CTIS newsflash â€“ 19. November 2024,
25. November 2024,European Medicines Agency,Roadmap,EMA Portfolio Roadmap 2024-2026,
25. November 2024,Medicines and Healthcare products Regulatory Agency,Notification,Innovative Licensing and Access Pathway,
25. November 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Submitting an application for review by the ACBS,
25. November 2024,South African Health Products Regulatory Authority,Form,Licence to Import a New Listed Electromagnetic Product,
25. November 2024,South African Health Products Regulatory Authority,Form,"Licence Use, Operate, Apply Install, or Keep Installed MRI Medical",
25. November 2024,South African Health Products Regulatory Authority,Form,"Licence Use, Operate, Apply Install, or Keep Installed MRI (Veterinary)",
25. November 2024,Swissmedic,Guidance,Reporting a serious incident - handling of labile blood products,
25. November 2024,Swissmedic,Form,Reporting serious incidents involving labile blood products,
25. November 2024,Swissmedic,Guidance,Notifications devitalised human tissue,
25. November 2024,Swissmedic,Guidance,Application establishment licence medicinal products,
25. November 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Using the 'TGA assessed' claim on medicine labels,
25. November 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Adopted International Scientific Guidelines,
25. November 2024,USA Food & Drug Administration FDA,Guidance,Q&A Developing Potential Cellular and Gene Therapy Products,
25. November 2024,USA Food & Drug Administration FDA,Guidance,510(k) Third Party Review Program & 3rd Part (EUA) Review,
25. November 2024,USA Food & Drug Administration FDA,Guidance,"Non-Spinal Bone Plates, Screws, Washers - (510(k)) Submissions",
25. November 2024,USA Food & Drug Administration FDA,Guidance,"Non-Spinal Bone Plates, Screws, Washers - Performance Criteria",
25. November 2024,USA Food & Drug Administration FDA,MDDT Tools,Wound Q,
25. November 2024,USA Food & Drug Administration FDA,Standards,Recent Additions to Consensus Standards,
25. November 2024,USA Food & Drug Administration FDA,Standard,New Alternative Standard related to mammography report assessments,
25. November 2024,World Health Organisation WHO,Meeting,Responsible use of the life sciences and dual-use research,
25. November 2024,World Health Organisation WHO,Guidance,"Human genome data collection, access, use and sharing",
18. November 2024,European Commission,Guidance,MDCG 2023-3 Rev. 1 Q&A on vigilance terms MDR IVDR,
18. November 2024,European Medicines Agency,Notification,Arrangements for requesting EMA certificates before end of year,
18. November 2024,European Medicines Agency,Report,Monthly statistics October 2024 Medicinal products for human use,
18. November 2024,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment Committee11-14 Nov. 2024,
18. November 2024,European Medicines Agency,Consultation,Regulatory Science Research Needs,
18. November 2024,European Medicines Agency,Consultation,European Platform for Regulatory Science Research,
18. November 2024,European Medicines Agency,Guidance,Q&A good manufacturing practiceÂ andÂ good distribution practice.,
18. November 2024,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report October 2024,
18. November 2024,ISO (International Organization for Standardization),Standard,ISO Update October 1. to 1. November 2024,
18. November 2024,Medicines and Healthcare products Regulatory Agency,Consultation,Regulations: Routes to market and in vitro diagnostic devices,
18. November 2024,Medicines and Healthcare products Regulatory Agency,Consultation,Harmonisation ICH E6 (R3) Guideline,
18. November 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Implementation of medical devices future regime,
18. November 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Early Access to Medicines Scheme - Information for Applicants,
18. November 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Clinical Trials Regulations webinar recordings,
18. November 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Marketing Authorisation Applications under Article 29,
18. November 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
18. November 2024,Medical Device Authority Malaysia,Guidance,Control of Obsolete & Discontinued Medical Device In Healthcare,
18. November 2024,Department of Health Hong Kong Special Administration,Guidance,Various Technical References have been updated,
18. November 2024,Swissmedic,Forms,Forms for November 2024,
18. November 2024,Swissmedic,Guidance,Mandatory reporting of adverse reactions during a clinical trials,
18. November 2024,Swissmedic,Guidance,Product information for human medicinal products,
18. November 2024,Swissmedic,Guidance,Patienteninformation fÃ¼r KomplementÃ¤rarzneimittel,
18. November 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,ICH guidelines adopted in Australia,
18. November 2024,USA Food & Drug Administration FDA,Guidance,Safety Assessment of Oligonucleotide-Based Therapeutics,
18. November 2024,USA Food & Drug Administration FDA,Guidance,FDA's Voluntary Qualified Importer Program,
18. November 2024,World Health Organisation WHO,Guidance,Digital transformation handbook for health supply chain architecture,
11. November 2024,Egyptian Drug Authority,Guidance,In-Use stability testing FAQ,
11. November 2024,Egyptian Drug Authority,Guidance,National Egyptian Crash Cart and Emergency Lists,
11. November 2024,Egyptian Drug Authority,Declaration,Procedures for registering human products,
11. November 2024,Egyptian Drug Authority,Declaration,Public dissemination of Clinical Trials scientific and regulatory data,
11. November 2024,European Commission,EUDAMED,Release Notes Playground v 3.10.0  Release Notes,
11. November 2024,European Commission,Update,Notified bodies survey on certifications and applications,
11. November 2024,European Medicines Agency,Guidance,European Shortages Monitoring Platform (ESMP),
11. November 2024,European Medicines Agency,Consultation,Revised list of enabling tools,
11. November 2024,European Directorate for the Quality of Medicines & HealthCare,News,OMCL Network welcomes TÃ¼rkiye as a full member,
11. November 2024,European Directorate for the Quality of Medicines & HealthCare,Guidance,Medication Review,
11. November 2024,Medicines and Healthcare products Regulatory Agency,Statement,Innovative Licensing and Access Pathway,
11. November 2024,"MEDSAFE, New Zealand",Guidance,Manufacture of medicines Edition 5.4,
11. November 2024,"NMPA-National Medical Products Administration, PR China",Report,China Medical Device Standards Management Annual Report (2023),
11. November 2024,South African Health Products Regulatory Authority,Announcement,SAHPRA Engagement Portal,
11. November 2024,Swissmedic,Forms,Forms for November 2024,
11. November 2024,Swissmedic,Guidance,Authorisation of medicinal product with known active substance,
11. November 2024,Swissmedic,Guidance,Implementation Human Research Act 1. November 2024,
11. November 2024,Swissmedic,Guidance,Combined  Studies,
11. November 2024,Swissmedic,Directory,MembersÂ of the Human Medicines Expert Committee (HMEC),
11. November 2024,Swissmedic,Journal,Swissmedic Journal October 2024,
11. November 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Refinements to the Personalised Medical Device Framework,
11. November 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Medical practitioners' guide to up-classifying surgical mesh,
11. November 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,How to submit a custom-made medical device notification,
11. November 2024,USA Food & Drug Administration FDA,Update,Breakthrough Devices Metrics & Marketing Authorizations List,
11. November 2024,USA Food & Drug Administration FDA,Pilot,Split Real Time Application Review (STAR),
11. November 2024,USA Food & Drug Administration FDA,Initiative,Mechanism on Substandard and Falsified Medical Products,
4. November 2024,Egyptian Drug Authority,Declaration,Extension of the deadline for human pharmaceuticals,
4. November 2024,Egyptian Drug Authority,Guidance,Rules and Procedures for Re-registration of Human Medical Products,
4. November 2024,European Commission,Guidance,MDCG 2024-13 - Ethylene oxide (EtO) for sterilisation of medical devices,
4. November 2024,European Commission,Guidance,MDCG 2022-5 rev.1 - borderline medical devices & medicinal products,
4. November 2024,European Commission,Consultation,joint scientific consultations on medical devices & in vitro diagnostic devices,
4. November 2024,European Commission,Guidance,Q&A Obligation to inform in case of interruption or discontinuation of supply,
4. November 2024,European Medicines Agency,Guidance,Advice on the use of paclitaxel-coated devices in peripheral artery disease,
4. November 2024,European Medicines Agency,Guidance,Registration guide for UI and API users - veterinary medicinal products,
4. November 2024,European Medicines Agency,Report,mHealth Data for Real World Evidence in Regulatory Decision Making,
4. November 2024,European Medicines Agency,Guidance,Product Management Service (PMS) â€“ Frequently Asked Questions (FAQs),
4. November 2024,European Medicines Agency,Guidance,Application of the amended Variations Regulation from 1 January 2025,
4. November 2024,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment CommitteeÂ (PRAC) 28-31 October 2024,
4. November 2024,European Directorate for the Quality of Medicines & HealthCare,News,Removal of expiry notifications from the EDQM DCEP Sharing Tool,
4. November 2024,"Health Sciences Authority (HSA), Singapore",Regulations,Health regulation,
4. November 2024,International Medical Device Regulators Forum,Consultation,Considerations for the Selection of IMDRF Adverse Event Terminology,
4. November 2024,International Medical Device Regulators Forum,White paper,White Paper on Developing a Regulatory Framework,
4. November 2024,Medicines and Healthcare products Regulatory Agency,Guidance,MHRA phase I accreditation scheme,
4. November 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Emerging Roadmap and transition provisions,
4. November 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Announcements,Application of Q&A on M12: Drug Interaction Studies,
4. November 2024,Saudi Food & Drug Authority,Guidance,Guidance on Innovative Medical Devices,
4. November 2024,Swissmedic,Forms,Forms for October 2024,
4. November 2024,Swissmedic,Guidance,Notifications devitalised human tissue,
4. November 2024,Swissmedic,Guidance,Anforderungen Ph. Helv. Substanzen,
4. November 2024,"Team Notified Body, Europe",Press Release,Team-NB views on implementation of MDR/IVDR Regulations,
4. November 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Good Clinical Practice (GCP) Inspection Program,
4. November 2024,USA Food & Drug Administration FDA,Guidance,Cybersecurity,
4. November 2024,USA Food & Drug Administration FDA,Guidance,M13A Bioequivalence for Immediate-Release Solid Oral Dosage Forms,
4. November 2024,USA Food & Drug Administration FDA,Executive Summ.,Total Product Lifecycle Considerations for Generative AI-Enabled Devices,
4. November 2024,USA Food & Drug Administration FDA,Journal,Perspective on the Regulation of Artificial Intelligence in HealthCare & Biomedicine,
4. November 2024,World Health Organisation WHO,Guidance,Regulatory Considerations for Artificial Intelligence in Health,
28. October 2024,Egyptian Drug Authority,Guidance,Eighth national guide to rationalize the use of antimicrobials,
28. October 2024,Egyptian Drug Authority,Guidance,Naming of Veterinary Pharmaceuticals 2024,
28. October 2024,European Commission,Update,Urgent Need to Revise the Medical Devices Regulation,
28. October 2024,European Commission,Letter,Letter of Concern - Heads of Medicines Agencies -HMA core group medical devices,
28. October 2024,European Commission,News,Medical Devices News Newsletter 3 | October 2024,
28. October 2024,European Medicines Agency,Medical devices,Expert panel advice at the request of the MDCG & EU Commission,
28. October 2024,European Medicines Agency,PECP,Class D in vitro diagnostic devices: expert panel views,
28. October 2024,European Medicines Agency,CECP,Class III and Class IIb medical devices: expert panel opinions,
28. October 2024,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment Committee 14-17. October 2024,
28. October 2024,European Medicines Agency,Guidance,Pilot on using clinical study data in medicine evaluation,
28. October 2024,European Medicines Agency,Guidance,Veterinary Medicinal Product Guidelines,
28. October 2024,European Directorate for the Quality of Medicines & HealthCare,Guidance,Essential oils in cosmetics:  Best practices for safety assessment,
28. October 2024,Association for the Advancement of Medical Instrumentation,Standard,ST58:2024; Chemical sterilization & high-level disinfection in health care facilities,
28. October 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Reference Medicinal Products (RMPs),
28. October 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Orphan medicinal products,
28. October 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Handling of Active Substance Master Files and Certificates of Suitability,
28. October 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Rolling review for marketing authorisation applications,
28. October 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Conditional Marketing Authorisations,
28. October 2024,Medicines and Healthcare products Regulatory Agency,Regulation,Post-market Surveillance Requirements (Amendment) 2024,
28. October 2024,Swissmedic,Guidance,"Inspections - manufacturing, distributing medicinal products or collecting blood",
28. October 2024,Swissmedic,Forms,Forms for October 2024,
28. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Custom-made Medical Device and Patient-matched Medical Device Notification,
28. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Refinements to the Personalised Medical Device Framework,
28. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Understanding personalised medical devices rules (including 3D-printed devices),
28. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Export of medicines from Australia guidance,
28. October 2024,USA Food & Drug Administration FDA,Guidance,Review Drug Master Files in Advance of  ANDA Submissions Under GDUFA,
28. October 2024,USA Food & Drug Administration FDA,Guidance,Postoperative Nausea and Vomiting: Developing Drugs for Prevention,
28. October 2024,USA Food & Drug Administration FDA,Guidance,"Recommendations for Development of Blood Collection,Processing,& Storage",
28. October 2024,USA Food & Drug Administration FDA,Guidance,Core Patient-Reported Outcomes in Cancer Clinical Trials: Guidance for Industry,
28. October 2024,USA Food & Drug Administration FDA,Snapshot,Clinical Neurodevelopmental Safety Studies in Neonatal Product Development,
28. October 2024,USA Food & Drug Administration FDA,Guidance,FDA-NIH CLINICAL RESEARCH Glossary of Terms and Definitions,
28. October 2024,USA Food & Drug Administration FDA,Guidance,Drug Interaction Information in Prescription Drug & Biological Product Labeling,
28. October 2024,USA Food & Drug Administration FDA,Update,Investigational Device Exemption (IDE) Application,
28. October 2024,USA Food & Drug Administration FDA,Dataset,Parkinsonâ€™s Disease at the Center of New Dataset,
28. October 2024,USA Food & Drug Administration FDA,Update,Total Product Life Cycle Advisory Program (TAP),
28. October 2024,USA Food & Drug Administration FDA,Guidance,"Preparation, Packing, Holding of Tattoo Inks Risk of Microbial Contamination",
21. October 2024,European Commission,Update,Notified Bodies Overview,
21. October 2024,European Commission,Guidance,MDCG 2021-25 rev.1 - Application of MDR requirements to legacy devices,
21. October 2024,European Medicines Agency,Guidance,Applicants seeking access to PRIME scheme,
21. October 2024,European Medicines Agency,Fachtsheet,PRIME Paving the way for promising medicines for patients,
21. October 2024,European Medicines Agency,Plan,Change management - HMA-EMA joint Big Data Steering Group,
21. October 2024,European Medicines Agency,Newsflash,CTIS newsflash 8. October 2024,
21. October 2024,European Medicines Agency,Concept Paper,Clinical evaluation of therapeutic 4 radiopharmaceuticals in Oncology,
21. October 2024,European Medicines Agency,Guidance,Registration guide for UI and API users,
21. October 2024,European Medicines Agency,Guidance,Veterinary pharmacovigilance inspections,
21. October 2024,European Medicines Agency,Guidance,Implementation of the European Pharmacopoeia Supplement 11.7,
21. October 2024,"Health Sciences Authority (HSA),Singapore",Guidance,Post-marketing Vigilance Requirements for Therapautic Products,
21. October 2024,"Health Sciences Authority (HSA),Singapore",Reimbursement,MediShield Life Council's recommendations accepted - 2024 review,
21. October 2024,ISO(International Organization for Standardization),Standard,ISO Update September 1. to 30. 2024,
21. October 2024,Department of Health and Social Care,Roadmap,Design for Life Roadmap,
21. October 2024,MEDSAFE New Zealand,Guidance,Requirements for information for prescribers and consumers,
21. October 2024,NMPA-National Medical Products Administration Peoples Republic of China,Announcements,2 medical device standards: Brain-Computer Interface Technology,
21. October 2024,Swissmedic,Forms,Forms for October 2024,
21. October 2024,Swissmedic,Guidance,Fast-track & Temporary authorisation procedure for human medicinal products,
21. October 2024,Swissmedic,Guidance,Authorisation of medicinal gases,
21. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Requesting the Minister for Health to reconsider our initial decision,
21. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Our response to questions asked about the Essential Principles consultation,
21. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Nitrosamine impurities acceptable intakes update - October 2024,
21. October 2024,USA Food & Drug Administration FDA,Guidance,CDRH Proposed Guidances for Fiscal Year 2025 (FY2025),
21. October 2024,USA Food & Drug Administration FDA,Guidance,Endosseous Dental Implants and Endosseous Dental Implant Abutments,
21. October 2024,USA Food & Drug Administration FDA,Guidance,Frequently Asked Questions about Labeling for Prescription Medicines,
21. October 2024,USA Food & Drug Administration FDA,Guidance,Supersaturation to Support Urinary Tract Health claims for Adult Cat Food,
21. October 2024,USA Food & Drug Administration FDA,Guidance,Temporary Policies for Compounding Certain Parenteral Drug Products,
21. October 2024,USA Food & Drug Administration FDA,Guidance,Requests for Reconsideration at the Division Level Under GDUFA,
21. October 2024,USA Food & Drug Administration FDA,Guidance,FDA Releases Updated Biosimilar Curriculum Toolkit,
21. October 2024,USA Food & Drug Administration FDA,Guidance,Long-Term Clinical Neurodev. Safety Studies - Neonatal Product Development,
21. October 2024,USA Food & Drug Administration FDA,Regulation,QMSR Correction,
21. October 2024,USA Food & Drug Administration FDA,Report,Accelerating Rare Disease Cures (ARC) Program Year Two Annual Report,
21. October 2024,USA Food & Drug Administration FDA,Snapshots,Device Trial Participation Snapshots,
21. October 2024,World Health Organisation WHO,Guidance,"Patient navigation for early detection, diagnosis and treatment of breast cancer",
14. October 2024,Drug Regulatory Authority of Pakistan,Guidance,Switch over from Web Based One Customs (WEBOC),
14. October 2024,Egyptian Drug Authority,Guidance,Preclinical testing and Clinical Investigation for Medical devices,
14. October 2024,Egyptian Drug Authority,Guidance,Application for Reliance Pathway - Laboratory Testing of Medical Products,
14. October 2024,European Commission,Guidance,MDCG 2024-12 Guidance & Templates for Conformity Assessment,
14. October 2024,European Commission,Guidance,MDCG 2024-11 Guidance on qualification of in vitro diagnostic medical devices,
14. October 2024,European Commission,Update,Notified Body Update (50) MDR & (13) IVDR,
14. October 2024,European Commission,Regulation,Harmonised standard aseptic processing of health care products,
14. October 2024,European Commission,Regulation,Harmonised standard aseptic processing health care products & clinical studies,
14. October 2024,European Medicines Agency,Guidance,Pre-authorisation procedural advice for users of the centralised procedure,
14. October 2024,European Medicines Agency,Guidance,Implementation of ISO standards for (IDMP),
14. October 2024,European Medicines Agency,Guidance,"Mandate, objectives and rules of procedure GMP/GDP inspectors working group",
14. October 2024,European Medicines Agency,Updates,Veterinary Medicine. New Authorizations and Safety Updatesre,
14. October 2024,European Medicines Agency,Consultation,Network strategy to 2028,
14. October 2024,European Medicines Agency,Guidance,Overview of comments received onÂ ICHÂ M14,
14. October 2024,European Directorate for the Quality of Medicines & HealthCare,Consultation,Pharmeuropa 36.4 just released,
14. October 2024,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report,
14. October 2024,"Health & Youth Care Inspectorate, Netherlands",Call for Action,Medical Device Manufacturers - Implement an effective PMS system,
14. October 2024,International Pharmaceutical Excipients Council Federation (IPEC),Guidance,Good Distribution Practices (GDP),
14. October 2024,Medicines and Healthcare products Regulatory Agency,Plan,MHRA Corporate Plan 2023-26,
14. October 2024,Medicines and Healthcare products Regulatory Agency,Plan,Business Plan 2024/25,
14. October 2024,International Medical Device Regulators Forum,Meeting,"26th Meeting Seattle, Washington  - Outcome Statement",
14. October 2024,International Medical Device Regulators Forum,Guidance,Common Data Set for Adverse Event Data Exchange Between Regulators,
14. October 2024,South African Health Products Regulatory Authority,Announcement,South African & Australian health to share regulatory information,
14. October 2024,Swissmedic,Journal,Swissmedic Journal September 2024,
14. October 2024,Swissmedic,CorrigendÃ»m,Reprocessing of Medical Devices,
14. October 2024,Swissmedic,Annual Report,Potential for improvement in hospitals,
14. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Advertising to health professionals,
14. October 2024,USA Food & Drug Administration FDA,Roadmap,Womenâ€™s Health Research Roadmap,
14. October 2024,USA Food & Drug Administration FDA,Guidance,Pharmaceutical Quality/Chemistry Manufacturing and Controls (PQ/CMC),
14. October 2024,USA Food & Drug Administration FDA,Podcast,Considerations of Drug Products that Contain Nano Materials,
14. October 2024,USA Food & Drug Administration FDA,Exemption,FDA Grants Exemption to Connected Trading Partners,
7. October 2024,ANVISA Brazil,Announcement,Anvisa and USA FDA sign Confidentiality Agreement,
7. October 2024,European Medicines Agency,Guidance,Guidance on the details of the classification of variations veterinary products,
7. October 2024,European Medicines Agency,Reflection paper,Artificial Intelligence (AI) in the medicinal product lifecycle,
7. October 2024,European Medicines Agency,Guidance,Risk management for elemental impurities in veterinaryÂ medicinal products V3,
7. October 2024,European Medicines Agency,Guidance,"Quality and equivalence of locally applied, locally acting cutaneous products",
7. October 2024,European Medicines Agency,Guidance,Overview of comments received on quality and equivalence of topical products,
7. October 2024,European Medicines Agency,Guidance,Q&A low global warming potential propellants pressurised metered dose inhalers,
7. October 2024,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment Committee 30 September-3 October 2024,
7. October 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: reclassify your product,
7. October 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply for manufacturer or wholesaler of medicines licences,
7. October 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Pre-submission Advice & Support,
7. October 2024,Department of Health The Government of the Hong Kong,Guidance,New arrangement of Processing of Renewal Application of Listed Medical Device,
7. October 2024,Swissmedic,Deadline,swissdamed: Deadline on 13 November 2024,
7. October 2024,Swissmedic,Guidance,Summary report on authorisation,
7. October 2024,Swissmedic,Guidance,Transfer of marketing authorisation,
7. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Understanding product standards for unapproved therapeutic vapes in Australia,
7. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Guidance supporting updated MDSO instrument,
7. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Special Access Scheme (SAS): Accessing unapproved therapeutic goods,
7. October 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Product standards: unapproved therapeutic vapes,
7. October 2024,"Therapeutic Goods Administration (TGA), Australia",Updates,Updates to the Prescribing Medicines in Pregnancy database - September 2024,
7. October 2024,Ministry of Health TÃ¼rkiye,Guidance,"Sale, Advertising, and Promotion of Medical Devices",
7. October 2024,USA Food & Drug Administration FDA,Guidance,Dental Impression Materials â€“Criteria for Safety & Performance,
7. October 2024,USA Food & Drug Administration FDA,Guidance,Dental Ceramics â€“ Criteria for Safety & Performance,
7. October 2024,USA Food & Drug Administration FDA,Guidance,Dental Cements - Criteria for Safety & Performance,
7. October 2024,USA Food & Drug Administration FDA,Guidance,Air Powered Dental Handpieces & Motors Criteria for Safety & Performance,
7. October 2024,USA Food & Drug Administration FDA,Guidance,Studies to Evaluate Residues of Veterinary Drugs in Human Food,
7. October 2024,USA Food & Drug Administration FDA,Report,CDERâ€™s Office of Medical Policy 2023 Annual Report,
7. October 2024,USA Food & Drug Administration FDA,Report,GDUFA Outcomes Support Development and Evaluation of Generic Drugs,
7. October 2024,USA Food & Drug Administration FDA,Guidance,"Q&A Electronic Systems, Records, and Signatures in Clinical Investigations",
7. October 2024,USA Food & Drug Administration FDA,Guidance,Total Product Life Cycle Advisory Program (TAP) Engagement Tips,
7. October 2024,USA Food & Drug Administration FDA,Updated,Total Product Life Cycle Advisory Program (TAP),
7. October 2024,USA Food & Drug Administration FDA,Snapshot,Clinical Pharmacology Considerations - Radiolabeled Mass Balance Studies,
7. October 2024,World Health Organisation WHO,Report,Responsible use of the life sciences and dual-use research,
7. October 2024,World Health Organisation WHO,Guidance,Guidance for best practices for clinical trials,
30. September 2024,ANVISA Brazil,Regulation,"925 Manufacture, marketing, import, of customized medical devices",
30. September 2024,ANVISA Brazil,Regulation,909 Registration of products in development or technology transfer,
30. September 2024,"East Africa Regulatory Affairs Association (EARAPA) NDA, Uganda",Circular,Fast-track Assessment of Variations (Ammendments) & CTD Dossier Applications.,
30. September 2024,Egyptian Drug Authority,Update,Technical Committee for Drug Control on 8/8/2024 on biopharmaceuticals,
30. September 2024,Egyptian Drug Authority,Announcement,Important announcement for importers of dental implants,
30. September 2024,Egyptian Drug Authority,Guidance,Release of Biological Preparations,
30. September 2024,Egyptian Drug Authority,Guidance,"Non-commercial samples of medical, laborator, diagnostic supplies & devices",
30. September 2024,Egyptian Drug Authority,Tool,EDA API Searching Tool,
30. September 2024,European Commission,Guidance,Validity of clinical studies for joint clinical assessments,
30. September 2024,European Commission,Guidance,MDCG 2021-4 rev.1 - transitional provisions class D IVDR,
30. September 2024,European Medicines Agency,Guidance,Guide to information on human medicines evaluated by EMA,
30. September 2024,European Medicines Agency,Guidance,QRD statements-metered dose inhalers containing fluorinated greenhouse gases,
30. September 2024,European Medicines Agency,Newsflash,CTIS newsflash â€“ 24. September 2024,
30. September 2024,European Medicines Agency,Guidance,Compilation of Union procedures on inspections and exchange of information,
30. September 2024,European Medicines Agency,Guidance,Important medical event terms list (MedDRA version 27.1),
30. September 2024,European Medicines Agency,Guidance,List of eligible industry stakeholder organisations,
30. September 2024,European Medicines Agency,Guidance,Advice on substances essential for the treatment of equine species,
30. September 2024,"Health Sciences Authority (HSA), Singapore",Guidance,Specification Package v1.0 for Electronic Common Technical Document (eCTD),
30. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,AI Airlock: the regulatory sandbox for AIaMD,
30. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Clinical investigations guidance,
30. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Access New Active Substance and Biosimilar Work Sharing Initiatives,
30. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply to release a vaccine or a blood product to market,
30. September 2024,Medical Dictionary for Regulatory Activities,Guidance,MedDRA Latest Versions and Support Documentation,
30. September 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Guideline for Akkermansia muciniphila strain ATCC BAA-835,
30. September 2024,USA Food & Drug Administration FDA,Guidance,The Accreditation Scheme for Conformity Assessment (ASCA) Program,
30. September 2024,USA Food & Drug Administration FDA,Guidance,Biocompatibility Testing of Medical Devices â€“(ASCA) Program,
30. September 2024,USA Food & Drug Administration FDA,Guidance,Safety and Essential Performance of Medical Electrical Equipment (ASCA),
30. September 2024,USA Food & Drug Administration FDA,Report,FDA Information Technology Strategy for Fiscal Years 2024 to 2027,
30. September 2024,USA Food & Drug Administration FDA,Guidance,Circular of Information for the Use of Human Blood and Blood Components,
30. September 2024,USA Food & Drug Administration FDA,Guidance,FDA Digital Health and Artificial Intelligence Glossary,
30. September 2024,USA Food & Drug Administration FDA,Proposed Rule,"Reclassification Antigen, Antibody, & Nucleic Acid-Based Hepatitis B Assays",
30. September 2024,USA Food & Drug Administration FDA,Guidance,Radiation Control Regulations For Manufacturers of Diagnostic X-Ray Equipment,
30. September 2024,USA Food & Drug Administration FDA,Guidance,Clinical Pharmacology Considerations for Radiolabeled Mass Balance Studies,
23. September 2024,Drug Regulatory Authority of Pakistan,Guidance,Guidelines on National Pharmacovigilance System (Edition 03),
23. September 2024,Egyptian Drug Authority,Guidance,Good Control Practices for Clinical Research,
23. September 2024,European Commission,Corrigendum,Horizontal Cybersecurity Requirements for Products with Digital Elements,
23. September 2024,European Medicines Agency,Notice,European Medicines Agencyâ€™s RMS Data Protection Notice,
23. September 2024,European Medicines Agency,Guidance,Environmental risk assessmentÂ ofÂ medicinal productsÂ for human use,
23. September 2024,European Medicines Agency,Report,Early dialogue with healthcare professional organisations for marketing authorisation,
23. September 2024,European Medicines Agency,Guidance,"How to create, submit and manage IRIS applications",
23. September 2024,European Medicines Agency,Meeting,"Clinical TrialsÂ Regulation (CTR) Collaborate Stakeholder meeting, ACT EU",
23. September 2024,European Medicines Agency,Guidance,Guidance for competent authorities on how to highlight VNRAs,
23. September 2024,European Medicines Agency,Paper,Efficacy based on single arm trials submitted as evidence for marketing authorisation,
23. September 2024,European Medicines Agency,Guidance,Pharmaceutical Risk Assessment Committee criteria to prioritise impact research,
23. September 2024,European Medicines Agency,Survey,SME Survey 2024,
23. September 2024,European Medicines Agency,Guidance,Q&A labelling requirements for centrally authorised metered dose inhalers,
23. September 2024,European Medicines Agency,Meeting,Committee for Medicinal Products for Human UseÂ (CHMP) 16-19 September 2024,
23. September 2024,European Medicines Agency,Guidance,CTIS Evaluation Timelines,
23. September 2024,European Union Agency for Cybersecurity (ENISA),Report,ENISA Threat Landscape 2024,
23. September 2024,"Health Sciences Authority (HSA), Singapore",Consultatiion,"""SHARE"": Your one stop digital portal for Class 2 CTGTP Registration",
23. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Wholesalers & manufacturers guidance - Windsor Framework,
23. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Established medicines: marketing authorisation application changes,
23. September 2024,Medicines and Healthcare products Regulatory Agency,Policy,MHRA Strategy for Improving Safety Communications,
23. September 2024,"Team Notified Body, Europe",Guidance,Team-NB Code of Conduct for Notified Bodies V5,
23. September 2024,Swissmedic,News,New implementing regulations for submitting Clinical Research Applications,
23. September 2024,Swissmedic,Guidance,Request to review devices that comply with the old legislation,
23. September 2024,Swissmedic,Guidance,Go-live of the SwissGMDP database,
23. September 2024,Swissmedic,Form,Gesuch Verzicht Betriebsbewilligung Arzneimittel (inkl. Blut) / TpP/GT/GVO),
23. September 2024,USA Food & Drug Administration FDA,News,FDA Authorizes First Over-the-Counter Hearing Aid Software,
23. September 2024,USA Food & Drug Administration FDA,Guidance,Clinical Evidence from Oncology Multiregional Clinical Development Programs,
23. September 2024,USA Food & Drug Administration FDA,Guidance,Study Data Technical Conformance Guide - Technical Specifications Document,
23. September 2024,USA Food & Drug Administration FDA,Guidanec,Data Standards Catalog,
23. September 2024,USA Food & Drug Administration FDA,Guidance,"Chemistry, Manufacturing, & Controls (CMC) Technical Section Filing Strategies",
23. September 2024,USA Food & Drug Administration FDA,Guidance,Conducting Clinical Trials With Decentralized Elements,
23. September 2024,USA Food & Drug Administration FDA,Guidance,Randomized Controlled Trials for Drug and Biological Products,
23. September 2024,USA Food & Drug Administration FDA,Database,"Approved Drug Products with Therapeutic Equivalence Evaluations, Orange Book",
23. September 2024,USA Food & Drug Administration FDA,Guidance,Chemical Analysis for Biocompatibility Assessment of Medical Devices,
16. September 2024,ANVISA Brazil,Regulation,"RESOLUTION RDC NO. 903, Procedures for the transfer of ownership",
16. September 2024,CDSCO India,Guidance,Draft Guidelines on Good Clinical Practice,
16. September 2024,European Commission,Guidance,Data Act Explained,
16. September 2024,European Commission,Report,The future of European Competitiveness,
16. September 2024,European Commission,Update,Notified Body Update MDR & IVDR,
16. September 2024,European Medicines Agency,Meetiing,Pharmacovigilance Risk Assessment Committee (PRAC) 2-5 September 2024,
16. September 2024,European Medicines Agency,Guidance,"Clinical development, medicinal products. treatment & prevention bipolar disorder",
16. September 2024,European Medicines Agency,Guidance,Info session on web-based electronic Application Form (eAF) add package,
16. September 2024,European Medicines Agency,Newsflash,CTIS newsflash â€“ 10 September 2024,
16. September 2024,European Medicines Agency,Guidance,Biological and chemical threats,
16. September 2024,European Medicines Agency,Guidance,Q&A regarding co-processedÂ excipientsÂ used in solid oral dosage forms,
16. September 2024,ISO (International Organization for Standardization),Standard,"ISO Update August 1, 2024 to August 31, 2024",
16. September 2024,International Medical Device Regulators Forum,Report,IMDRF Document Implementation Report,
16. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines Pipeline data,
16. September 2024,Medicines and Healthcare products Regulatory Agency,Consultation,MHRA consultation on statutory fees,
16. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Early Access to Medicines Scheme - Information for Applicants,
16. September 2024,South African Health Products Regulatory Authority,Form,Medical Device Manufacture Licence,
16. September 2024,South African Health Products Regulatory Authority,Guidance,Renewal of Human and Veterinary Medicines Requirements and Process,
16. September 2024,"Team Notified Body, Europe",Position Paper,Transfer Agreement for Surveillance of Legacy Devices IVD,
16. September 2024,"Team Notified Body, Europe",Position Paper,Team-NB Position Paper list (update September 11th 2024)),
16. September 2024,Swissmedic,Directory,List Countries with recognised GMP control systems,
16. September 2024,Swissmedic,Guidance,Electronic exchange of ICSRs in E2B(R3) format through B2B gateway,
16. September 2024,Swissmedic,Form,Meldung unerwÃ¼nschter Tierarzneimittelwirkungen Synthetika oder Impfstoffe,
16. September 2024,Swissmedic,Form,Schengen Certificate,
16. September 2024,USA Food & Drug Administration FDA,Guidance,Withdrawn Guidances (Biologics),
16. September 2024,USA Food & Drug Administration FDA,Guidance,Appeal Options to Mammography Facilities  Adverse Accreditation Decisions,
16. September 2024,USA Food & Drug Administration FDA,Guidance,Amendments to Abbreviated New Drug Applications ANDA Under GDUFA,
16. September 2024,USA Food & Drug Administration FDA,Guidance,Providing Regulatory Submissions in Electronic Format (eCTD),
16. September 2024,USA Food & Drug Administration FDA,Guidance,Formal Meetings and Requests for Feedback for CBER-Regulated Products,
16. September 2024,USA Food & Drug Administration FDA,Final Rule,Mammography Quality Standards Act (MQSA),
16. September 2024,USA Food & Drug Administration FDA,Classification,Medical Devices; Immunology and Microbiology Devices; Exome Sequencing,
16. September 2024,USA Food & Drug Administration FDA,Standard,Three additional standards to advance innovation in sterilization processes,
16. September 2024,World Health Organisation WHO,Guidance,Implementation toolkit for accessible telehealth services,
9. September 2024,Egyptian Drug Authority,Guidance,Time limit granted to bulletins in which Safety Update occurs,
9. September 2024,Egyptian Drug Authority,Guidance,Requirements for variable files submitted to General Directorate of Stability,
9. September 2024,Egyptian Drug Authority,Guidance,Transfer / addition of the place of primary and secondary packaging,
9. September 2024,Egyptian Drug Authority,Guidance,Endocrine part of the Egyptian drug registry manufacturing),
9. September 2024,Egyptian Drug Authority,Guidance,Role of Oncology Pharmacists in Radiation Therapy,
9. September 2024,European Medicines Agency,Notice,Data Protection Notice for EudraVigilance Human (EV),
9. September 2024,European Medicines Agency,Standard Operating Procedure,"For assignment of micro-, small- or medium-sized-enterprise",
9. September 2024,European Medicines Agency,Guidance,AI in medicines regulation: use of large language models (LLMs),
9. September 2024,European Directorate for the Quality of Medicines & HealthCare,News,PDG announces global membership initiative,
9. September 2024,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report August 2024,
9. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Ionising Radiation (Medical Exposure) Regulations 2017,
9. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device,
9. September 2024,"MEDSAFE, New Zealand",Journal,Prescriber Update Vol. 45. No. 3 - September 2024,
9. September 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Announcements,"Pediatric Chemical Food, Cough, and Asthma Preparations (No. 106)",
9. September 2024,Saudi Food & Drug Authority,Guidance,(GVP) Specific Considerations II: Pregnant and breastfeeding women,
9. September 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,3 International Scientific Guidelines Adopted by TGA since 2. September 2024,
9. September 2024,Swissmedic,Form,Mobile technologies â€“ Submission of films,
9. September 2024,Swissmedic,Guidance,Marketing / interruption of distribution for veterinary medicinal products,
9. September 2024,Swissmedic,Guidance,Electronic data sets from pivotal bioequivalence studies,
9. September 2024,Swissmedic,Guidance,Packaging texts for veterinary medicinal products,
9. September 2024,Swissmedic,Guidance,SEND data sets for new authorisation human medicinal products with new API,
9. September 2024,Swissmedic,Guidance,Combined Studies,
9. September 2024,Swissmedic,Guidance,Accompanying documentation authorisation and variation for medicinal products,
9. September 2024,Swissmedic,Guidance,Changes to the guidance document Time limits for authorisation applications,
9. September 2024,Swissmedic,Guidance,Export Certificates,
9. September 2024,Swissmedic,Journal,Swissmedic Journal August 2024,
9. September 2024,National Institute of Standards and Technology (NIST),Blog,Cybersecurity Insights,
9. September 2024,USA Food & Drug Administration FDA,Guidance,Bioresearch Monitoring Technical Conformance Guide,
9. September 2024,USA Food & Drug Administration FDA,Guidance,Control of Nitrosamine Impurities in Human Drugs,
9. September 2024,USA Food & Drug Administration FDA,News,Whole Genome Sequencing (WGS) Program,
9. September 2024,USA Food & Drug Administration FDA,Guidance,Voluntary Patient Preference Information over the Total Product Life Cycle:,
9. September 2024,World Health Organisation WHO,Guidance,WHO updates laboratory biosecurity guidance,
2. September 2024,Egyptian Drug Authority,Guidance,Changes mentioned in the deadline letters not proven in the medical requirement,
2. September 2024,Egyptian Drug Authority,Support,Technical support links for the Cosmetics Listing Platform EgyCosm,
2. September 2024,European Medicines Agency,Guidance,ICHÂ guidelineÂ E11A on pediatric extrapolation Step 5,
2. September 2024,European Medicines Agency,Guidance,Compilation of union procedures on inspections and exchange of information,
2. September 2024,"Health Sciences Authority (HSA), Singapore",Consultatiion,Guidance on Change Management Program (CMP) for SaMD,
2. September 2024,International Council for Harmonisation,Guidance,The ICH E11A Guideline reaches Step 4 of the ICH Process,
2. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device,
2. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Clinical trials for medicines: apply for authorisation in the UK,
2. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Quarterly Reports â€“ guidance and template for manufacturers / sponsors,
2. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Windsor Framework for Medicines comes into effect 1. January 2025,
2. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Pharmacovigilance following agreement of the Windsor Framework,
2. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,UK-wide licensing for human medicines,
2. September 2024,Medicines and Healthcare products Regulatory Agency,Consultation,Consultation on the International Council for Harmonisation (ICH) M14,
2. September 2024,Medicines and Healthcare products Regulatory Agency,Consultation,MHRA consultation on statutory fees,
2. September 2024,Medicines and Healthcare products Regulatory Agency,Guidance,International Recognition Procedure,
2. September 2024,"MEDSAFE, New Zealand",Consultation,Regulation of Therapeutic Products in New Zealand: Clinical Trials,
2. September 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,International Scientific Guidelines Adopted by TGA from the EU,
2. September 2024,"Therapeutic Goods Administration (TGA), Australia",Form,Submission of the Clinical Trial application CTA,
2. September 2024,Swissmedic,Requirements,Responsible Person,
2. September 2024,Swissmedic,Guidance,Electronic exchange of ICSRs in E2B(R3) format through B2B gateway,
2. September 2024,Swissmedic,Guidance,Electronic exchange of ICSRs in E2B(R2) format through PV Gateway,
2. September 2024,Swissmedic,Form,For application under Art. 13 TPA VMP,
2. September 2024,Swissmedic,Form,Formular Gesuch Herstellerangaben Nichtstandardisierbare AM/TpP,
2. September 2024,National Institute of Standards and Technology (NIST),Guidance,NIST Releases Second Public Draft of Digital Identity Guidelines for Final Review,
2. September 2024,USA Food & Drug Administration FDA,Fees,Biosimilar User Fee Amendments,
2. September 2024,USA Food & Drug Administration FDA,Guidance,MDR Enhancements,
2. September 2024,USA Food & Drug Administration FDA,Reporting Program,Voluntary Malfunction Summary Reporting Program,
2. September 2024,USA Food & Drug Administration FDA,Guidance,Voluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers,
2. September 2024,USA Food & Drug Administration FDA,Hub,OMHHE Enhance Equity Research Hub,
2. September 2024,USA Food & Drug Administration FDA,Educational Materials,Multimedia Education Materials | Biosimilars,
2. September 2024,USA Food & Drug Administration FDA,Webinar,"IVDs - MDR Requirements, Correction. Removal Reporting, & QMS Requirements",
26. August 2024,Egyptian Drug Authority,Guidance,Update on the Mechanisms for Submitting and Evaluating Stability Studies,
26. August 2024,European Commission,Update,Notified Body Update MDR & IVDR,
26. August 2024,European Commission,Consultation,Ammendment (EU) 2022/1107 Common specifications for class D IVD,
26. August 2024,European Medicines Agency,Guidance,Plasma Master File (PMF) submissions,
26. August 2024,European Medicines Agency,Guidance,Clinical Trial Information System Sponsor Handbook,
26. August 2024,European Medicines Agency,Guidance,Good pharmacovigilance practicesÂ (GVP),
26. August 2024,ISO (International Organization for Standardization),Standard,"ISO Update July 1, 2024 to July 31, 2024",
26. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply for the early access to medicines scheme (EAMS),
26. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Good laboratory practice (GLP) for safety tests on chemicals,
26. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,AI Airlock: the regulatory sandbox for AIaMD,
26. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Exporting active UK substances for use in EEA and Northern Ireland,
26. August 2024,Medical Device Authority Malaysia,Update,Medical Devices with Expired EC Certificates and Self Declared Class B IVD,
26. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidelines,17. International Scientific Guidelines Adopted from the EU,
26. August 2024,"Therapeutic Goods Administration (TGA), Australia",News,Sponsors and manufacturers reminded about upcoming financial deadlines,
26. August 2024,"Therapeutic Goods Administration (TGA), Australia",News,Post-market review of spinal cord stimulator devices,
26. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Essential Principles checklist,
26. August 2024,Swissmedic,Information Sheet,3D printers medical devices,
26. August 2024,USA Food & Drug Administration FDA,Fees,FY 2025 PDUFA Program Fee Invoices and Rates,
26. August 2024,USA Food & Drug Administration FDA,Guidance,Product-Specific Guidance Meetings Between FDA and ANDA Applicants GDUFA,
26. August 2024,USA Food & Drug Administration FDA,Guidance,Frequently Asked Questions Quality Management System Regulation QMSR,
26. August 2024,USA Food & Drug Administration FDA,Guidance,Predetermined Change Control Plans or Medical Devices,
26. August 2024,USA Food & Drug Administration FDA,Guidance,Acceptable Media for Electronic Product User Manuals,
26. August 2024,USA Food & Drug Administration FDA,Guidance,FAQ CDER Center for Clinical Trial Innovation (C3TI),
26. August 2024,USA Food & Drug Administration FDA,Guidance,Electronic Submission Template for Medical Device De Novo Requests,
26. August 2024,USA Food & Drug Administration FDA,Guidance,Title: FDA and Industry Procedures for Section 513(g) Requests for Information,
26. August 2024,USA Food & Drug Administration FDA,Guidance,FDA Drug Recall Process Snapshot,
26. August 2024,USA Food & Drug Administration FDA,Guidance,Product-Specific Guidances for Generic Drug Development,
26. August 2024,USA Food & Drug Administration FDA,Guidance,Mammography Quality Standards Act & Regulation Amendments,
26. August 2024,Association for the Advancement of Medical Instrumentation AAMI,Guidance,New Consensus on the Sterilization of Single-Use Systems for Manufacturing,
26. August 2024,World Health Organisation WHO,Publication,"WHO Drug Information, Volume 38, Number 2, 2024",
26. August 2024,World Health Organisation WHO,Publication,WHO Expert Committee on Biological Standardization: seventy-ninth report,
19. August 2024,CDSCO India,Guidance,Draft Guidelines on Good Distribution Practices for Pharmaceutical Products,
19. August 2024,Egyptian Drug Authority,Guidance,Updating the categories of medical supplies allowed to obtain annual import plans,
19. August 2024,Egyptian Drug Authority,Guidance,Good Regulatory Oversight of Clinical Trials by Egyptian Drug Authority,
19. August 2024,Egyptian Drug Authority,Guidance,Transfer of the type of registered pharmaceuticals,
19. August 2024,European Commission,Report,Cyber security in the health and medicine sector:,
19. August 2024,European Medicines Agency,Guidance,Biological and chemical threats,
19. August 2024,European Medicines Agency,Guidance,"Q&A, Mutual Recognition Agreement (MRA) between the EU and the USA",
19. August 2024,European Medicines Agency,Guidance,FAQs How to manage a clinical trials,
19. August 2024,European Medicines Agency,Guidance,"FAQs How to create, submit and withdraw a CTA",
19. August 2024,European Medicines Agency,Guidance,Step-by-step guide Supervise a CT â€“ Ad Hoc Assessment,
19. August 2024,European Medicines Agency,Guidance,Instructorâ€™s Guide: Supervise a CT Ad Hoc Assessment,
19. August 2024,European Medicines Agency,Guidance,FAQs Supervise a CT â€“ Ad Hoc Assessment,
19. August 2024,European Medicines Agency,Guidance,FAQs Transitional trials from EudraCT to CTIS,
19. August 2024,European Medicines Agency,Guidance,Quick guide Transitional trials from EudraCT to CTIS (sponsor users),
19. August 2024,European Medicines Agency,Guidance,Clinical Trial Information System Sponsor Handbook,
19. August 2024,European Medicines Agency,Guidance,Guide to CTIS Training Catalogue,
19. August 2024,IEEE Standards Association | IEEE SA,Standards,Notice of New Standard Product IEEE/ISO 11073-10206-2024,
19. August 2024,IEEE Standards Association | IEEE SA,Paper,Key Parameters for Identifying Electronic Health Records without Violating Privacy,
19. August 2024,Ministry of Food and Drug Safety of Republic of Korea,Regulation,Regulations on In Vitro Diagnostic Medical Device and Classification,
19. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Pre-submission Advice & Support,
19. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines Pipeline data,
19. August 2024,Department of Health The Government of the Hong Kong,Guidance,Classification of General Medical Devices (TR-003),
19. August 2024,Swissmedic,Information Sheet,Klassierung und AbklÃ¤rung von Transfusionsreaktionen,
19. August 2024,Swissmedic,Information Sheet,Haemovigilance - Nebenwirkungen bei Blutspenden,
19. August 2024,Swissmedic,Information Sheet,Reporting quality defects in labile blood products,
19. August 2024,Swissmedic,Information Sheet,Non-standardised medicinal products and medicinal product groups,
19. August 2024,Swissmedic,Transitional Provisions,EU IVDR Equivalence with EU Regulation on Medical Devices,
19. August 2024,"Therapeutic Goods Administration (TGA), Australia",Consultation,Australian Medical Device Essential Principles - Alignment with the EU,
19. August 2024,National Institute of Standards and Technology (NIST),Standards,First 3 Finalized Post-Quantum Encryption Standards,
19. August 2024,USA Food & Drug Administration FDA,Consultation,FDA IT Strategy for FY 2024 â€“ FY 2027,
12. August 2024,CDSCO India,Circular,Implementation of Schedule M and WHO Technical Report Serie,
12. August 2024,Egyptian Drug Authority,Guidance,Lot Release of Biological Products in Egypt,
12. August 2024,European Commission,Regulation,Designation of EU UDI issuing entities,
12. August 2024,European Commission,EUDAMED,Release note v3.9.0,
12. August 2024,European Medicines Agency,Guidance,ICHÂ GuidelineÂ M13A onÂ bioequivalence for immediate release solid dosage forms,
12. August 2024,European Medicines Agency,Guidance,ICHÂ E2D Post-approval safety data management - ScientificÂ guideline,
12. August 2024,European Medicines Agency,Guidance,ICH reflection paper on real-world data to generate real world evidence,
12. August 2024,European Medicines Agency,Arrangement,Joint Controllership Arrangement - Union product database (UPD),
12. August 2024,European Medicines Agency,Guidance,Good pharmacovigilance practices (GVP) 5 Revisions,
12. August 2024,European Medicines Agency,List,Union list of critical medicines: EudraVigilance Dictionary (XEVMPD),
12. August 2024,European Medicines Agency,Guidance,Clinical Trial Information System (CTIS) - Sponsor handbook,
12. August 2024,European Medicines Agency,Guidance,"FAQ, Substance and product data management services",
12. August 2024,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report July 2024,
12. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Register medical devices to place on the market,
12. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Export medical devices,
12. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device,
12. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Exporting active UK substances for use in EEA and Northern Ireland,
12. August 2024,Department of Health The Government of the Hong Kong,Guidance,Various Guidance Notes and Code of Practice have been updated,
12. August 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,Inspection of Medical Device Business Quality Management Standards,
12. August 2024,Swissmedic,Guidance,Swissdamed,
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,"Disinfectants, sterilants and sanitary products",
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Changes to the Permissible Ingredients Determination,
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Medical device conformity assessment application,
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Should your product be in the ARTG,
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Varying entries in the ARTG: medical devices and IVDs,
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Access Generic Medicines work-sharing initiative operational procedures update,
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Form,Application to amend the Poisons Standard,
12. August 2024,"Therapeutic Goods Administration (TGA), Australia",Form,Business Plan 2024-25,
12. August 2024,USA Food & Drug Administration FDA,Discussion Paper,Health Equity For Medical Devices,
12. August 2024,USA Food & Drug Administration FDA,Guidance,MDSAP Audit Approach,
12. August 2024,USA Food & Drug Administration FDA,Plan,Language Access Plan,
12. August 2024,USA Food & Drug Administration FDA,Guidance,Optimizing the Dosage of Drugs and Biologics for Oncology Treatment,
12. August 2024,USA Food & Drug Administration FDA,Guidance,Developing drugs for treatment of Unresponsive Nonmuscle Bladder Cancer,
5. August 2024,CDSCO India,Circular,Circular regarding Requirement of Toxicity Studies for New Drugs SNDs and FDCs,
5. August 2024,Egyptian Drug Authority,Guidance,Procedures for issuing a replacement for lost / damaged permit,
5. August 2024,European Medicines Agency,Newsflash,CTIS newsflash â€“ 26 July 2024,
5. August 2024,European Medicines Agency,Report,Real-world evidence framework to support EU regulatory decision-making,
5. August 2024,European Medicines Agency,Infosheet,Review of real-world data studies,
5. August 2024,European Medicines Agency,Guidance,Compilation of Union procedures on inspections,
5. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,International Recognition Procedure,
5. August 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Access New Active Substance and Biosimilar Work Sharing Initiatives,
5. August 2024,Medicines and Healthcare products Regulatory Agency,Report,Human Medicines Regulations 2012 Advisory Bodies Annual Report 2023,
5. August 2024,Medicines and Healthcare products Regulatory Agency,Report,British Pharmacopoeia Commission Annual Report 2023,
5. August 2024,Medicines and Healthcare products Regulatory Agency,Report,MHRA Annual Report and Accounts,
5. August 2024,"Health Sciences Authority (HSA), Singapore",Updates,Regulatory Updates for Therapeutic Product Registration (effective 1 Aug 2024),
5. August 2024,"Health Sciences Authority (HSA), Singapore",Updates,Guidance documents for therapeutic products,
5. August 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,Expedited Approval Scheme for Medical Device Listing Applications,
5. August 2024,Medical Device Authority Malaysia,Updates,Pilot Survey for Unique Device Identification (UDI) In Malaysia,
5. August 2024,Swissmedic,Guidance,Terms of Reference - Round Table on Medical Technology,
5. August 2024,Swissmedic,Guidance,Ph.Helv. / Anforderungen / Phyto,
5. August 2024,Swissmedic,Guidance,Anforderungen PhHelv KomplMedAM,
5. August 2024,Swissmedic,Guidance,Handbuch HOMANT Offline 2.4.7.,
5. August 2024,Swissmedic,Guidance,HB Handbuch HOMANT Asia,
5. August 2024,Swissmedic,Guidance,Code of Conduct: members of the Swissmedic Medicines Expert Committees,
5. August 2024,Swissmedic,Guidance,Packaging for human medicinal products,
5. August 2024,National Institute of Standards and Technology (NIST),Guidance,Secure Software Development Practices for Generative AI,
5. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Essential Principle 13B guidance,
5. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Regulation of software based medical devices,
5. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Adoption of 13 international guidelines,
5. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Nitrosamine impurities acceptable intakes update,
5. August 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Submitting a Drug Master File (DMF),
5. August 2024,USA Food & Drug Administration FDA,Report,Office of Surveillance and Epidemiology 2023 Annual Report,
5. August 2024,USA Food & Drug Administration FDA,Report,Office of New Drugs (OND) Research Outcomes Report FY2022-23,
5. August 2024,USA Food & Drug Administration FDA,Fees,"OTC Monograph Order Request (OMOR), Medical Device User Fees",
5. August 2024,USA Food & Drug Administration FDA,Guidance,"M12 Drug Interaction Studies, Q&A M12 Drug Interaction Studies",
5. August 2024,USA Food & Drug Administration FDA,Guidance,Reprocessing Single-Use Medical Devices: Information for Health Care Facilities,
5. August 2024,USA Food & Drug Administration FDA,SOPP,8426: Assignment of Biological & Drug Product Proper Names & Biological Suffixes,
29. July 2024,Egyptian Drug Authority,Guidance,Unified link / electronic portal for all submission links to  Directorate of Stability,
29. July 2024,Egyptian Drug Authority,Guidance,Requirements for delivering samples to the General Directorate of Evaluation,
29. July 2024,Egyptian Drug Authority,Guidance,Monitoring the quality of biologicals after marketing,
29. July 2024,Egyptian Drug Authority,Guidance,Mechanisms of the regulatory guide for the rules for implementing,
29. July 2024,European Medicines Agency,Guidance,Chapter 3.II: XEVPRM User Guidance,
29. July 2024,European Medicines Agency,Guidance,Development and Manufacture of Oligonucleotides,
29. July 2024,European Medicines Agency,Statement,International collaboration - real-world evidence (RWE) for regulatory decisions,
29. July 2024,European Medicines Agency,Guidance,Guideline on the chemistry of active substances,
29. July 2024,European Medicines Agency,Concept paper,Guideline for demonstration of therapeutic equivalence for nasal products,
29. July 2024,European Medicines Agency,Meeting,Highlights Committee for Medicinal Products for Human Use 22-25 July 2024,
29. July 2024,Health Canada,Consultation,Proposed changes to the guidance on recognized standards,
29. July 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Good clinical practice for clinical trials,
29. July 2024,South African Health Products Regulatory Authority,Guidance,Guideline for the API Master File (APIMF) Procedure,
29. July 2024,South African Health Products Regulatory Authority,Consultation,2.21 ZA-SAHPRA eCTD Specifications v3.1,
29. July 2024,Swissmedic,Guidance,Electronic exchange of ICSRs through PV Gateway,
29. July 2024,Swissmedic,Guidance,Swiss Module 1 Specification for eCTD Version 1.5,
29. July 2024,Swissmedic,Guidance,Online help for the MD publication service,
29. July 2024,Swissmedic,Guidance,Incident report user,
29. July 2024,Swissmedic,Guidance,Medical devices FAQs Patients,
29. July 2024,Swissmedic,Guidance,Vigilance contact person for medical devices,
29. July 2024,Swissmedic,Guidance,Out-of-Stock Situation,
29. July 2024,Swissmedic,Form,Declaration of interests and Confidentiality Swissmedic Medicines Expert Committee,
29. July 2024,Swissmedic,Form,Einfuhr von immunologischen Arzneimittelnoder oder von Blut und Blutprodukten,
29. July 2024,Swissmedic,Form,Application for Temporary Authorization,
29. July 2024,"Therapeutic Goods Administration (TGA), Australia",Consultation,Proposed changes to the regulation of assistive technologies,
29. July 2024,"Therapeutic Goods Administration (TGA), Australia",Consultation,Revision of the guidance document TGA Instructions for Disinfectant Testing,
29. July 2024,USA Food & Drug Administration FDA,Guidance,Postapproval Manufacturing Changes to Biosimilar Products Q&A,
29. July 2024,USA Food & Drug Administration FDA,Guidance,Recommendations for COVID-19 Convalescent Plasma,
29. July 2024,USA Food & Drug Administration FDA,SOPP,SOPP 8101.1: Meetings with Sponsors and Applicants for Drugs & Biologics,
29. July 2024,USA Food & Drug Administration FDA,Guidance,Real-World Data: Electronic Health Records & Claims Data to Support Decisions,
29. July 2024,USA Food & Drug Administration FDA,Guidance,Container Closure System and Component Changes: Glass Vials and Stoppers.,
29. July 2024,USA Food & Drug Administration FDA,Guidance,Providing Over-the-Counter Monograph Submissions in Electronic Format,
29. July 2024,USA Food & Drug Administration FDA,Seeking Comment,Immunogenicity Risk of Host Cell Proteins in Recombinant Peptides,
29. July 2024,USA Food & Drug Administration FDA,Seeking Comment,Biosimilar Product Development Guidance,
29. July 2024,USA Food & Drug Administration FDA,Guidance Snapshot,Digital Health for Remote Data Acquisition in Clinical Investigations,
29. July 2024,World Health Organisation WHO,Publication,Improving access to medicines for neurological disorders,
22. July 2024,Egyptian Drug Authority,Guidance,Procedures of scientific advice for biological products,
22. July 2024,European Commission,Regulation,New EU rules on substances of human origin,
22. July 2024,European Medicines Agency,News,: CTIS newsflash - 12 July 2024,
22. July 2024,European Medicines Agency,Q&A,Q2 2024 System Demo,
22. July 2024,European Medicines Agency,Guidance,EMA EudraVigilance Registration Manual,
22. July 2024,European Medicines Agency,Guidance,EudraVigilance - EVWEB User Manual,
22. July 2024,European Medicines Agency,Guidance,Addendum clinical tials of vaccines in immunocompromised subjects,
22. July 2024,European Directorate for the Quality of Medicines & HealthCare,Seeking Assistance,Ph. Eur. seeks feedback on the use of plastic additive 18,
22. July 2024,ISO (International Organization for Standardization),Standard,"ISO Update June 1, 2024 to June 30, 2024",
22. July 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Announcements,Temporary Import and Use of Medical Devices Urgently for Clinical Use,
22. July 2024,Department of Health The Government of the Hong Kong,MDACS,Medical Device Information System,
22. July 2024,Department of Health The Government of the Hong Kong,Guidance,Classification of In Vitro Diagnostic Medical Devices (IVDMDs) (TR-006),
22. July 2024,Department of Health The Government of the Hong Kong,Guidance,Guidance Notes for Changes of Listed Medical Devices (GN-10),
22. July 2024,MedTech Europe,Template,Manufacturerâ€™s Declaration in relation to Regulation (EU) 2024/1860,
22. July 2024,MedTech Europe,Report,Facts & Figures 2024,
22. July 2024,South African Health Products Regulatory Authority,Guidance,Guideline on Co-applicancy,
22. July 2024,"Team Notified Body, Europe",Template,IVD Confirmation Letter Template-V2-20240710,
22. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Adopted International Scientific Guidelines,
22. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Adopted International Scientific Guidelines,
22. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Adopted International Scientific Guidelines,
22. July 2024,USA Food & Drug Administration FDA,Guidance,Drugs for the Treatment of Partial Onset Seizures: Adults to Pediatric Patients,
22. July 2024,USA Food & Drug Administration FDA,Publication,Designs of clinical swallowability assessments of solid oral dosage forms,
22. July 2024,USA Food & Drug Administration FDA,Guidance,Application User Fees for Combination Products,
22. July 2024,USA Food & Drug Administration FDA,Guidance,Pediatric Inflammatory Bowel Disease: Developing Drugs for Treatment,
22. July 2024,USA Food & Drug Administration FDA,Guidance,Blood Pressure and Pulse Donor Eligibility Requirements â€“ Compliance Policy,
22. July 2024,USA Food & Drug Administration FDA,Adenda,Guidance Documents CBER is Planning to Publish During Calendar Year 2024,
22. July 2024,USA Food & Drug Administration FDA,Toolkit,Supply Chain Security Toolkit for Medical Products,
22. July 2024,USA Food & Drug Administration FDA,Newsletter,Division of Standards and Conformity Assessment,
22. July 2024,USA Food & Drug Administration FDA,Guidance,Clinical Pharmacology Considerations  -Oligonucleotide Therapeutics,
22. July 2024,USA Food & Drug Administration FDA,Guidance,Clinical Pharmacology Considerations  for Radiolabeled Mass Balance Studies,
22. July 2024,World Health Organisation WHO,Guidance,"Establishing quality specifications for medicines, vaccines and in vitro diagnostics",
15. July 2024,Egyptian Drug Authority,Guidance,EEC/ 93/42CMDD in case of expiry of quality certificates,
15. July 2024,Egyptian Drug Authority,Formulary,Conventional Anticancer Drugs,
15. July 2024,European Commission,Guidance,MDCG 2020-16 rev.3 Guidance on Classification Rules for IVDR,
15. July 2024,European Commission,Regulation,"Amending EU) 2017/745 & (EU) 2017/746,  gradual roll-out of Eudamed",
15. July 2024,European Commission,Information session,MDR/IVDR for international regulators â€“ 4 July 2024 | IVDR Transition,
15. July 2024,European Medicines Agency,Fees,New Fee Regulation (applicable from 1 January 2025),
15. July 2024,European Medicines Agency,Update,2023 annual report of the European Medicines Agency,
15. July 2024,European Medicines Agency,Report,Focus group on submission predictability: Final report,
15. July 2024,European Medicines Agency,Q&A,Questions and Answers on the 'OPEN' Framework for Non-EU authorities,
15. July 2024,European Medicines Agency,Guidance,Procedural advice on paediatric applications,
15. July 2024,European Medicines Agency,Guidance,eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD),
15. July 2024,European Medicines Agency,Meeting,Highlights fifth EMA- Association of the European Self Care Industry (AESGP),
15. July 2024,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment CommitteeÂ (PRAC) 8-11 July 2024,
15. July 2024,European Medicines Agency,Report,2023 SME Annual Report,
15. July 2024,European Medicines Agency,Recommendations,Classification ofÂ advanced therapy medicinal products,
15. July 2024,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report June 2024,
15. July 2024,Medicines and Healthcare products Regulatory Agency,Guidance,International Recognition Procedure,
15. July 2024,Medicines and Healthcare products Regulatory Agency,Blog Post,Navigating the Future: Building the AI and Digital Regulations Service,
15. July 2024,Medical Device Authority Malaysia,Timeline,MeDC@St3.0Â PROJECT DEVELOPMENT TIMELINE,
15. July 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Announcements,Standards Mutations,
15. July 2024,Swissmedic,Guidance,Pflichten mit der DurchfÃ¼hrung der Instandhaltung von Medizinprodukten,
15. July 2024,Swissmedic,Journal,Swissmedic Journal June 2024,
15. July 2024,"Team Notified Body, Europe",Guidance,Transfer Agreement for Surveillance of Legacy Devices V2,
15. July 2024,"Team Notified Body, Europe",List,Team-NB Position Paper list (update July 2nd 2024),
15. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Authorised Prescriber: online system guidance,
15. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Exporting Ã¢ Ventilator,
15. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Transmissible Spongiform Encephalopathies (TSE),
15. July 2024,USA Food & Drug Administration FDA,Guidance,Q&A Misinformation About Medical Devices and Prescription Drugs,
15. July 2024,USA Food & Drug Administration FDA,Guidance,Purpose and Content of Use-Related Risk Analyses,
15. July 2024,USA Food & Drug Administration FDA,Guidance,Clinical Considerations for Studies of Devices to Treat Opioid Use Disorder,
15. July 2024,USA Food & Drug Administration FDA,Guidance Reminder,Prepare to transition to Laser Notice No. 56,
15. July 2024,USA Food & Drug Administration FDA,Guidance,"510k Submissions, Dental Composite Resin Devices | Dental Curing Lights",
15. July 2024,USA Food & Drug Administration FDA,SOPP,Processing and Review Management for Investigational New Drug Applications,
15. July 2024,World Health Organisation WHO,Guidance,WHO updates laboratory biosecurity guidance | Radiation safety culture Newsletter: WHO pharmaceuticals NEWSLETTER,
8. July 2024,ANVISA Brazil,Technical Note,"RDC ANVISA No. 886, of June 26, 2024",
8. July 2024,Egyptian Drug Authority,Consultation,Guideline for Preclinical testing and clinical investigation for Medical devices,
8. July 2024,European Commission,Guidance,Update - MDCG 2021-5 Rev.1 - Guidance on standardisation for medical devices,
8. July 2024,European Commission,Factsheet,Cross-border Healthcare 2022: Recent data implementation of Dir. 2011/24/EU,
8. July 2024,European Medicines Agency,Template,Products Management Services (PMS) - (IDMP) in Europe - Chapter 7,
8. July 2024,European Medicines Agency,Paper,ICH - Integrating real-world evidence into regulatory decision-making,
8. July 2024,European Directorate for the Quality of Medicines & HealthCare,Report,2023 EDQM annual report published in new engaging digital format,
8. July 2024,European Directorate for the Quality of Medicines & HealthCare,News,European Pharmacopoeia Supplement 11.6,
8. July 2024,International Medical Device Regulators Forum,Consultation,Good machine learning practice for medical device development,
8. July 2024,International Medical Device Regulators Forum,SOP,IMDRF Standard Operating Procedures,
8. July 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
8. July 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device,
8. July 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Implementation of medical devices future regime,
8. July 2024,Medical Device Authority Malaysia,Announcement,Implementation of MDA-CAB Workshop 2024 Outcomes,
8. July 2024,Swissmedic,Application,Fee reduction: clinical investigations & performance studies - Medical Devices,
8. July 2024,Swissmedic,Guidance,Guidance document Formal requirements,
8. July 2024,Swissmedic,Guidance,SwissPAR,
8. July 2024,Swissmedic,Forms,New authorisation of human medicinal products,
8. July 2024,Swissmedic,Form,Gesuch Verzicht Betriebsbewilligung Arzneimittel (inkl. Blut) / TpP/GT/GVO,
8. July 2024,Swissmedic,Form,Order form for a CPP (Certificate of a Pharmaceutical Product),
8. July 2024,Swissmedic,Guidance,Clinical investigations with medical devices,
8. July 2024,Swissmedic,Guidance,Performance studies with IVD,
8. July 2024,"Team Notified Body, Europe",Template,Transfer Agreement for Surveillance of Legacy Devices,
8. July 2024,"Therapeutic Goods Administration (TGA), Australia",Publication,Cost Recovery Implementation Statement 2024-2025,
8. July 2024,"Therapeutic Goods Administration (TGA), Australia",Form,Certified copies of TGA licences and certificates,
8. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Regulatory changes for software based medical devices,
8. July 2024,USA Food & Drug Administration FDA,Report,Modernizing the New Drugs Regulatory Program - Impact Narrative 2023.,
8. July 2024,USA Food & Drug Administration FDA,News,CDRH Announces Expansion of the Total Product Life Cycle Advisory Program,
8. July 2024,USA Food & Drug Administration FDA,Update,NEW Version 2.9 FDALabel: Full-Text Search of Drug Product Labeling,
8. July 2024,USA Food & Drug Administration FDA,Guidance,Recognition of Voluntary Consensus Standards - Pharmaceutical Quality,
8. July 2024,USA Food & Drug Administration FDA,Guidance,Pharmacoepidemiological Studies Real-World. Safety Assessment of Medicines,
8. July 2024,USA Food & Drug Administration FDA,Standard,Measuring the Size of Nanoparticles in Aqueous Media,
1. July 2024,European Commission,Guidance,MDCG 2024-10 - Clinical evaluation of orphan medical devices,
1. July 2024,European Commission,Consultation,EU Health Technology Assessment Regulation,
1. July 2024,European Commission,Report,Serious Adverse Reactions and Events For Tissues And Cells,
1. July 2024,European Medicines Agency,Template,GLP compliance: Non-clinical studies GLP compliance (annex to the cover letter),
1. July 2024,European Medicines Agency,Guidance,ICHÂ M12 on drug interaction studies - ScientificÂ guideline,
1. July 2024,European Medicines Agency,Guidance,Pre-authorisation guidance,
1. July 2024,European Medicines Agency,Guidance,Transfer of marketing authorisation: questions and answers,
1. July 2024,European Medicines Agency,Guidance,Q&A Regulation (EU) 2023/1182 for centrally authorised medicinal products,
1. July 2024,European Medicines Agency,Meeting,Committee for Medicinal Products for Human UseÂ 24-27 June 2024,
1. July 2024,European Medicines Agency,Guidance,Clinical investigation of recombinant & human plasma-derived factor IX products,
1. July 2024,European Medicines Agency,Guidance,Clinical Trial Information System (CTIS) - Sponsor handbook,
1. July 2024,European Medicines Agency,News,CTIS newsflash - 28 June 2024,
1. July 2024,European Medicines Agency,Guidance,Paediatric investigation plan (PIP) - Key elements guidance,
1. July 2024,European Directorate for the Quality of Medicines & HealthCare,News,Extractable elements in plastic materials for pharmaceutical use (2.4.35) adopted,
1. July 2024,European Directorate for the Quality of Medicines & HealthCare,Report,National requirements for non-prescription medicines & reclassification of medicines,
1. July 2024,International Medical Device Regulators Forum,Guidance,In Vitro Diagnostic Medical Device Market Authorization Table of Contents,
1. July 2024,International Medical Device Regulators Forum,Guidance,Non-In Vitro Diagnostic Medical Device Market Authorization Table of Contents,
1. July 2024,Swissmedic,Form,BW101_10_019e_FO Confirmation electronic submission,
1. July 2024,Swissmedic,Template,FSC-Example of a product list,
1. July 2024,Swissmedic,Checklist,Inspektion von Systemen der Vigilance betreffend Medizinprodukten,
1. July 2024,Swissmedic,Guidance,Authorisation of veterinary medicinal products,
1. July 2024,Swissmedic,News,Go-live for the swissdamed Actors module,
1. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Medical device regulation changes,
1. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Prescription lenses: exempt medical devices,
1. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,IVD sponsors: a roadmap to market,
1. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Determinations for Australian conformity assessment bodies,
1. July 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Sponsor six monthly report - supply of unapproved therapeutic goods,
1. July 2024,USA Food & Drug Administration FDA,Notice,Laboratory Developed Tests: Small Entity Compliance Guide,
1. July 2024,USA Food & Drug Administration FDA,Standards,"List of Recognized Standards, Recognition List Number: 062",
1. July 2024,USA Food & Drug Administration FDA,Report,New Drugs Regulatory Program Modernization â€“ Impact Narrative Update 2023.,
1. July 2024,USA Food & Drug Administration FDA,Guidance,Diversity Action Plans - Underrepresented Populations in Clinical Studies,
1. July 2024,USA Food & Drug Administration FDA,Update,eSTAR Program,
1. July 2024,USA Food & Drug Administration FDA,Report,Real-World Evidence Submissions CBER and CDER,
1. July 2024,USA Food & Drug Administration FDA,Science,Natural Language Processing - Directional Pharmacokinetic Drug-Drug Interactions,
1. July 2024,USA Food & Drug Administration FDA,Guidance,Essential Drug Delivery Outputs for Devices Delivering Drugs & Biologics,
24. June 2024,Bureau of Indian Standards,Standard,IS 23485Â Medical Devices - QMS Requirements & Safety & Performance,
24. June 2024,Egyptian Drug Authority,Guidance,Announcement of updates in the General Directorate of Stability,
24. June 2024,European Commission,Guidance,Phthalates in certain medical devices,
24. June 2024,European Commission,Guidance,"MDCG 2022-13 Rev.1 Designation, re-assessment and notification of CABs",
24. June 2024,European Commission,Regulation,Regulation (EC) 1234/2008 variations to the terms of marketing authorisations,
24. June 2024,European Medicines Agency,News,Faster access to clinical trial information in Europe,
24. June 2024,European Medicines Agency,Guidance,15. Updates Clinical Trial Information System CTIS,
24. June 2024,European Medicines Agency,Guidance,What EMA publishes and when,
24. June 2024,"Health Products Regulatory Authority (HPRA)Â , Ireland",Guidance,Updated questions and answers on the Windsor Framework,
24. June 2024,International Council for Harmonisation,Meeting,"ICH Assembly Meeting, Fukuoka, Japan, June 2024",
24. June 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,20 medical device registration review guidelines,
24. June 2024,Swissmedic,Guidance,Simplification of requirements for renewed authorisation of medicinal products,
24. June 2024,Swissmedic,Guidance,Requesting product certificates (CPP),
24. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Conformity assessment procedures for immunohematology reagents,
24. June 2024,USA Food & Drug Administration FDA,Regulations,Final rule that establishes certification regulations for certain medical gases,
24. June 2024,USA Food & Drug Administration FDA,Guidance,Facility Readiness: Goal Date Decisions Under GDUFA,
24. June 2024,USA Food & Drug Administration FDA,Update,Recognized Consensus Standards database,
24. June 2024,USA Food & Drug Administration FDA,Report,Enhancing Clinical Study Diversity,
24. June 2024,USA Food & Drug Administration FDA,Request,input on certain Non-Device Software Functions and Impacts to Patient Safety,
24. June 2024,USA Food & Drug Administration FDA,Study,Interpretation of info about Rx drugs in scientific publications vs. promotional pieces,
24. June 2024,USA Food & Drug Administration FDA,Guidance,"Delaying, Denying, Limiting, or Refusing a Drug or Device Inspection",
24. June 2024,USA Food & Drug Administration FDA,Guidance,Demonstrating Interchangeability With a Reference Product: Update,
24. June 2024,USA Food & Drug Administration FDA,Update,Laboratory Developed Tests,
24. June 2024,World Health Organisation WHO,Report,Global Patient Safety Report 2024,
17. June 2024,European Commission,Guidance,MDCG 2024-1-5 - Urogynaecological Surgical Mesh Implants (June 2024),
17. June 2024,European Commission,Meeting,MDCG Subgroup on Standards (WG 2),
17. June 2024,European Commission,Guidance,Guidance on outcomes for joint clinical assessments,
17. June 2024,European Commission,Guidance,Reporting requirements in joint clinical assessments,
17. June 2024,European Medicines Agency,Guidance,Variations categories and procedures: Regulation (EC) No 1234/2008,
17. June 2024,European Medicines Agency,Guidance,IRIS guide for applicants,
17. June 2024,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment CommitteeÂ (PRAC) June 2024,
17. June 2024,European Directorate for the Quality of Medicines & HealthCare,Report,Certification Monthly Report,
17. June 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Standards,List of Mandatory Standards for Medical Device Products,
17. June 2024,"MEDSAFE, New Zealand",Guidance,Guidelines on the Regulation of Therapeutic Products in New Zealand,
17. June 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Software and artificial intelligence (AI) as a medical device,
17. June 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Transparency for machine learning-enabled medical devices: guiding principles,
17. June 2024,"Therapeutic Goods Administration (TGA), Australia",News,Proactive monitoring of highest-risk medical device clinical trials,
17. June 2024,"Therapeutic Goods Administration (TGA), Australia",Checklist,Essential Principles checklist,
17. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Good Manufacturing Practice (GMP) requirements for medicinal products,
17. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Assessed listed medicines evidence guidelines,
17. June 2024,USA Food & Drug Administration FDA,Report,Report on the State of Pharmaceutical Quality,
17. June 2024,USA Food & Drug Administration FDA,Guidance,Evaluation Methods for Artificial Intelligence (AI)-Enabled Medical Devices,
17. June 2024,USA Food & Drug Administration FDA,News,CDER Emerging Drug Safety Technology Program (EDSTP),
17. June 2024,USA Food & Drug Administration FDA,Guidance,Transparency for Machine Learning-Enabled Medical Devices,
17. June 2024,USA Food & Drug Administration FDA,Guidance,Bayesian statistical analysis plans to clinical trials demonstration program,
17. June 2024,USA Food & Drug Administration FDA,Reminder,Deadline Registration and Listing of Cosmetic Product Facilities and Products,
17. June 2024,USA Food & Drug Administration FDA,Guidance,The Limitations of Medical Data in AI,
17. June 2024,USA Food & Drug Administration FDA,Guidance,Diabetic Foot Infections: Developing Drugs for Treatment,
17. June 2024,USA Food & Drug Administration FDA,Guidance,Clinical Pharmacology - Development of Oligonucleotide Therapeutics,
10. June 2024,CDSCO India,Guidance,Guidance for Industry on Pharmacovigilance Requirements for Human Vaccines,
10. June 2024,Egyptian Drug Authority,Guidance,Pharmaceutical Practices for Diabetes,
10. June 2024,Egyptian Drug Authority,Update,Fast Track system for all quality files for locally made products,
10. June 2024,European Directorate for the Quality of Medicines & HealthCare,News,Pharmacopoeial Discussion Group achievements,
10. June 2024,European Medicines Agency,Meeting,Committee for Medicinal Products for Human Use (CHMP) 27-30 May 2024,
10. June 2024,European Medicines Agency,Newsflash,CTIS newsflash â€“ 31 May 2024,
10. June 2024,European Medicines Agency,Guidance,Paediatric investigation plan (PIP) - Key elements guidance,
10. June 2024,European Medicines Agency,Guidance,Guidance & Timeline for Simultaneous National Scientific Advice (SNSA),
10. June 2024,ISO (International Organization for Standardization),Standard,"ISO Update May 1, 2024 to June 1, 2024",
10. June 2024,Medical Device Authority Malaysia,Announcement,Implementation of Electronic Establishment License Certificate,
10. June 2024,Medical Device Authority Malaysia,Announcement,Implementation of the One-license Policy for Each Establishment Role,
10. June 2024,"MEDSAFE, New Zealand",Newsletter,Prescriber Update,
10. June 2024,Swissmedic,Guidance,Time limits for authorization applications,
10. June 2024,Swissmedic,Form,Drug Master File DMF,
10. June 2024,Swissmedic,Guidance,Meeting for applicants held with the Authorisation sector,
10. June 2024,Swissmedic,Guidance,Temporary authorisation for human medicinal products,
10. June 2024,Swissmedic,Guidance,Variations and extensions HAM,
10. June 2024,Swissmedic,Information Sheet,Swissmedic eGov Portal â€“ OCABR standard functions-2023,
10. June 2024,Swissmedic,Guidance,Incident economic operators,
10. June 2024,Swissmedic,Information Sheet,Archive access,
10. June 2024,Swissmedic,Information Sheet,eMessage functions,
10. June 2024,Swissmedic,Information Sheet,eIAM Portal Administrator,
10. June 2024,Swissmedic,Form,Declaration by the Responsible Person for foreign manufacturers,
10. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Clinical trial notification (CTN) form - user guide,
10. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Good Clinical Practice (GCP) Inspection Program,
10. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Cosmetics or therapeutic goods,
10. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Serious Scarcity Substitution Instruments (SSSIs),
10. June 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,112 adopted this International Scientific Guidelines June 2024,
10. June 2024,USA Food & Drug Administration FDA,Regulation,To Administratively Destroy Illegal Imported Devices,
10. June 2024,USA Food & Drug Administration FDA,Announcement,Participation in three New Collaborative Communities,
10. June 2024,USA Food & Drug Administration FDA,Guidance,Processes and Practices Applicable to Bioresearch Monitoring Inspections,
10. June 2024,USA Food & Drug Administration FDA,Guidance,Electronic Submission for Marketing Applications Content (BIMO) CBER,
10. June 2024,USA Food & Drug Administration FDA,SOPP 8795,Posting and Announcement of PMAs Exemption Approvals and Denials,
3. June 2024,CDSCO India,Circular,Testing and evaluation of Medical Devices/ IVDs by Medical Devices Testing Lab.,
3. June 2024,Egyptian Drug Authority,Guidance,E-labelling of Medical Leaflets of Medicinal Products for Human Use,
3. June 2024,Egyptian Drug Authority,Updates,Fast Track for all files submitted to manage variables for human pharmaceuticals,
3. June 2024,European Commission,Dashboard,Study supporting the monitoring of availability of medical devices in the EU,
3. June 2024,European Commission,Guidance,MDCG 2022-4 Rev 2 provisions under Article 120 of the MDR legacy devices,
3. June 2024,European Commission,Newsletter,MEDICAL DEVICES NEWS Newsletter,
3. June 2024,European Commission,Consultation,Health technology assessment â€“ Assessing and Managing Conflicts of Interest,
3. June 2024,European Commission,Regulation,(EU) 2017/745 and (EU) 2017/746 as regards a gradual roll-out of Eudamed,
3. June 2024,European Commission,Regulation,Quality & Safety for Substances of Human Origin for Human Application,
3. June 2024,European Medicines Agency,Guidance,"ICH M14 plan, design and analysis of pharmacoepidemiological studies",
3. June 2024,European Medicines Agency,Report,"Annual report highlights progress in science, medicines and health in 2023",
3. June 2024,"Health Sciences Authority (HSA), Singapore",Responses,Amendments to Regulation 23 of the Health Products Regulations,
3. June 2024,International Council for Harmonisation,Guidance,ICH M12 Guideline:+ Q&A DRUG INTERACTION STUDIES,
3. June 2024,"Health Products Regulatory Authority (HPRA)Â , Ireland",Guidance,For Health Institutions who manufacture & use In-house IVDs,
3. June 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,48 Guidelines 1 â€“ 24 for the Registration and Review of Medical Devices,
3. June 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,48 Guidelines 25 â€“ 48 for the Registration and Review of Medical Devices,
3. June 2024,Medicines and Healthcare products Regulatory Agency,Guidance,International Recognition Procedure,
3. June 2024,South African Health Products Regulatory Authority,Guidance,Patient Information Leaflet for Human Medicines (Categories A D),
3. June 2024,South African Health Products Regulatory Authority,Communication,Summary of Medicine Safety Regulatory Decisions,
3. June 2024,South African Health Products Regulatory Authority,Communication,Regulatory Information Management System â€“ Update on Progress,
3. June 2024,Swissmedic,Guidance,Performance studies with IVD,
3. June 2024,Swissmedic,Guidance,Clinical investigations with medical devices,
3. June 2024,Swissmedic,Guidance,Swissmedic eGov Portal â€“ Standard functions CPP,
3. June 2024,Swissmedic,Guidance,Clinical Trial Application Dossier,
3. June 2024,Swissmedic,Guidance,Guideline Amendments Clinical Trials,
3. June 2024,Swissmedic,Checklist,Die Inspektion der Instandhaltung von Medizinprodukten,
3. June 2024,Swissmedic,Guidance,Swiss M1 Implementation Guidance,
3. June 2024,"Therapeutic Goods Administration (TGA), Australia",Publication,Australiaâ€™s breast implant risk management framework,
3. June 2024,"Therapeutic Goods Administration (TGA), Australia",Publication,Cosmetic injectables: import and supply in Australia,
3. June 2024,"Therapeutic Goods Administration (TGA), Australia",Publication,Action Plan for Medical Devices Progress Report Card: December 2023,
3. June 2024,USA Food & Drug Administration FDA,Guidance,Safety of Residues of Veterinary Drugs in Human Food,
3. June 2024,USA Food & Drug Administration FDA,Guidance,Platform Technology Designation Program for Drug Development,
3. June 2024,USA Food & Drug Administration FDA,Update,Drugs@FDA Data Files,
27. May 2024,Egyptian Drug Authority,Guidance,Antimicrobial Use in Infections with Multi-Drug Resistant Organisms (MDROs),
27. May 2024,European Directorate for the Quality of Medicines & HealthCare (EDQM),Guidance,Draft guideline on â€˜Content of the dossier for sterile substancesâ€™,
27. May 2024,European Commission,Report,Study on the implementation of Article 17 of Regulation (EU) 2017/745,
27. May 2024,European Commission,Communication,European Health Union: acting together for people's health,
27. May 2024,European Medicines Agency,Guidance,Medical devices: new guidance for industry andÂ notified bodies,
27. May 2024,European Medicines Agency,Newsflash,CTIS newsflash,
27. May 2024,European Medicines Agency,Guidance,IDMP: Chapter 7: XEVMPD and SIAMED II to PMS â€“ Initial migration guide,
27. May 2024,European Medicines Agency,Guidance,IRIS guide for applicants,
27. May 2024,European Medicines Agency,Guidance,Support for industry on clinical data publication; Anonymisation,
27. May 2024,European Medicines Agency,Q&A,Regulatory Procedure Management for the Product Lifecycle Management,
27. May 2024,International Medical Device Regulators Forum,Template,8 Slide Template for IMDRF Membership Application Presentations,
27. May 2024,Medical Device Authority Malaysia,Registration,Re-Registration Medical Device Applications in the Medc@st 2.0+ System,
27. May 2024,Medical Device Authority Malaysia,Consultation,Draft Guidance Document Change Notification for Registered Medical Device,
27. May 2024,Department of Health and Social Care UK,Policy Paper,Explanatory Memo on EU regulations 2017/745 & 2017/746 (COM(2024)43),
27. May 2024,Medicines and Healthcare products Regulatory Agency,Standard,Implementation of the future regulations,
27. May 2024,Medicines and Healthcare products Regulatory Agency,Standard,Statement of policy intent: international recognition of medical devices,
27. May 2024,Medicines and Healthcare products Regulatory Agency,Consultation,Common specification requirements for in vitro diagnostic devices,
27. May 2024,South African Health Products Regulatory Authority,Guidance,Reliance - General ECTD & human medicines,
27. May 2024,South African Health Products Regulatory Authority,Guidance,Resubmission Of Shipment Documentation For SAHPRA Review and Stamp,
27. May 2024,South African Health Products Regulatory Authority,Guidance,"12 Documents, Medical Device Registration Voluntary Feasibility Study",
27. May 2024,Team AB,News,MHRA's International Recognition Policy for Medical Device Regulations,
27. May 2024,Team NB,Survey,Team-NB 2023 Annual Sector Survey & Press Release,
27. May 2024,USA Food & Drug Administration FDA,Reclassification,Ophthalmic Devices; Ultrasound Cyclodestructive Device,
27. May 2024,USA Food & Drug Administration FDA,Update,ASCA-Accredited Testing Laboratories,
27. May 2024,USA Food & Drug Administration FDA,Report,FY 2023 GDUFA Science and Research Report,
27. May 2024,USA Food & Drug Administration FDA,SOP,Resolution of Internal Differences of Opinion in Regulatory Decision-Making,
27. May 2024,World Health Organisation WHO,Guidance,Data requirements & protocol for efficacy of vector control products,
27. May 2024,World Health Organisation WHO,List,"WHO bacterial priority pathogens list, 2024",
20. May 2024,CDSCO India,Notice,Adverse Events reported under Materiovigilance Programme of India,
20. May 2024,CDSCO India,Circular,Transition Class C & D Medical Devices under Licensing regime w.e.f 01.10.2023,
20. May 2024,European Commission,Update,49 EU MDR and 12 EU IVDR Notified Bodies,
20. May 2024,European Commission,Report,"Combine clinical trials of medicinal products, medical devices and IVDs",
20. May 2024,European Commission,Templates,"MDCG 2024-6, 7, 8 and 9 - Preliminary (re-)assessment review templates",
20. May 2024,European Commission,EUDAMED,The new version of EUDAMED 2.14.1 has been deployed.,
20. May 2024,European Commission,Survey,Notified bodies survey on certifications and applications,
20. May 2024,European Medicines Agency,Guidance,Implementation of ISO standards IDMP,
20. May 2024,European Medicines Agency,IDMP,Implementation of ISO standards IDMP Chapter 1 Registration Requirements,
20. May 2024,European Medicines Agency,Guidance,EudraVigilance registration documents,
20. May 2024,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment CommitteeÂ (PRAC) 13-16 May 2024,
20. May 2024,Department of Health The Government of the Hong Kong,MDACS,Overview of the Medical Device Administrative Control System (GN-01),
20. May 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Consultation,Registration & Review of Prefilled Catheter Irrigators (Draft for Comments),
20. May 2024,ISO (International Organization for Standardization),Standard,"ISO Update April 1, 2024 to May 1, 2024",
20. May 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Good manufacturing practice and good distribution practice,
20. May 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply for a licence to market a medicine in the UK,
20. May 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices regulations: compliance and enforcement,
20. May 2024,Swissmedic,Guidance,Guidance document for requesting product certificates (CPP),
20. May 2024,Swissmedic,Checklist,Inspektion von Aufbereitungseinheiten fÃ¼r Medizinprodukte (AEMP),
20. May 2024,Swissmedic,Reglement,Reglement Schweizerische PharmakopÃ¶egremien,
20. May 2024,Swissmedic,Information Sheet,Quick instruction for use of the FO_submission form,
20. May 2024,Swissmedic,Guidance,Guidance on the Submission Process for Clinical Trials with Medicinal Products,
20. May 2024,Swissmedic,Guidance,Temporary Authorisation to use an unauthorised medicinal product,
20. May 2024,Swissmedic,Directory,List Countries with recognised GMP control systems,
20. May 2024,Swissmedic,Form,Einfuhr von immunologischen Arzneimittelnoder oder von Blut und Blutprodukten,
20. May 2024,Swissmedic,Information Sheet,"import licence for immunological medicinal products, or blood products",
20. May 2024,Swissmedic,Guidance,Change name or domicile of the authorisation holder,
20. May 2024,Swissmedic,Guidance,Information sheet Requirements ZL TrP/GT/GMO,
20. May 2024,"Therapeutic Goods Administration (TGA), Australia",Form,Notification of a change in sponsorship,
20. May 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Good Clinical Practice (GCP) Inspection Program,
20. May 2024,USA Food & Drug Administration FDA,Catalog,Regulatory Science Tools Catalog,
20. May 2024,USA Food & Drug Administration FDA,List,Artificial Intelligence and Machine Learning (AI/ML)-Enabled Medical Devices,
20. May 2024,USA Food & Drug Administration FDA,Report,2023 Drug Trials Snapshots Summary Report,
20. May 2024,USA Food & Drug Administration FDA,MDDT Tools,IntraOcular Lens Implant Symptoms (AIOLIS) Instrument.,
13. May 2024,Egyptian Drug Authority,Consultation,Draft regulatory guide for the examination of human use products files,
13. May 2024,Egyptian Drug Authority,Extension,Exceptional period for entering cosmetic notification on the e-platform,
13. May 2024,European Commission,Update,48 EU MDR and 12 EU IVDR Notified Bodies,
13. May 2024,European Medicines Agency,Form,"(CTIS) structured data form - substantial, non-substantial modification",
13. May 2024,European Medicines Agency,Recommendation,(PRAC recommendations on signals adopted 8-11 April 2024 Framework for Action: Cross-agency One Health task force framework for action,
13. May 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Software and artificial intelligence (AI) as a medical device,
13. May 2024,Medicines and Healthcare products Regulatory Agency,Collection,AI Airlock: the regulatory sandbox for AIaMD,
13. May 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Send and receive information on adverse drug reactions (ADRs),
13. May 2024,Medical Device Authority Malaysia,Circular Letter,Medical Devices Subject to Trade Restrictions,
13. May 2024,"Health Sciences Authority (HSA), Singapore",Memorandum,HSA signs memorandum of understanding with Malaysia,
13. May 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Regulation of software based medical devices,
13. May 2024,USA Food & Drug Administration FDA,Guidance,REMS Logic Model:A Framework to Link Program Design With Assessment ,
13. May 2024,USA Food & Drug Administration FDA,Guidance,Remanufacturing of Medical Devices,
13. May 2024,USA Food & Drug Administration FDA,Request for Comment,Clinical Research Terms - Innovative Clinical Trial Design,
13. May 2024,USA Food & Drug Administration FDA,Record,eSubmitter Application History,
13. May 2024,USA Food & Drug Administration FDA,Initiative,General Framework for Adopting LLMs in Regulatory Application,
13. May 2024,USA Food & Drug Administration FDA,Annual Summary,Biological Product and HCT/P Deviation Reports,
13. May 2024,World Health Organisation WHO,Guidance,Prevention of infections from intravascular peripheral catheters,
6. May 2024,Egyptian Drug Authority,Guidance,Naming of Human Pharmaceutical Products,
6. May 2024,European Medicines Agency,Guidance,ICH Q3C (R9) Guideline on impurities guideline for residual solvents - Step 5,
6. May 2024,European Medicines Agency,Guidance,Quality of medicines questions and answers: Part 1,
6. May 2024,European Medicines Agency,Guidance,Defining the Scope of an NIRS Procedure,
6. May 2024,European Medicines Agency,Guidance,Appendix 1: Acceptable intakes established for N-nitrosamines,
6. May 2024,European Medicines Agency,Concept Paper,Risk Assessment Human Medicinal Products Reproduction and Lactation,
6. May 2024,European Medicines Agency,Template,Template for scientific document (parts B-F),
6. May 2024,European Medicines Agency,Report,SME office annual report,
6. May 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Send and receive information on adverse drug reactions (ADRs),
6. May 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
6. May 2024,Medicines and Healthcare products Regulatory Agency,Policy Paper,Impact of AI on the regulation of medical products,
6. May 2024,Medicines and Healthcare products Regulatory Agency,News,MHRAâ€™s AI regulatory strategy ensures patient safety & industry innovation into 2030,
6. May 2024,"Health Sciences Authority (HSA), Singapore",Guidance,NEX2US Newsletter Issue 10 | April 2024,
6. May 2024,International Medical Device Regulators Forum,Guidance,Assessment & Decision Process for Recognition of CAB Regulatory Reviews,
6. May 2024,International Medical Device Regulators Forum,Guidance,Competence and Training Requirements for CABs Conducting Reviews,
6. May 2024,International Medical Device Regulators Forum,Guidance,Regulatory Authority Assessment Method for CAB Review,
6. May 2024,International Medical Device Regulators Forum,Guidance,Requirements for Regulatory Authority Recognition of CABs Conducting Reviews,
6. May 2024,International Medical Device Regulators Forum,Guidance,Principles of Labelling for Medical Devices and IVD Medical Devices,
6. May 2024,International Medical Device Regulators Forum,Guidance,Essential Principles of Safety and Performance of Medical Devices and IVDs,
6. May 2024,International Medical Device Regulators Forum,Guidance,"Competence, Training, and Conduct Requirements for Reg.  Reviewers",
6. May 2024,International Medical Device Regulators Forum,Guidance,Regulatory Review Report: Guidance Regarding Information to be Included,
6. May 2024,International Medical Device Regulators Forum,Whitepaper,IMDRF 25th Session Workshop: White Paper on Reliance,
6. May 2024,Swissmedic,Guidance,Parallel Import of a human medicinal product according to Art. 14 para. 2 and 3,
6. May 2024,Swissmedic,Guidance,Guidance document for requesting product certificates (CPP),
6. May 2024,Swissmedic,Form,Meldung einer vermuteten unerwÃ¼nschten Arzneimittelwirkung (UAW),
6. May 2024,"Therapeutic Goods Administration (TGA), Australia",Checklist,Essential Principles checklist,
6. May 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Regulatory requirements for in-house IVDs,
6. May 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Boundary and combination products and their product category,
6. May 2024,USA Food & Drug Administration FDA,Guidance,Enforcement Policy for Certain IVDs,
6. May 2024,USA Food & Drug Administration FDA,Guidance,Enforcement Policies Tests During a Section 564 Declared Emergency,
6. May 2024,USA Food & Drug Administration FDA,Guidance,Use of a Standard for Uniform Blood & Blood Component Container Labels,
6. May 2024,USA Food & Drug Administration FDA,Guidance,"Derived Materials in the Manufacture of Cell, Gene Therapy &Tissue-Engineered",
6. May 2024,USA Food & Drug Administration FDA,Guidance,Safety Testing of Human Allogeneic Cells for Use in Cell-Based Medical Products,
6. May 2024,USA Food & Drug Administration FDA,Report,2023 Office of New Drugs (OND) Annual Report,
6. May 2024,USA Food & Drug Administration FDA,Report,2023 Office of Translational Sciences Annual Report,
6. May 2024,USA Food & Drug Administration FDA,Newsletter,Whatâ€™s New in Regulatory Science CDER,
6. May 2024,USA Food & Drug Administration FDA,News,Helping to Ensure the Safety and Effectiveness of Laboratory Developed Tests,
6. May 2024,USA Food & Drug Administration FDA,MDDT Tools,Apple Atrial Fibrillation History Feature,
29. April 2024,Drug Regulatory Authority of Pakistan,Guidance,Post Registration Variation Â for pharmaceutical and biologic products,
29. April 2024,Egyptian Drug Authority,Guidance,Papers to submit to General Department of Evaluation and Control,
29. April 2024,European Commission,Update,46 EU MDR and 12 EU IVDR Notified Bodies,
29. April 2024,European Commission,Approved,"Gradual roll-out of Eudamed, improve transition of IVD",
29. April 2024,European Medicines Agency,Guidance,Strengthening supply chains of critical medicines,
29. April 2024,European Medicines Agency,Report,EMAâ€™s biennial report on stakeholder engagement activities,
29. April 2024,European Medicines Agency,Meeting,Committee for Medicinal Products for Human UseÂ (CHMP) 22-25 April 2024,
29. April 2024,East Africa Regulatory Affairs Association (EARAPA),REOI,Regulatory Process for Certification or Listing of Priority IVDs,
29. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: apply for a variation to your marketing authorisation,
29. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply for a licence to market a medicine in the UK,
29. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
29. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device,
29. April 2024,Department of Health The Government of the Hong Kong,MDACS,Update-Listed Rapid Antigen Tests for COVID-19 under MDACS,
29. April 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Consultation,Technical review of the laparoscopic surgical system,
29. April 2024,"SEGOB Secretariat of the Interior or the Secretariat for Governance, Mexico",Standard,"PROY-NOM-137-SSA1-2024,Labeling of medical devices.",
29. April 2024,Swissmedic,Form,Gesuch Betriebsbewilligung - Basisformular Arzneimittel (inkl. Blut),
29. April 2024,Swissmedic,Form,Gesuch Betriebsbewilligung - Zusatzblatt Arzneimittel (inkl. Blut),
29. April 2024,Swissmedic,Form,Gesuch Betriebsbewilligung - Basisformular TpP/GT/GVO,
29. April 2024,Swissmedic,Form,Gesuch Betriebsbewilligung - Zusatzblatt TpP/GT/GVO,
29. April 2024,Swissmedic,Guidance,Application establishment licence - medicinal products TP/GT/GMO,
29. April 2024,Swissmedic,Guidance,Authorisation of human medicinal product - known active substance,
29. April 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Established acceptable intake for nitrosamines in medicines,
29. April 2024,USA Food & Drug Administration FDA,Report,Postmarketing Requirements and Commitments: Reports,
29. April 2024,USA Food & Drug Administration FDA,Record,eSubmitter Application History,
29. April 2024,USA Food & Drug Administration FDA,Announcement,Home as a Health Care Hub,
29. April 2024,USA Food & Drug Administration FDA,Guidance Snapshots,E19 A Selective Approach to Safety Data Collection,
29. April 2024,USA Food & Drug Administration FDA,Guidance,Promotional Labeling and Advertising Considerations Biologics Q&A,
29. April 2024,USA Food & Drug Administration FDA,Guidance,Content Format of Composition Statement of Ingredients Labeling NDAs ANDAs,
29. April 2024,USA Food & Drug Administration FDA,Guidance x 3,Cancer Clinical Trial Eligibility Criteria,
29. April 2024,USA White House Office for Information and RegulatoryÂ Affairs,Conclusion,Regulatory Review Medical Devices; Laboratory Developed Tests,
29. April 2024,World Health Organisation WHO,Guidance,The selection and use of essential medicines (2023) - TRS 1049,
22. April 2024,Egyptian Drug Authority,Form,Updating The Registeration Form,
22. April 2024,European Directorate for the Quality of Medicines & HealthCare,Deadline,Survey on strategy for Ph. Eur. quality standards for MABs,
22. April 2024,European Directorate for the Quality of Medicines & HealthCare,Consultation,Guidance Traceability of Medicines in Hospital Settings,
22. April 2024,European Commission Medical Device Coordination Group,Guidance,MDCG 2024-4 Safety reporting in performance studies of EU IVDR Template: MDCG 2022-9 / Rev.1 Summary of safety and performance,
22. April 2024,European Commission Medical Device Coordination Group,Guidance,MDCG 2024-5 - Guidance on the Investigatorâ€™s Brochure content,
22. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,RegulatoryConnect,
22. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Rolling review for marketing authorisation applications,
22. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,150-day assessment for national applications for medicines,
22. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,MAH submission of Nitrosamine risk and confirmatory testing,
22. April 2024,Medical Device Authority Malaysia,Announcement,Quotation Medical Device Testing Services,
22. April 2024,Medical Device Authority Malaysia,Directive,Implementation of One License Policy For Each Establisment Role,
22. April 2024,Department of Health The Government of the Hong Kong,MDACS,Update-Medical Device Information System,
22. April 2024,Swissmedic,Guidance,Medical Device Software,
22. April 2024,Swissmedic,Form,New authorisation of human medicinal products,
22. April 2024,Swissmedic,Guidance,GMP compliance by foreign manufacturers,
22. April 2024,Swissmedic,Form,Status of authorisation applications abroad,
22. April 2024,"Therapeutic Goods Administration (TGA), Australia",Consultation,Availability of Instructions For Use (IFU) in more flexible formats,
22. April 2024,"Therapeutic Goods Administration (TGA), Australia",Standard,Sunscreen Standard update,
22. April 2024,USA Food & Drug Administration FDA,Announcement,New Dataset - Chemical Characterization Methods for Biocompatibility,
22. April 2024,USA Food & Drug Administration FDA,Announcement,CDER Center for Clinical Trial Innovation (C3TI),
22. April 2024,USA Food & Drug Administration FDA,SOPP 8101.2,Scheduling and Documentation of Meetings with Industry,
22. April 2024,USA Food & Drug Administration FDA,Guidance,Data Standards Catalog,
22. April 2024,USA Food & Drug Administration FDA,Reports,CDRH Issues 2024 Safety and Innovation Reports,
22. April 2024,USA Food & Drug Administration FDA,Guidance Snapshots,Pharmacokinetics Impaired Renal Function,
22. April 2024,USA Food & Drug Administration FDA,CDER Discussion,Proposed Rule to Help Patients Understand Their Prescription Medication Information,
22. April 2024,World Health Organisation WHO,Guidance,"WHO pharmaceuticals newsletter - No. 2, 2024",
15. April 2024,ANVISA Brazil,Normative Instruction,Procedure for acceptance of applications - Mutual Recognition,
15. April 2024,CDSCO India,Guidance,Stabilty Studies of In-vitro Diagnostic Medical Device (IVDMD),
15. April 2024,Egyptian Drug Authority,Guidance,Mechanism of inquiry and follow-up of the position of stability studies,
15. April 2024,European Directorate for the Quality of Medicines & HealthCare (EDQM),Press Release,JP and Ph. Eur. launch harmonisation project for API & Finished Form,
15. April 2024,European Commission,Final Report,Study on the implementation of Article 17 of EU MDR in EU,
15. April 2024,European Commission,Dashboard,A Study & Dashboard reprocessing and reuse of single-use-devices,
15. April 2024,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment Committee 8-11 April 2024,
15. April 2024,ISO (International Organization for Standardization),Standard,"ISO Update March 1, 2024 to April 1, 2024",
15. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,International Recognition Procedure,
15. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Borderlines with medical devices and other products in Great Britain,
15. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: apply for a parallel import licence,
15. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Clinical trials for medicines: apply for authorisation in the UK,
15. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device,
15. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: reclassify your product,
15. April 2024,Medicines and Healthcare products Regulatory Agency,Pharmacopoeia Guidance,ATMP T Cell and NK Cell Characterisation Assays,
15. April 2024,Department of Health and Social Care,Guidance,Medical technology innovation classification framework,
15. April 2024,Department of Health and Social Care,Policy Paper,Medical technology strategy,
15. April 2024,"MEDSAFE, New Zealand",Consultation,Outcome of the consultation on standards for contraceptive devices,
15. April 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,Clinical Evaluation and Registration Review of Absorbable Sutures,
15. April 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Consultation,Registration & Review of Matrix Soft Tissue Wound Repair,
15. April 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Notice,Medical Device Registration Review Guideline Plan (No. 17 [2024]),
15. April 2024,Saudi Food & Drug Authority,Guidance,General Considerations for Preclinical Studies Submissions,
15. April 2024,Swissmedic,Form,Adverse Reaction Report CT ATMP,
15. April 2024,Swissmedic,Information Sheet,"Reporting Adverse reactions with ATMPs,(bacteriophages, etc.)",
15. April 2024,Swissmedic,Technical interpretation,Retention Samples,
15. April 2024,Swissmedic,Form,Reporting a suspected adverse drug reaction (UAW),
15. April 2024,Swissmedic,Checklist,Application for operating license to handle controlled substances,
15. April 2024,Swissmedic,Regulation,Regulations on fee collection,
15. April 2024,Swissmedic,Form,Field Safety Corrective Action (FSCA) Report,
15. April 2024,"Therapeutic Goods Administration (TGA), Australia",Form,Clinical trial notification (CTN) form,
15. April 2024,USA Food & Drug Administration FDA,Record,eSubmitter Application History,
8. April 2024,CDSCO India,Notice,Strengthening of Private Medical Device Testing Laboratory,
8. April 2024,Egyptian Drug Authority,Guidance,Third edition regulatory guide for the decision of the EDA  No. (450) of 2023,
8. April 2024,Egyptian Drug Authority,Guidance,Rational use of antifungals,
8. April 2024,European Medicines Agency,Procedure,Procedural Advice on Zero day MR procedure,
8. April 2024,European Medicines Agency,Q&A,Pharmacovigilance Legislation,
8. April 2024,"Health Sciences Authority (HSA), Singapore",Guidance,Regulatory Updates for Therapeutic Product Registration,
8. April 2024,"Health Sciences Authority (HSA), Singapore",Guidance,Points to Consider for Singapore Labelling,
8. April 2024,"Health Sciences Authority (HSA), Singapore",Guidance,Implementation of electronic labelling (e-labelling) Non Pres. GS,
8. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,"Assistive technology: definitions, examples and safe use",
8. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,ICH Technical Requirements for Pharmaceuticals for Human Use Guidelines,
8. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Drugs and pharmaceutical electronic market information tool (eMIT),
8. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,UK Parallel Import Licences Following Agreement of the Windsor Framework,
8. April 2024,Medicines and Healthcare products Regulatory Agency,Blog,DSUR Submissions and Fees are Changing from 1 June 2024,
8. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Innovative Licensing & Access Pathway & Target Product Profile Toolkit,
8. April 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Consultation,Notice on the public solicitation: industry standards for clinical evaluation,
8. April 2024,Department of Health The Government of the Hong Kong,MDACS,Medical Device Information System,
8. April 2024,Swissmedic,Guidance,Export Certificates,
8. April 2024,Swissmedic,Strategisches Dokument,Verhaltenskodex Swissmedic,
8. April 2024,Swissmedic,Journal,Swissmedic Journal March 2024,
8. April 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Updated guidelines for Assessed listed medicines,
8. April 2024,USA Food & Drug Administration FDA,eSTAR,eSTAR is now available for voluntary use for 513(g),
8. April 2024,USA Food & Drug Administration FDA,Guidance,FDA Regional Implementation Guide for E2B(R3) Electronic Transmission of Individual Case Safety Reports for Drug and Biological Products,
8. April 2024,USA Food & Drug Administration FDA,Guidance,Providing Regulatory Submissions in Electronic Format: IND Safety Reports,
8. April 2024,USA Food & Drug Administration FDA,Guidance,E-Submission of Expedited Safety Reports From IND-Exempt BA/BE Studies,
8. April 2024,USA Food & Drug Administration FDA,Guidance,Data Integrity for In Vivo Bioavailability and Bioequivalence Studies,
8. April 2024,USA Food & Drug Administration FDA,Report,The Office of Pharmaceutical Quality (OPQ) Issues Annual Report for 2023,
8. April 2024,USA Food & Drug Administration FDA,"Snapshot, Podcast, Guidance",Considerations for Antibody-Drug Conjugates,
8. April 2024,USA Food & Drug Administration FDA,Guidance MDDT,Lethal Arrhythmia Database Qualified as an MDDT,
8. April 2024,USA Food & Drug Administration FDA,Report,CDERâ€™s Office of Communications (OCOMM) Annual Report for 2023,
8. April 2024,Medicines Control Authority of Zimbabwe (MCAZ),Invitation,new system of processing applications for registration - Circular 26 of 2023,
8. April 2024,World Health Organisation WHO,Guidance,Implementation guide to the routine health information system toolkit,
1. April 2024,Drug Regulatory Authority of Pakistan,Guidance,Good Clinical Practice (GCP) Inspections,
1. April 2024,Egyptian Drug Authority,Declaration,Registration of pharmaceutical form medical supplies (Dosage form),
1. April 2024,European Commission,Guidance,Responsible use of generative Artificial Intelligence in research,
1. April 2024,European Commission,Request,Use of brain stimulators not having an intended medical purpose,
1. April 2024,European Commission,Overview,Devices subject to the clinical evaluation consultation procedure,
1. April 2024,European Commission,Guidance,Quantitative Evidence Synthesis: Direct and Indirect Comparisons,
1. April 2024,European Commission,Guidance,Overview of language requirements for manufacturers of medical devices,
1. April 2024,European Medicines Agency,Guidance,"Quality, non-clinical and clinical requirements for investigationalÂ advanced therapy medicinal productsÂ inÂ clinical trials",
1. April 2024,European Medicines Agency,Guidance,Pre-authorisation procedural advice for users of the centralised procedure,
1. April 2024,European Medicines Agency,Guidance,"Preparation, conduct and reporting of EU pharmacovigilance inspections",
1. April 2024,European Medicines Agency,Fees,Regulatory information â€“ adjusted fees for applications to EMA from 1 April 2024,
1. April 2024,International Medical Device Regulators Forum,Outcome Statement,25th Session of the IMDRF 11-15 March 2024,
1. April 2024,International Medical Device Regulators Forum,Jurisdictional Updates,25th Session of the IMDRF Regulatory Updates,
1. April 2024,International Medical Device Regulators Forum,Working Group Updates,25th Session of the IMDRF Working Groups,
1. April 2024,International Medical Device Regulators Forum,Industry Workshops,25th Session of the IMDRF Industry Workshop â€œRelianceâ€,
1. April 2024,Medical Device Authority Malaysia,Announcement,Faster Approval For Establishment License Application,
1. April 2024,Medical Device Authority Malaysia,Guidance,Establishment License Application,
1. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Regulation of devices in Northern Ireland,
1. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply for manufacturer or wholesaler of medicines licences,
1. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,"Clinical trials for medicines: manage authorisation, report safety issues",
1. April 2024,Medicines and Healthcare products Regulatory Agency,Guidance,RegulatoryConnect,
1. April 2024,Medicines and Healthcare products Regulatory Agency,Report,SaBTO annual report 2022 to 2023,
1. April 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,For the review of medical device usability engineering registration,
1. April 2024,"NMPA-National Medical Products Administration, Peoples Republic of China",Guidance,For the registration review of high-frequency surgical devices,
1. April 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Uniform recall procedure for therapeutic goods (URPTG),
1. April 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Authorised Prescriber Scheme,
1. April 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Supporting documentation for inclusion of a medical device,
1. April 2024,USA Food & Drug Administration FDA,SOPP,Managing MDUFA User Fee Payments and Billing,
1. April 2024,USA Food & Drug Administration FDA,Annual Report,National Center For Toxicological Research,
1. April 2024,USA Food & Drug Administration FDA,Guidance,Handling & Retention of Bioavailability BA & Bioequivalence BE Testing Samples,
1. April 2024,USA Food & Drug Administration FDA,Guidance,Animal Studies for Dental Bone Grafting - Premarket Notification (510(k)),
1. April 2024,World Health Organisation WHO,Technical brief,Artificial intelligence in sexual and reproductive health and rights,
1. April 2024,World Health Organisation WHO,Publication,Benefits & risks of using  AI for pharmaceutical development & delivery,
25. March 2024,CDSCO India,Circular,PSUR of Medical devices / IVD through MedicalÂ DevicesÂ Portal,
25. March 2024,European Commission,Press Release,Political agreement on European Health Data Space,
25. March 2024,European Commission,Press Release,EU AI Act: first regulation on artificial intelligence,
25. March 2024,European Commission,Posters,Prevention of non-communicable diseases,
25. March 2024,European Commission,Report,Prevention of non-communicable diseases,
25. March 2024,European Commission,Guidance,Deliverables of MDCG Subgroups â€“ March 2024,
25. March 2024,European Commission,Consultation,Benefit-risk assessment of phthalates in certain medical devices,
25. March 2024,European Medicines Agency,Guidance,Electronic submission of information on investigational products,
25. March 2024,European Medicines Agency,Meeting,Committee for Medicinal Products for Human UseÂ (CHMP) March 2024,
25. March 2024,InternationalÂ ElectrotechnicalÂ Commission,Standard,IEC 80601-2-78:2019+AMD1:2024 medical robots forâ€¦,
25. March 2024,InternationalÂ ElectrotechnicalÂ Commission,Standard,IEC 63412-1:2024 PRVÂ Ultrasonics - Shear-wave elastography,
25. March 2024,InternationalÂ ElectrotechnicalÂ Commission,Standard,IEC 80601-2-58:2024 lens removal and vitrectomy devices,
25. March 2024,InternationalÂ ElectrotechnicalÂ Commission,Standard,IEC 61674:2024 Dosimeters X-ray diagnostic imaging,
25. March 2024,South African Health Products Regulatory Authority,News,South African eCTD 3.0 Launch,
25. March 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medicines: reclassify your product,
25. March 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Advanced therapy medicinal products: regulation and licensing,
25. March 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Export drugs and medicines: special rules,
25. March 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device,
25. March 2024,"MEDSAFE, New Zealand",Consultation,Proposed updates to Pharmacovigilance Guidance,
25. March 2024,Italian Medicines Agency,Guidance,Ancillary medicinal substances incorporated in medical device,
25. March 2024,Swissmedic,Guidance,Application for license to grow cannabis for medical purposes,
25. March 2024,"Therapeutic Goods Administration (TGA), Australia",Consultation,Companion diagnostics guidance update,
25. March 2024,USA Food & Drug Administration FDA,Guidance,Controlled Correspondence Related to Generic Drug Development,
25. March 2024,USA Food & Drug Administration FDA,Guidance,"Manufacture of Batches in Support of NADAs, ANADAs, & CNADAs",
25. March 2024,USA Food & Drug Administration FDA,Guidance,Pharmacokinetics in Patients with Impaired Renal Function,
25. March 2024,USA Food & Drug Administration FDA,Guidance,Real-World Evidence: Non-Interventional Studies Drug & Biologics,
25. March 2024,USA Food & Drug Administration FDA,Update,Breakthrough Devices Program Metrics & Marketing Authorizations List,
25. March 2024,USA Food & Drug Administration FDA,Proposed Rule,Drug Products with Demonstrable Difficulties for Compounding,
25. March 2024,USA Food & Drug Administration FDA,Report,Division of Applied Regulatory Science Annual Report 2023,
25. March 2024,USA Food & Drug Administration FDA,Paper,Harnessing the Potential of Artificial Intelligence,
18. March 2024,ANVISA Brazil,Notice,Updates safety and performance requirements for medical devices,
18. March 2024,European Commission,Proposal,Better lifecycle management of medicine authorisation,
18. March 2024,European Commission,Guidance,MDCG 2024-3 - Clinical Investigation Plan for medical devices,
18. March 2024,European Commission,Survey,Notified Bodies Survey on certifications and applications (MDR/IVDR) Report:Member State Coordination Group on HTA (8 March 2024),
18. March 2024,European Commission,Factsheet,Steering innovation to address unmet medical needs,
18. March 2024,European Commission,Factsheet,Access to medicines in all Member States,
18. March 2024,European Medicines Agency,Guidance,Pharmacovigilance Risk Assessment Committee 4-7 March 2024,
18. March 2024,European Medicines Agency,Guidance,EudraVigilance support guide,
18. March 2024,European Medicines Agency,Guidance,Procedural advice for orphan medicinal product,
18. March 2024,European Medicines Agency,Guidance,Innovation Task Force (ITF) briefing meetings,
18. March 2024,International Medical Device Regulators Forum,Guidance,Adverse Event Terminology,
18. March 2024,Medicines and Healthcare products Regulatory Agency,Report,Equity in Medical Devices:Independent Review,
18. March 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Established Medicines marketing authorisation application changes,
18. March 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device,
18. March 2024,Medicines and Healthcare products Regulatory Agency,Guidance,British Pharmacopoeia Environmental sustainability,
18. March 2024,East Africa Regulatory Affairs Association (EARAPA),Announcement,PPB Kenya becomes Affilate member of MDSAP Program.,
18. March 2024,Swissmedic,Form,Quality defect report,
18. March 2024,Swissmedic,Guidance,Guidance Industry eCTD,
18. March 2024,Swissmedic,Guidance,Members list of Veterinary Medicines Expert Committees (VMEC),
18. March 2024,"Therapeutic Goods Administration (TGA), Australia",Notice,Referring to cosmetic injectables in advertising,
18. March 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Clinical trial notification (CTN) form - user guide,
18. March 2024,USA Food & Drug Administration FDA,Guidance,"Early Alzheimerâ€™s Disease: Developing Drugs for Treatment,",
18. March 2024,USA Food & Drug Administration FDA,Guidance,Select Updates for the Premarket Cybersecurity Guidance,
18. March 2024,USA Food & Drug Administration FDA,Guidance,"Reportable Labeling Changes for NDA, ANDA Nonprescription Drugs",
18. March 2024,USA Food & Drug Administration FDA,Guidance,Evaluation of Thermal Effects of Medical Devices,
18. March 2024,USA Food & Drug Administration FDA,Guidance,E2D(R1) Post-Approval Safety Data,
18. March 2024,USA Food & Drug Administration FDA,Guidance,The Q-Submission Program,
18. March 2024,USA Food & Drug Administration FDA,Proposed Rule,Labeling Requirements for New Animal Drugs,
18. March 2024,World Health Organisation WHO,Mobile App,Biosafety risk assessment,
11. March 2024,Egyptian Drug Authority,Declaration,Extension to complete the scientific files of veterinary preparations,
11. March 2024,European Commission,Consultation,EU Health Technology Assessment Regulation,
11. March 2024,European Commission,Guidance,Advice on the indirect antiglobulin tests on request from the MDCG,
11. March 2024,European Commission,Update,44 Notified Bodies EU MDR 2017/746 medical devices,
11. March 2024,European Commission,Update,12 Notified Bodies EU IVDR 2017/746 in vitro diagnostics,
11. March 2024,European Commission,Regulation,Harmonised standards for terminal sterilisation and packaging,
11. March 2024,European Medicines Agency,Guidance,Excipients in the labelling and package leaflet of medicinal products,
11. March 2024,"Health Products Regulatory Authority (HPRA)Â , Ireland",Newsletter,HPRA Medical Devices 29 February 2024,
11. March 2024,Medicines and Healthcare products Regulatory Agency,Guidance,"Medicines: packaging, labelling and patient information leaflets",
11. March 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Established Medicines marketing authorisation application changes,
11. March 2024,"Health Sciences Authority (HSA), Singapore",Guidance,13 Guidance documents for medical devices - March 2024,
11. March 2024,ISO (International Organization for Standardization),Standard,"ISO Update February 1, 2024 to March 1, 2024",
11. March 2024,Swissmedic,Report,Authorisations of complementary & herbal medicinal products in 2023,
11. March 2024,Swissmedic,Journal,Swissmedic Journal 02/2024,
11. March 2024,Swissmedic,Consultation,ICH Guideline E2D(R1) launched in Switzerland,
11. March 2024,Swissmedic,Guidance,Guidance document Time limits for authorization applications,
11. March 2024,Swissmedic,Guidance,Members list of Human Medicines Expert Committees (HMEC),
11. March 2024,"Therapeutic Goods Administration (TGA), Australia",Notice,Health Canada agreement on GMP inspections initiative,
11. March 2024,"Therapeutic Goods Administration (TGA), Australia",Notice,"Update to manufacturing principles for medicines, API & Sunscreens",
11. March 2024,"Therapeutic Goods Administration (TGA), Australia",Publication,PIC/S Guide to GMP for medicinal products â€“ version 16,
11. March 2024,"Therapeutic Goods Administration (TGA), Australia",Publication,Establishment of the Medicines Repurposing Program,
11. March 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Changes to the Permissible Ingredients Determination,
11. March 2024,"Therapeutic Goods Administration (TGA), Australia",Update,Update to listed medicine ingredients in March 2024,
11. March 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Advertising health services,
11. March 2024,USA Food & Drug Administration FDA,Guidance,"Understanding in Informed Consent Guidance for Sponsors,",
11. March 2024,USA Food & Drug Administration FDA,Guidance,Q14 Analytical Procedure Development,
11. March 2024,USA Food & Drug Administration FDA,Guidance,Q2(R2) Validation of Analytical Procedures,
11. March 2024,USA Food & Drug Administration FDA,Guidance,Augmented Reality and Virtual Reality Medical Devices,
11. March 2024,World Health Organisation WHO,Policy Brief,Medication without harm,
4. March 2024,ANVISA Brazil,Technical Note,The use of smartwatches for blood glucose measurement,
4. March 2024,CDSCO India,Guidance,Applications of PSURs MA of New Drugs SNDs FDCs Biologicals,
4. March 2024,Egyptian Drug Authority,Guidance,Management of variables for veterinary preparations,
4. March 2024,Egyptian Drug Authority,Draft Guidance,Naming of Human Pharmaceutical Products,
4. March 2024,Egyptian Drug Authority,Publication,Impact Analysis for Risk Based Lot Release for Biologics,
4. March 2024,Egyptian Drug Authority,Update,The MeDevice database,
4. March 2024,European Commission,Factsheet,Factsheet on EU actions on rare diseases,
4. March 2024,European Medicines Agency,Infographic,Orphan Medicines in the EU,
4. March 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Access Consortium,
4. March 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply for a licence to market a medicine in the UK,
4. March 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Established Medicines marketing authorisation application process,
4. March 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
4. March 2024,Medicines and Healthcare products Regulatory Agency,Report,Medicines and Medical Devices Act report 2024,
4. March 2024,Medicines and Healthcare products Regulatory Agency,Report,England Rare Diseases Action Plan 2024,
4. March 2024,National Institute of Standards and Technology (NIST),Guidance,Version 2.0 of Landmark Cybersecurity Framework,
4. March 2024,"Health Sciences Authority (HSA), Singapore",Regulation,Proposed Amendments to Regulation 23,
4. March 2024,"Health Sciences Authority (HSA), Singapore & Korea MFDS and Singapore HAS, Republic of Korea",News,Mutual Recognition Agreement on GMP for Medicinal Products,
4. March 2024,Swissmedic,Form,GMP/GCP/GVP/Medical Devices Inspections in Switzerland,
4. March 2024,Team NB,Position Paper,Classification of SARS CoV 2,
4. March 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Reformatting Product Information: Frequently asked questions,
4. March 2024,USA Food & Drug Administration FDA,Guidance,Reporting Amount of Listed Drugs and Biologics Conformance,
4. March 2024,USA Food & Drug Administration FDA,Guidance,Clinical Pharmacology Considerations for Antibody-Drug Conjugates,
4. March 2024,USA Food & Drug Administration FDA,Rule,"Animal Drugs; Approval,  Withdrawal, Change of Sponsor",
4. March 2024,USA Food & Drug Administration FDA,Report,LEADER 3D Public Report of External Engagement Analysis,
4. March 2024,USA Food & Drug Administration FDA,Update,Digital Diagnostics: Over-the-Counter (OTC) and Point-of-Care (POC),
4. March 2024,USA Food & Drug Administration FDA,Update,Harmonization & Interoperability Enhancement for Lab.Data (SHIELD),
26. February 2024,ACTIVE PHARMACEUTICAL INGREDIENTS COMMITTEE (APIC),Guidance,Quality Agreement Guideline & Template,
26. February 2024,CDSCO India,Guidance,Neutral Code for manufacturing of Medical Devices for export,
26. February 2024,Egyptian Drug Authority,Guidance,Post Market Quality Testing of Biotherapeutic Product in Egypt,
26. February 2024,European Commission,Press Release,Medical devices:  Council endorses new measures,
26. February 2024,European Commission,News,Possible second call for EU reference laboratories for high-risk IVD,
26. February 2024,European Medicines Agency,Meeting,(CHMP) Medicinal Products for Human UseÂ 19-22 February 2024,
26. February 2024,International Council for Harmonisation,Training Material,Bioanalytical Method Validation and Study Sample Analysisâ€,
26. February 2024,International Council for Harmonisation,Guidance,ICH Q3C(R9) Guideline reaches Step 4 of the ICH Process,
26. February 2024,International Council for Harmonisation,Guidance,ICH E2D(R1) draft Guideline reaches Step 2 of the ICH process,
26. February 2024,Medical Device Authority Malaysia,Guidance,Placement of HIV Self-test (HIVST) Kit un Malaysia Market,
26. February 2024,Medicines and Healthcare products Regulatory Agency,ATMP Guidance,Characterisation-Capsid Particle Population in rAAV Product,
26. February 2024,"MEDSAFE, New Zealand",Guidance,Submit an application for pseudoephedrine provisional consent,
26. February 2024,Swissmedic,Information Sheet,Medical Device Requirements for CAPA plans,
26. February 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,System or procedure packs,
26. February 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Medical device labelling obligations,
26. February 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Regulation of menstrual cups in Australia,
26. February 2024,"Therapeutic Goods Administration (TGA), Australia",Pilot Program,Pilot GMP Single Inspection Program,
26. February 2024,"Therapeutic Goods Administration (TGA), Australia",Checklist,Medical Devices Essential Principles Checklist,
26. February 2024,"TEAM AB, UK",Announcement,The formation of Team-AB,
26. February 2024,USA Food & Drug Administration FDA,Guidance,Select Updates for User Fee Small Business Qualification,
26. February 2024,USA Food & Drug Administration FDA,Guidance,Assessing COVID-19 in Outpatients in Clinical Trials of Drugs,
26. February 2024,USA Food & Drug Administration FDA,Letter to Industry,Fraudulent Unreliable Data in Premarket Submissions,
26. February 2024,USA Food & Drug Administration FDA,News,New Website - Clinical Pharmacology Pediatrics Program,
26. February 2024,USA Food & Drug Administration FDA,Report,Office of Generic Drugs 2023 Annual Report,
26. February 2024,USA Food & Drug Administration FDA,Update,Diagnostic Data Program,
19. February 2024,African Union Development Agency-NEPAD (AUDA-NEPAD)),News,2023 Edition on African Medicines Regulatory Harmonization (AMRH),
19. February 2024,European Commission,EUDAMED,All User guides and templates v2.14,
19. February 2024,European Medicines Agency,Catalogues,HMA-EMA real-world data sources and studies,
19. February 2024,CDSCO India,Guidance,sampling of drugs cosmetics and medical devices by Drugs Inspectors,
19. February 2024,International Medical Device Regulators Forum,Guiding Principles,To Support Medical Device Health Equity,
19. February 2024,International Medical Device Regulators Forum,Procedure,IMDRF Terms of Reference,
19. February 2024,Medicines and Healthcare products Regulatory Agency,Guidance,The Innovative Devices Access Pathway (IDAP),
19. February 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Implementation of medical devices future regime,
19. February 2024,Medicines and Healthcare products Regulatory Agency,Request,For regulators to publish an update on their strategic approach to AI,
19. February 2024,Swissmedic,Technical Interpretation,Shipment under Quarantine,
19. February 2024,USA Food & Drug Administration FDA,Guidance,Use of Data Monitoring Committees in Clinical Trials,
19. February 2024,USA Food & Drug Administration FDA,Guidance,Advanced Manufacturing Technologies Designation Program,
19. February 2024,USA Food & Drug Administration FDA,Guidance,Charging for Investigational Drugs Under an IND: Q&A,
19. February 2024,USA Food & Drug Administration FDA,Guidance,Product-Specific for Generic Drug Development,
19. February 2024,USA Food & Drug Administration FDA,SOPP 8419,Section 505(o)(4) Required Safety Labeling Changes,
19. February 2024,USA Food & Drug Administration FDA,Report,FDA Information Technology Operating Plan,
19. February 2024,USA Food & Drug Administration FDA,Report,FY23 Drug Safety Priorities Report,
19. February 2024,World Health Organisation WHO,List,Medically Important Antimicrobials List for Human Medicine,
12. February 2024,European Commission,Guidance,MDCG 2024-2 Procedures for the updates of the European Medical Device Nomenclature,
12. February 2024,European Commission,Survey,Notified Bodies on certifications and applications (MDR/IVDR) (Survey results with data status 31 October 2023),
12. February 2024,European Commission,Video,From Theory to Practice: Implementing the EU Health Technology Assessment Regulation,
12. February 2024,European Medicines Agency,Pilot Program,FDA & EMA Parallel Scientific Program for Complex Generics,
12. February 2024,European Medicines Agency,Pilot Program,Pharmacovigilance Risk Assessment Committee 5-8 February,
12. February 2024,Egyptian Drug Authority,Guidance,Conditions that must be met while submitting files to the Evaluation and Accreditation Department,
12. February 2024,Health Canada,Draft guidance,How to interpret â€˜significant changeâ€™ of a medical device,
12. February 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Register a homeopathic medicine,
12. February 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Regulating medical devices in the UK,
12. February 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Access New Active Substance and Biosimilar Work Sharing Guidance: Implementing the UKâ€™s AI regulatory principles,
12. February 2024,Medical Device Authority Malaysia,Subscription,MDA Regulatory Information Subscription (MDA-RIS),
12. February 2024,MedTech Europe,Joint Statement,Supporting Use of eIFU in the medical devices sector,
12. February 2024,Swissmedic,Journal,Swissmedic Journal,
12. February 2024,Swissmedic,Guidance,Industry Electronic exchange of ICSRs through PV Gateway,
12. February 2024,Swissmedic,News,swissdamed â€“ Swiss Database on Medical Devices,
12. February 2024,USA Food & Drug Administration FDA,Guidance,Conducting Remote Regulatory Assessments Q&A,
12. February 2024,USA Food & Drug Administration FDA,Guidance,Reporting Amount of Listed Drugs and Biological Products,
12. February 2024,USA Food & Drug Administration FDA,Final Rule,Biologics License Applications and Master Files,
12. February 2024,USA Food & Drug Administration FDA,Guidance,Notifying FDA of a Discontinuance or Interruption in Manufacturing of Finished Products or API Under Section 506C of the FD&C Act,
12. February 2024,USA Food & Drug Administration FDA,Report,Office of Digital Transformation Annual Report,
12. February 2024,USA Food & Drug Administration FDA,Report,Office of Clinical Pharmacology Annual Report,
12. February 2024,USA Food & Drug Administration FDA,Report,SOPP 8401.2: Administrative Processing of BLA and NDA Supplements,
5. February 2024,European Commission,MDCG Template,Device Specific Vigilance Guidance (DSVG),
5. February 2024,European Commission,MDCG Template,DSVG 01 Devices for Cardiac Ablation,
5. February 2024,European Commission,MDCG Template,DSVG 02 Coronary Stents and associated delivery systems,
5. February 2024,European Commission,MDCG Template,DSVG 03 Cardiac Implantable Electronic Devices (CIEDs),
5. February 2024,European Commission,MDCG Template,DSVG 04 Breast Implants,
5. February 2024,European Commission,EUDAMED,Playground 3.7.0 has been deployed.,
5. February 2024,European Medicines Agency,News,CTIS newsflash - 26 January 2024 (europa.eu),
5. February 2024,European Medicines Agency,News,One year left to transition to the new Clinical Trials Information System,
5. February 2024,European Medicines Agency,Guidance,ICH Q14 Analytical procedure development - Scientific guideline,
5. February 2024,European Medicines Agency,Guidance,Production API and Registration Process,
5. February 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies - GOV.UK (www.gov.uk),
5. February 2024,Medical Device Authority Malaysia,Guidance,GENERAL MEDICAL DEVICE â€“ GROUPING,
5. February 2024,Medical Device Authority Malaysia,Guidance,IMPORTATION OF MEDICAL DEVICE FOR PERSONAL USE,
5. February 2024,Medical Device Authority Malaysia,Guidance,POST MARKET INFORMATION EXCHANGE ASEAN STATES,
5. February 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Advertising personalised medical devices,
5. February 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,eCTD AU module 1 and regional information,
5. February 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Special Access Scheme (SAS) online system guidance,
5. February 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Authorised Prescriber Scheme online system guidance,
5. February 2024,"Health Sciences Authority (HSA), Singapore",Updates,reclassified medicines,
5. February 2024,International Medical Device Regulators Forum,Consultation,SaMD: Considerations for Device and Risk Characterization,
5. February 2024,Swissmedic,Guidance,Product information for human medicinal products,
5. February 2024,Swissmedic,Guidance,Variations and extensions HAM,
5. February 2024,USA Food & Drug Administration FDA,Final Rule,Quality Management System Regulation QMSR,
5. February 2024,USA Food & Drug Administration FDA,Guidance,Collection of Race and Ethnicity Data in Clinical Trials,
5. February 2024,USA Food & Drug Administration FDA,Guidance,Human Gene Therapy Products Incorporating Genome Editing,
5. February 2024,USA Food & Drug Administration FDA,Guidance,Development of Chimeric Antigen Receptor (CAR) T Cell Products,
5. February 2024,USA Food & Drug Administration FDA,Guidance,Postmarketing Safety Surveillance of Drug and Biological Products,
5. February 2024,USA Food & Drug Administration FDA,News,Reclassification Process for Most High Risk IVDs,
5. February 2024,World Health Organisation WHO,Report,Imagining futures of 3D bioprinting,
29. January 2024,European Commission,News,Proposal to extend transition periods for certain IVDs,
29. January 2024,European Medicines Agency,Guidance,Major update of the SME user guide,
29. January 2024,European Medicines Agency,Guidance,The clinical evaluation of anticancer medicinal products,
29. January 2024,European Medicines Agency,Report,Veterinary medicines: Highlights of 2023,
29. January 2024,European Medicines Agency,Meeting highlights,Committee for Medicinal Products for Human UseÂ (CHMP),
29. January 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Annual Reports,
29. January 2024,International Society for Pharmaceutical Engineering (ISPE),Guidance,Recombinant AAV Comparability & Lifecycle Management,
29. January 2024,International Society for Pharmaceutical Engineering (ISPE),Guidance,Allogeneic Cell Therapy,
29. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
29. January 2024,Global Fund,Guidance,Q&A Quality Assurance Policy for Pharmaceutical Products and  Medical Devices (including IVDand Core Personal Protective Equipment,
29. January 2024,International Accreditation Forum (IAF),Guidance,(IAF MDN) Including Medical Device Risk Classifications,
29. January 2024,Organisation for Economic Co-operation and Development,Publication,Collective action for responsible AI in health,
29. January 2024,USA Food & Drug Administration FDA,SOPP 8101.1,Regulatory Meetings for Drugs and Biological Products,
29. January 2024,USA Food & Drug Administration FDA,Guidance,Characterization of Metallic Coatings and/or Calcium Phosphate Coatings on Orthopedic Devices,
29. January 2024,USA Food & Drug Administration FDA,Guidance,Conducting Remote Regulatory Assessments Q&A,
29. January 2024,USA Food & Drug Administration FDA,Guidance,Revising ANDA Labeling Following Revision of the RLD Labeling Guidance for Industry: Guidance for Industry,
29. January 2024,USA Food & Drug Administration FDA,Guidance,ANDA Submissions â€“ Amendments and Requests for Final Approval to Tentatively Approved ANDAs: Guidance for Industry,
29. January 2024,USA Food & Drug Administration FDA,Guidance,CVM GFI #286 (VICH GL60) - Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Medicinal Products,
29. January 2024,USA Food & Drug Administration FDA,Best Practices,Postmarketing Safety Surveillance of Human Drug and Biological Products; Final Document; Availability,
29. January 2024,USA Food & Drug Administration FDA,Update,ASCA-Accredited Testing Laboratories,
29. January 2024,USA Food & Drug Administration FDA,News,FDA's ISTAND Pilot Program accepts submission of first artificial intelligence-based and digital health technology for neuroscience,
29. January 2024,USA Food & Drug Administration FDA,Website,For Healthcare Professionals | FDAâ€™s Examples of Drugs that Interact with CYP Enzymes and Transporter Systems,
22. January 2024,European Commission,Plan,Joint implementation and preparedness plan for Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR),
22. January 2024,European Commission,Data Act,Harmonised rules on fair access to and use of data ,
22. January 2024,European Commission,Guidance,Overview of language requirements for manufacturers of medical devices,
22. January 2024,European Medicines Agency,Report,Human medicines: highlights of 2023,
22. January 2024,European Medicines Agency,Report,Big Data Steering Group (BDSG): 2023 report,
22. January 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,"Reclassification of medical devices in direct contact with the heart, central circulatory and central nervous systems",
22. January 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Reclassification of medical devices that administer medicines or biologicals by inhalation,
22. January 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Reclassification of medical devices that are substances to be introduced into the body or applied to and absorbed by the skin,
22. January 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Reclassification of spinal implantable medical devices,
22. January 2024,"Therapeutic Goods Administration (TGA), Australia",Guidance,Reclassification of active medical devices with a diagnostic function,
22. January 2024,Egyptian Drug Authority,Guidance,Registration of Human Pharmaceutical Products,
22. January 2024,Egyptian Drug Authority,Draft Guidance,Examination of human use product files,
22. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Notify the MHRA about a clinical investigation for a medical device,
22. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Medical devices: UK approved bodies,
22. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply for a licence to market a medicine in the UK,
22. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,MHRA launches new fees calculator,
22. January 2024,USA Food & Drug Administration FDA,Important Info,Final Rule to Amend the Mammography Quality Standards Act,
22. January 2024,USA Food & Drug Administration FDA,Pilot Program,Accelerate Development of Rare Disease Therapies,
22. January 2024,USA Food & Drug Administration FDA,Report,CDRH 2023 Annual Report,
22. January 2024,USA Food & Drug Administration FDA,Deadline,Advancing Real-World Evidence Program submission deadline,
22. January 2024,USA Food & Drug Administration FDA,Statement,FDA and CMS: Accurate and Reliable Diagnostic Tests,
22. January 2024,Swissmedic,Guidance,Document Authorisation according to Art. 14 para. 1 abis-quater TPA,
22. January 2024,Swissmedic,Guidance,Author. of immuno. veterinary medicinal prod. epizootic outbreak,
22. January 2024,Swissmedic,Guidance,Authorisation of human medicinal products under Art. 13 TPA,
22. January 2024,Swissmedic,Guidance,Fast-track authorisation procedure,
22. January 2024,Swissmedic,Guidance,Temporary authorisation of human medicinal products,
22. January 2024,Swissmedic,Guidance,Authorisation of human medicinal product known API,
15. January 2024,European Commission,Guidelines,Medical imaging studies and reports,
15. January 2024,European Commission,Dashboard,Study supporting the monitoring of availability of medical devices,
15. January 2024,European Medicines Agency,Meeting,Pharmacovigilance Risk Assessment CommitteeÂ (PRAC),
15. January 2024,Egyptian Drug Authority,Guidelines,NuclearÂ and Radiation Safety and Nuclear Pharmacy Practice,
15. January 2024,Egyptian Drug Authority,Updates,"Requirements of centers, bioequivalence and solubility studies",
15. January 2024,Medicines and Healthcare products Regulatory Agency,Standard,Implementation of medical devices future regime,
15. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Exporting active UK substances for use in EEA and Northern Ireland,
15. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Borderline products: how to tell if your product is a medicine,
15. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Register medical devices to place on the market,
15. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Labelling and packaging-Windsor Framework,
15. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Export Medical Devices,
15. January 2024,USA Food & Drug Administration FDA,News,Vaporized Hydrogen Peroxide for Medical Device Sterilization,
15. January 2024,USA Food & Drug Administration FDA,News,New Drug Therapy Approvals 2023,
15. January 2024,USA Food & Drug Administration FDA,News,New Webpage for Searching Pharmaceutical Quality Documents,
15. January 2024,USA Food & Drug Administration FDA,Guidance,510(k) Submissions for Devices Labeled as Sterile,
15. January 2024,USA Food & Drug Administration FDA,Guidance,Q5A(R2) Viral Safety Evaluation of Biotechnology Products,
15. January 2024,USA Food & Drug Administration FDA,Guidance,Requests for Reconsideration at the Division Level Under GDUFA,
15. January 2024,USA Food & Drug Administration FDA,Forms,Tools for Cosmetic Product Facility Registration and Product Listing,
15. January 2024,USA Food & Drug Administration FDA,SOPP,Administrative Processing of Original Biologics License Applications Report: CTTI and FDA share strategies â€œCTTI Report 2024â€,
15. January 2024,USA Food & Drug Administration FDA,Report,Congressional Research Service â€“ FDA Regulation of Medical Devices,
15. January 2024,USA Food & Drug Administration FDA,Report,CDER Annual Report 2023,
15. January 2024,USA Food & Drug Administration FDA,QMSR News,Medical Devices; Quality System Regulation Amendments QMSR,
15. January 2024,ISO (International Organization for Standardization),Standard,"ISO Update December 1, 2023Â to January 1, 2024",
15. January 2024,Swissmedic,Guidance,Application licence for medicinal products or TpP/GT/GMO,
15. January 2024,Swissmedic,Guidance,Verzicht Betriebsbewilligung Arzneimittel (inkl. Blut) /TpP/GT/GVO,
15. January 2024,Swissmedic,Form,"Applications for, discontinuation of an establishment licence",
15. January 2024,Swissmedic,Announcement,Certification from the former notified body ECM (Aachen DE),
15. January 2024,Ministry of Health Sciences Authority Singapore,Fees,Regulatory fee revision for health products,
8. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Operational Information Sharing,
8. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply for a traditional herbal registration (THR),
8. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply for a variation to your marketing authorisation,
8. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Apply for a licence to market a medicine in the UK,
8. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,150-day assessment for national applications for,
8. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Register a homeopathic medicine,
8. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Unfettered Access Procedure for marketing authorisations approved in Northern Ireland,
8. January 2024,Medicines and Healthcare products Regulatory Agency,Guidance,Written Confirmations for export to EEA and Northern Ireland,
8. January 2024,Medicines and Healthcare products Regulatory Agency,News,International Recognition Procedure (IRP) goes live,
8. January 2024,Medicines and Healthcare products Regulatory Agency,News,The British Pharmacopoeia (BP) 2024 edition now legally effective,
8. January 2024,CDSCO India,News,Launching of National Single Window System (NSWS) Portal,
8. January 2024,USA Food & Drug Administration FDA,Letter to Industry,Medical Device Transition to Electronic Export Documents,
8. January 2024,USA Food & Drug Administration FDA,Update,ASCA-Accredited Testing Laboratories,
8. January 2024,Medical Device Authority Malaysia,Important Notice,Expiry of CAB Registration for Newera International,
8. January 2024,Swissmedic,Guidance,Swiss Single Registration Number â€“ CHRN,
8. January 2024,Swissmedic,Guidance,Export Certificates,
8. January 2024,Swissmedic,Guidance,Terms of Reference - Round Table on Medical Technology,
8. January 2024,Swissmedic,Guidance,Organisatiion Regulations: Organisationsreglement Swissmedic,
8. January 2024,Swissmedic,Directory,Overview of documents to be submitted,
8. January 2024,Swissmedic,Directory,List countries with comparable control of human medicinal products,
8. January 2024,Swissmedic,Guidance,Packaging for human medicinal products,
8. January 2024,Swissmedic,Form,New authorisation of human medicinal products,
8. January 2024,Swissmedic,Guidance,Guidance document Authorisation of Asian medicinal products),
8. January 2024,Swissmedic,Form,Import of a human medicinal product(parallel import),
8. January 2024,Swissmedic,Guidance,Import of a human medicinal product (parallel import),
8. January 2024,Saudi Food & Drug Authority,Guidance,Requirements for Clinical Trials of Medical Devices,
8. January 2024,Department of Health The Government of the Hong Kong,Technical Reference,Artificial Intelligence Medical Devices (AI-MD),
